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Abstract
Infection is  one of  the factors  that  may contribute to  non-healing of  chronic
wounds; the presence of antibiotic resistant bacteria serves to exacerbate the
problem due to limited treatment options. Bacteria utilise several mechanisms to
survive  exposure to  antibiotics,  including  synthesis  of  deactivating  enzymes,
target  modification  or  substitution,  changes  to  membrane  permeability,
upregulation of efflux pumps and the formation of a biofilm. Quorum sensing is
a density-dependent mechanism of bacterial cell to cell communication that can
be instrumental  in  co-ordinating  biofilm initiation.  Hyperbaric  oxygen therapy
(HBOT) is an option offered to some patients with chronic wounds, including
diabetic foot ulcers. Evidence suggests that HBOT can reduce the incidence of
major amputation in these patients. As well as the direct toxicity of increased
tissue oxygenation on anaerobic bacteria HBOT may also increase levels of
reactive oxygen and nitrogen species in the wound environment.  This study
aimed to investigate the effects of hyperoxia and oxidative damage on three
specific  mechanisms of  antibiotic  resistance:  the  activity  of  penicillinase,  an
antibiotic deactivating enzyme synthesised by bacteria; the activity of quorum
sensing signalling molecules (AHLs); and biofilms and their associated bacteria.
It also analysed the population dynamics of, primarily, bacteria in diabetic foot
ulcers  during  HBOT,  by  the  use  of  molecular  analysis  tools  such  as  PCR-
DGGE. The presence of fungal  species was investigated in wounds prior to
HBOT and in two wounds at two points during HBOT. This study found that
hydrogen peroxide, hypochlorous acid and peroxynitrite reduced the activity of
penicillinase in vitro. Hypochlorous acid reduced the activity of a range of AHLs
in vitro but not in vivo. Oxygen concentration did not have any impact on biofilm
mass, nor did it significantly affect the ability of an oxidant-generating enzyme to
reduce live bacterial cells within a biofilm. The population dynamics of bacterial
species  identified  in  all  the  wounds  were  complex  and  did  not  undergo
identifiable changes during HBOT. Fungal species were identified in all wounds
prior  to  HBOT,  though  different  profiles  were  observed  in  the  two  wounds
investigated during HBOT. These results suggest that oxidants could play a role
in the attenuation of antibiotic resistance in chronic wound bacteria. It is unclear
whether HBOT alters the population dynamics of non-healing wound microflora.
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Chapter 1
Introduction
1.1. Introduction
Antibiotic resistance has become a regular feature of news reports. Government
targets to reduce the incidence of methicillin-resistant  Staphylococcus aureus
(MRSA)  in  our  hospitals  are  not  just  constructed  to  quell  public  fears;
nosocomial infections also carry a high financial burden. Antibiotic resistance is
not restricted to Staphylococcus aureus (S. aureus), other organisms of clinical
relevance include Enterococcus faecium (E. faecium), Escherichia coli (E. coli),
Pseudomonas aeruginosa  (P. aeruginosa),  and several  Acinetobacter species
(Arias & Murray, 2009). To illustrate the extent of this problem, in 2006, 25-50%
of S. aureus isolates were found to be resistant to oxacillin in much of Europe,
and in  Britain,  10-25% of  E. faecium isolates were found to  be vancomycin
resistant (Gould, 2008).
Bacteria utilize several mechanisms to resist antibiotics, an arsenal that is now
considered  to  include  living  within  a  biofilm.  A biofilm  is  a  heterogeneous
community of organisms within a matrix of extracellular polymeric substances
(EPS). Biofilm bacteria have been shown to be more resistant to antibiotics than
their  planktonic  counterparts,  a  problem  which  is  now  recognised  in  many
clinical areas. Recalcitrant infections associated with medical implants (e.g. hip
prostheses  and cardiac  pacemakers),  urinary catheters,  endotracheal  tubes,
and some chronic conditions (e.g. otitis media, sinusitis and chronic wounds)
are all thought to involve biofilms (Costerton et al. 2003). At present, the failure
of antibiotic therapy to resolve infection may result in removal of the prosthesis
(Fernandes and Dias. 2013) or, in the case of diabetic chronic wounds, limb
amputation (Ramsey et al. 1999).
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A consensus on the exact definition of chronic wounds is still to be determined,
but it has been suggested that they are wounds that have not healed within 3
months (Werdin  et al.  2009) and include venous, pressure and diabetic foot
ulcers  (DFU).  Many  factors  contribute  to  non-healing:  hypoxia;  ischemia;
underlying pathology (e.g. diabetes) and the presence of infection (Demidova-
Rice  et  al.  2012).  A therapeutic  option  for  some patients  is  the  delivery  of
hyperbaric oxygen (HBO); the inhalation of 100% oxygen at a pressure greater
than  that  at  sea  level.  The  clinical  benefits  of  HBO  include  increased
angiogenesis, increased fibroblast proliferation, facilitated phagocytic response
and direct killing of obligate anaerobes (Mader  et al. 1987). Though HBO has
been shown to enhance the effects of some antibiotics (Bornside, 1967), it is so
far unknown whether it can modify, either positively or negatively, mechanisms
of antibiotic resistance.
1.2. Antibiotic resistance 
Antibiotics are compounds that are either bacteriocidal or bacteriostatic and are
produced naturally by microorganisms, though it is common practice also to use
this name for synthesised chemotherapeutic agents, and semi-synthetic agents
(modified natural compounds). The main mechanisms of action against bacteria
(Table  1.1) are  inhibition  of  cell  wall  synthesis;  disruption  of  membrane
structure; inhibition of nucleic acid synthesis; and inhibition of protein synthesis
(Neal, 1997, Page, 1997).
An intrinsic ability to resist antibiotics, released into their immediate environment
by co-habitants, has been an evolutionary process for bacteria, necessary for
their  survival.  However,  the  extensive  use  of  antibiotics  in  medicine  and
agriculture,  coupled  with  the  acquisition  of  genes  carrying  resistance,  has
resulted in strains that are resistant to multiple drugs, reducing the therapeutic
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arsenal at the disposal of clinicians (Davies and Davies. 2010). Bacteria may
use several  mechanisms to  resist  antibiotics;  the production of  de-activating
enzymes,  target  modification/substitution,  altered  membrane  permeability,
induction of efflux pumps and biofilm lifestyle (Section 1.4). The phenomenon of
persister  cells,  cells  that  are  neither  inhibited  nor  killed  by  bactericidal
concentrations  of  antibiotics,  will  be  discussed  in  the  section  on  biofilms
(Section1.4).
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Table 1.1. Antibiotic modes of action (Neal, 1997, Page, 1997).
Mode of Action Antibiotic Group Examples
Inhibition of cell wall synthesis 
(a) Prevention of cross linking between peptidoglycan 
chains
(b) Prevention of elongation of peptidoglycan backbone
Penicillins
Cephalosporins
Carbapenems
Monobactams
Glycopeptides
Amoxicillin
Cefuroxime
Imipenem
Aztreonum
Vancomycin
Disruption of membrane structure
Selectivity towards lipopolysaccharide of outer membrane Polymixins Polymixin B
Inhibition of nucleic acid synthesis
(a) Inhibition of DNA gyrase
(b) Inhibition of dihdropteroate synthetase
(c) Inhibition of dihydrofolate reductase
(d) Inhibition of DNA supercoiling
(e) Inhibition of DNA-dependent RNA polymerase
Quinolones
Sulphonamides
Nitroimidazoles
Rifamycins
Levofloxacin
Sulphadiazine
Trimethoprim
Metronidazole
Rifampin
Inhibition of protein synthesis
(a) Blocks the binding of transfer RNA to messenger RNA-
ribosome complex
(b) Incorrect reading of messenger RNA
(c) Inhibition of ribosome translocation
(d) Inhibition of transpeptidation
Tetracyclines
Aminoglycosides
Macrolides
Tetracycline
Gentamycin
Erythromycin
1.2.1. De-activating enzymes
De-activating  enzymes  can  act  in  one  of  three  ways,  catalysing  hydrolysis,
group transfer and redox processes. The classic example of hydrolytic enzymes
is the β-lactamase family of enzymes, found in both Gram-positive and Gram-
negative bacteria, which catalyse the cleavage of the β-lactam ring, a common
structural  feature  of  penicillins,  cephalosporins,  carbapenems  and
29
monobactams (Fig. 1.1). The classification and nomenclature of β-lactamases
have undergone various forms; the simplest is that based on sequence (Ambler,
1980) and consists of four classes, A, B, C and D. Class A includes extended
spectrum β-lactamases (ESBLs), globally widespread enzymes that are able to
hydrolyse a wider spectrum of drugs, due to amino acid mutations. A second
classification  system,  based  on  function  (Bush et  al. 1995)  organises  the
enzymes according to substrate and susceptibility to inhibition with drugs such
as clavulanic acid, a serine β-lactamase inhibitor (Table 1.2).
 
Figure 1.1.  Chemical structure of a penicillin-type antibiotic. The arrow indicates the β-lactam
ring.
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 Table 1.2. Interrelatedness between two β-lactamase classification systems.
Adapted from Table1, page 10 (Helfand & Bonomo, 2003).
Ambler (sequence) Bush (function)
Class A – serine β-lactamases
penicillinases and ESBLs
Group  2a,  2b,  2be,  2br,  2c,  2e   penicillinases;
clavulanic acid susceptible
Class B – metallo-β-lactamases Group 3a, 3b, 3c - metallo- β-lactamases
Class C – serine β-lactamases
cephalosporinases
Group 1 – cephalosporinases
clavulanic acid resistant
Class D – serine β-lactamases
oxacillinases
Group 2f- oxacillinases
Group 4 – miscellaneous
The mode of action of β-lactamases depends on the constituents at the active
site. Classes A, C and D enzymes utilize a serine ester at the active site which
disrupts the β-lactam ring at the amide bond to form a covalent acyl enzyme
complex, which catalyses the hydrolysis of the ring liberating the active enzyme
and the inactivated drug (Matagne et al. 1998). Class B enzymes are known as
metallo-enzymes and utilize divalent cations (usually zinc) at the active site (de
Seny et al. 2001). These enzymes catalyse the cleavage of the amide bond of
the β-lactam ring (Bounaga et al. 1998).
Resistance to the macrolide erythromycin can also include hydrolysis; this has
been observed in E. coli (Arthur et al. 1987) and Pseudomonas sp. GD100 (Kim
et al. 2002); an esterase is synthesized which catalyses the hydrolysis of the β-
lactam ring of the antibiotic. Antibiotics that lack a hydrolytically vulnerable ring
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can still  be inactivated by covalent group transfer,  such as that observed in
resistance to chloramphenicol. Acetyl-CoA is necessary for this process, acting
as donor of an acetyl group to the primary hydroxyl of chloramphenicol, via the
action of chloramphenicol acetyltransferase (Leslie et al. 1988).
 Group  transfer  is  also  involved  in  the  ability  of  organisms  such  as  P.
aeruginosa  and  Mycobacterium  tuberculosis to  resist  aminoglycosides
(gentamycin,  kanamycin,  streptomycin).  The  transfer  of  functional  groups,
resulting in loss of inhibition of protein synthesis; is facilitated by a diverse group
of  enzymes  which  constitute  three  main  families,  aminoglycoside
phosphotransferases  (Doi et  al. 1968),  aminoglycoside  acetyltransferases
(Brzezinska et al. 1972), and aminoglycoside adenyltransferases (Angelatou et
al. 1982). The modified aminoglycosides have reduced affinity for their binding
target, bacterial RNA.
Tetracycline is an inhibitor of bacterial protein synthesis; resistance is usually
achieved by ribosomal protection and efflux of the antibiotic from the bacterial
cell,  processes  facilitated  by  the  tet  family  of  genes,  widely  distributed
throughout  Gram-positive  and  Gram-negative  bacteria  (Chopra  &  Roberts,
2001).  However,  tetX,  found  on  two  transposons  isolated  from  Bacteroides
fragilis codes for a product that is involved in cellular redox processes. TetX is
an oxygen requiring, flavin-dependent monooxygenase, shown to hydroxylate
tetracycline rendering the antibiotic unstable (Yang et al. 2004). Though not yet
identified in  any clinically resistant  bacterial  strains,  of  cause for  concern  is
destabilization of tigecycline, a new generation tetracycline that is unaffected by
other resistance mechanisms (Moore et al. 2005).
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1.2.2. Target modification or substitution
Several mechanisms of target modification have been identified which reduce
susceptibility to antibiotic drugs yet appear to maintain sufficient cell function.
One such modification is the methylation of an adenine residue in the bacterial
23S rRNA. The methylase is encoded by inducible erm genes, and is thought to
initiate a conformational change in the ribosome which results in resistance to
erythromycin (Lai & Weisblum, 1971).
Type II bacterial topoisomerases, which include DNA gyrase and topoisomerase
IV, are necessary for DNA replication in bacteria, and are targets of quinolone
(nalidixic  acid  and  ciprofloxacin)  and  coumarin  (novobiocin)  antibiotics.
Mutations to the gyr and grl  genes which code for DNA gyrase subunits GyrA
and GyrB,  and topoisomerase IV subunits  GrlA and GrlB respectively,  have
been  found  to  lead  to  resistance  to  these  drugs,  with  limited  fitness  costs
(Vickers et al. 2007).
Dihydrofolate  reductase  (DHFR)  is  an  essential  component  in  purine  and
pyrimidine  biosynthesis  and  is  inhibited  by  the  antibiotic  trimethoprim.
Resistance  to  this  drug  in  S.  aureus  is  conferred  by  a  single  amino  acid
substitution in DHFR (Dale et al. 1997); decreased trimethoprim binding occurs
though binding of enzyme substrates do not differ significantly between wild-
type and mutant DHFR, suggesting again that fitness costs to the bacterium are
minimal (Vickers et al. 2009).
Inhibition  of  bacterial  cell  wall  synthesis  is  a  function  of  a  broad  range  of
antibiotics,  including  the  penicillins,  cephalosporins  and  glycopeptides;  two
resistance mechanisms come into play here, structural changes to the target
and  the  synthesis  of  a  new  protein  with  the  same  function  but  which  is
unrecognizable  to  the  antibiotic.  A  structural  change  to  the  peptidoglycan
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molecule results in a 1000-fold reduction in binding efficiency of vancomycin
(Bugg et  al. 1991).  This  drug  normally  binds  to  the  C-terminus  of  the
peptidoglycan  precursor  containing  an  acyl-D-alanyl-D-alanine,  however,  in
resistant bacteria this terminus is substituted with either D-alanyl-D-lactate or D-
alanyl-D-serine (Walsh et al. 1996), with no reduction in the efficiency of cross-
linking between peptidoglycan polymer chains.
Amino acid  changes in penicillin-binding proteins (PBPs) can result  in lower
drug binding affinities (Nagai et al. 2002) and confer resistance to several β-
lactam  antibiotics.  However,  of  greater  concern  is  a  second  resistance
mechanism, the inducible synthesis of a novel PBP (PBP2a, encoded by mecA,
a  gene  acquired  via  a  mobile  genetic  element)  which  is  responsible  for
resistance in MRSA (Ubukata et al. 1989). Despite carrying the fitness cost of
having to activate supplementary genes MRSA continues to be a substantial
clinical problem.
1.2.3. Altered membrane permeability
The outer membrane of Gram-negative bacteria provides a selective barrier to
molecules,  including  antibiotics,  conferring  an  intrinsic  resistance.  However,
some drugs, including β-lactams, can enter the bacterium through non-specific
porins, membrane-bound protein channels. Substitutions at strategic positions
within the structure of a porin has been found to reduce conductance, lowering
the permeability of the outer membrane to β-lactam antibiotics (De et al. 2001);
porin-deficient phenotypes of  Enterobacter spp. are associated with resistant
strains (Charrel et al. 1996).
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1.2.4. Induction of efflux pumps
Working synergistically with selective membrane permeability are efflux pumps,
maintaining a high level  of  intrinsic antibiotic resistance by actively pumping
drugs out of the organism. Several types of pump have now been identified in
Gram-negative  and  Gram-positive  bacteria  (Piddock,  2006),  and  may  be
specific  or  broad-ranging  in  their  substrates.  However,  resistance  can  be
increased  due  to  over  expression  of  the  pumps;  higher  minimum inhibitory
concentrations  (MICs)  of  antibiotics  for  post-therapy  P.  aeruginosa  clinical
isolates than pre-therapy isolates are associated with the over expression of
OprM, a protein component of a multidrug efflux pump (Ziha-Zarifi et al. 1999).
The efflux pump structure in this organism is encoded by an operon consisting
of  mexA-mexB-OprM  and the multi-drug resistant (MDR) mutant OCR1 over
expresses  this  operon.  Evidence  indicates  that  this  may be  due  to  a  point
mutation in the regulator gene mexR (Poole et al. 1996), whose normal function
is to repress the operon. OCR1 exhibits increased antibiotic resistance.
The clinical importance of efflux pump over expression is a cause for concern; it
has been estimated that up to 46% of P. aeruginosa isolates are MexA-MexB-
OprM  overproducing  strains  (Hocquet et  al. 2007).  Coupled  with  regulated
membrane permeability control and enzymatic degradation of β-lactams, these
strains carry a high level of multiple drug resistance.
1.3. Chronic wounds
The financial, physical and emotional consequences of non-healing wounds are
considerable;  despite  many months,  or  even years,  of  treatment  aggressive
surgical debridement or amputation of a limb is a common outcome (Ramsey et
al. 1999) Normal healing is a complex and dynamic process that usually follows
three phases; inflammation, proliferation and remodelling (Table 1.3.). 
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Table. 1.3. The stages of normal wound healing (Broughton et al, 2006).
Stage Process Events
Inflammation Haemostasis Clotting cascade
Initiation  of
inflammation
Platelets  release  pro-inflammatory  mediators,
vasoconstriction  is  followed  by  vasodilation  and  increased
blood vessel porosity
Removal  of
bacteria  and
debris
Neutrophils  and macrophages phagocytose bacteria,  debris
and  damaged  tissue.  Macrophages  release  factors  that
stimulate  angiogenesis  and  cells  that  reepithelialise  the
wound
Decline  in
inflammation
Levels of pro-inflammatory mediators falls
Proliferation New tissue 
formation
Angiogenesis
Entry of fibroblasts for production of collagen and 
extracellular matrix
Formation of granulation tissue. Epithelialization.
Contraction and wound closure
Remodelling Maturation Type III collagen replaced by stronger type I. Collagen fibres
realigned and cross-linked
Any factor that disrupts or prolongs the processes outlined in Table 1.3 may
result in a chronic wound. Most chronic wounds fall into one of three categories:
venous leg ulcers, pressure ulcers and diabetic foot ulcers (Mustoe et al. 2006).
There  are  thought  to  be  many  potential  contributors  to  non-healing,  e.g.
hypoxia,  ischaemia,  underlying  pathology  and  the  presence  of  infection
(Demidova-Rice et al. 2012).
Hypoxia occurs when oxygen delivery is less than that necessary for normal
tissue function (Sen, 2009).  A particular problem for chronic wounds is their
increased demand for  oxygen:  (i)  healing tissue has a high demand for the
cellular fuel adenosine triphosphate (ATP) (Im & Hoopes, 1970), (ii) molecular
oxygen is necessary for the hydroxylation of pro-collagen peptides (Kivirikko et
al. 1989), a required step for collagen deposition, and (iii) oxygen is a substrate
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for  NADPH oxidase during the respiratory burst  of  neutrophils.  Hypoxia  has
been shown to reduce neutrophil bactericidal effects (Allen et al. 1997).
The effect of oxygen concentration on angiogenesis is complex and the exact
molecular mechanisms involved are still not fully explained. On the one hand
hypoxia is known to stimulate the production of hypoxia-inducible factor (HIF-1)
which binds to hypoxia-inducible genes,  resulting in the transcription of  pro-
angiogenic growth factors, including vascular endothelial growth factor (VEGF),
a key regulator of angiogenesis (Karamysheva, 2008). However, the ability of
hyperoxia to increase levels of VEGF in wounds has also been demonstrated
(Sheikh et  al. 2000)  and  the  supposition  that  this  leads  to  angiogenesis  is
supported  in  a  study  involving  a  murine  wound  model  (Hopf et  al. 2005);
angiogenesis was significantly lower in mice breathing 21% oxygen compared
to those breathing 100% oxygen. It is accepted clinically that hypoxic wounds
form granulation tissue1 poorly; fibroblasts, the cells that form the basis of this
tissue,  require  oxygen to  function effectively and vascularization of  tissue is
essential for this process, so despite stimulation of VEGF production in hypoxic
wounds, and the fact that hypoxia indirectly stimulates increased expression of
VEGF receptors on endothelial cells (Takagi et al. 1996), neovascularization is
still impaired.
Considering the role of oxygen in the formation of collagen and the requirement
for  collagen  for  the  structural  integrity  of  new  blood  vessels  it  has  been
proposed  that  this  is  the  key  reason  for  increased  angiogenesis  in  well
oxygenated wounds (Hopf  et  al.  2005).  Hopf  suggests  that  reactive  oxygen
species (ROS) may also have a role to play in the initiation of angiogenesis;
1 Perfused fibrous connective tissue.
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hydrogen peroxide stimulates  VEGF production  and collagen synthesis,  and
ROS production in immune cells is oxygen dependent. The significance of ROS
as beneficial cellular signalling molecules, at low concentrations, is now fairly
well accepted (Miki and Funato, 2012). It seems that hypoxia in normal, healthy
tissue results in cellular and tissue responses that can maintain function if the
hypoxic episode is transient and/or not too severe. The situation in damaged
tissue is very different due to the inherent higher demand for oxygen to facilitate
tissue healing.
Ischaemia is defined as a reduction in blood perfusion to tissue and it has been
estimated  that  at  least  80%  of  patients  with  diabetic  foot  syndrome2 have
peripheral  arterial  disease (Weck  et  al.  2011).  Reduced perfusion  results  in
hypoxic tissue, with all the associated problems outlined previously. However,
concurrent to this is a reduction in the delivery of nutrients, immune cells and
specific molecules that are necessary for wound healing.
Underlying pathology can have an enormous impact on both the type of wound
that develops and the state of healing. For diabetic patients non-healing foot
ulcers  may  be  initiated  and  exacerbated  by  several  disease  conditions,
including peripheral neuropathy, peripheral oedema, vascular dysfunction and
foot deformities. It is beyond the scope of this chapter to elucidate the many
pathological  processes associated  with  diabetes,  however  three biochemical
mechanisms in particular are thought to be involved in generating the above
diabetic complications; the formation of advanced glycation end products3 (Goh
& Cooper, 2008), oxidative damage (Brownlee, 2005) and impaired leukocyte
2 An umbrella term for diabetic patients that have evidence of several pathologies associated with their 
feet.
3 Advanced glycation end products (AGEs) are formed following interactions between sugars and 
proteins, lipids or nucleic acids.
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function (Delamaire et al. 1997). The common ground of diabetic pathology, and
other chronic wound related pathologies, is that of reduced tissue oxygenation,
either due to micro or macrovascular disease (Jeffcoate & Harding, 2003).
1.3.1. Infected chronic wounds
Though  no  wound  is  sterile,  the  presence  of  clinical  infection  has  been
determined to  be a contributory factor  to  non-healing (Gjodsbol et  al. 2006,
Robson & Heggers, 1969). Wounds containing bacterial population growth to
105 colony forming unit (CFU) ml-1 of fluid/tissue (105 rule) are considered to be
particularly susceptible to non-healing (Bowler, 2003).
The microflora of  chronic  wounds has been extensively studied,  though the
choice  of  sampling  techniques  and  analysis  tools  determine  the  range  of
bacteria  found.  Commonly  used  techniques  include  swabs,  tissue  biopsy,
curettage  and  fine-needle  aspiration.  Debate  continues  over  the  benefits  of
taking tissue biopsies rather than swabs; it is argued that swabs do not reflect
species that invade deeper tissue (Stephens et al. 2003), and biopsies may be
considered  to  be  too  localized  and  not  representative  of  the  whole  wound
(Bowler, 2003). As in other environmental niches, bacterial species in chronic
wounds do not exist in isolation; synergistic or antagonistic relationships result
in complex communities, demonstrating temporal adaptations.
For  many  years  the  identification  of  wound  microflora  has  depended  on
standard culture techniques in hospital laboratories; samples are incubated on
agar or in liquid medium for 16 to 48 hours (or for up to five days if clinically
indicated),  and  are  usually  identified  to  species  level  by  following  various
protocols which may include (i) isolation media, (ii) Gram stains, (iii) oxidase
test,  (iv)  catalase  test  and  (v)  coagulase  test  (Agency  2007).  Antibiotic
sensitivities are given for prominent identified species. The main drawback of
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this  method  is  the  inability  to  identify  viable  but  non-culturable  (VBNC)
organisms and those with fastidious growth requirements. Anaerobic bacteria
may be a group particularly under-represented (Bowler and Davies, 1999). A
more realistic picture of wound microorganism diversity has been achieved with
the use of molecular techniques; the polymerase chain reaction (PCR) followed
by gel electrophoresis e.g. denaturing gradient gel electrophoresis (DGGE) and
usually sequencing. A study examining the microbial diversity of chronic wounds
compared  results  from  routine  culture  methods  and  PCR,  followed  by
sequencing.  Of  18  microorganisms  detected  by  sequencing  only  5  were
detected  by  routine  culture  (Frank et  al. 2009).  Another  study  using  high-
throughput pyrosequencing identified an average of 17 bacterial genera in each
sample compared to three species identified by standard culture (Han  et al.
2011). Molecular analysis requires careful consideration of the choice of primer
sets to reduce bias, but can also present evidence of novel bacteria in wounds
(Hill et al. 2003, this study, Chapter 3).
This  leads  us  back  to  the  role  of  individual  species  in  the  pathogenicity  of
wound infection. The 105   rule is often deemed to be too simplistic a guideline,
particularly  in  relation  to  the  synergistic  interaction  between  aerobes  and
anaerobes.  For  example,  aerobes  may  consume  oxygen  in  a  localized
environment facilitating the survival of anaerobes. In a guinea pig wound model
a challenge inoculation of E. coli at 9 × 105 CFU ml-1 did not interfere with wound
healing;  a  separate  challenge  with  Bacteroides  fragilis (B.  fragilis)  at
9.3 × 105 CFU ml-1  also  did  not  affect  healing,  however  when  a  challenge
consisting of equal amounts of each organism (total 9.2  × 105 CFU ml-1) was
used the wounds became inflamed and exuded pus (Kelly, 1980). Despite the
overall  bacterial  load  remaining  the  same  the  interaction  between  the  two
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species had a detrimental effect on the wounds. A more recent study (Pastar et
al. 2013) demonstrated that a wound model inoculated with both S. aureus and
P. aeruginosa incurred delayed healing compared to single species inoculation,
and  that  this  was  due  to  the  induction  of  virulence  factors  in  S. aureus  by
P. aeruginosa.
The above examples indicated that just two species of bacteria were sufficient
to delay healing in a wound, but is this specific to these particular organisms or
does the  species  diversity  determine the  outcome in  a  wider  context?  In  a
clinical study involving chronic leg ulcers the presence of four or more bacterial
groups resulted in a failure to heal of 42%, a significantly higher rate than for
wounds containing less than four bacterial groups (Trengove et al. 1996). The
authors did not see any correlations between individual groups and failure to
heal,  though  it  is  not  clear  how  they  determined  this  as  the  analysis  was
qualitative and did not explore quantitatively whether a particular species was
more abundant in a particular wound, just that a bacterial group was present.
Unfortunately, some groups were too broadly defined; anaerobes, for example,
were categorized as one group. However, the study did determine that there
were  temporal  changes  in  the  bacterial  community  composition  (median
number of swabs taken per patient was 9 over a 6 month period); in 82% of
patients at least one new group was identified in subsequent swabs.
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1.3.2. Prevalent bacteria found in chronic wounds
Several studies have examined the bacterial diversity of chronic wounds, using
cultural and molecular methods, and the list of organisms found often reflects
the  type  of  wound,  i.e.  venous,  diabetic  or  pressure  ulcer;  however  some
commonalities do occur (Table 1.4). S. aureus is a notable inclusion in most of
the  studies  and  was  identified  as  the  most  prevalent  organism  in  diabetic
chronic wounds when three different molecular methods were compared (Dowd
et al. 2008). However, a causal relationship between presence of a species and
non-healing cannot be assumed. It does not necessarily follow that because an
organism is prevalent in chronic wounds it is the reason that they do not heal; it
may  be  thriving  in  an  ideal  growth  environment  but  have  no  significant
pathological role.
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Table 1.4.  Most prevalent organisms found in chronic wounds. DFU, diabetic foot ulcer; CVU,
chronic venous ulcer; PU, pressure ulcer; C, culture; M, molecular analysis; N/S, not specified.
Study Aerobe Anaerobe Type Method
Goldstein et al. 
1996
S. aureus Individual  species  not
specified
DFU C
Chincholikar & 
Pal, 2002
S. aureus
P. aeruginosa
Bacteroides melaninogenicus
Bacteroides fragilis
DFU C
Raja, 2007 S. aureus DFU C
Gerding, 1995 Peptostreptococcus sp.
Bacteroides sp.
DFU C
Abdulrazak et al. 
2005
S. aureus
P. aeruginosa
Bacteroides fragilis DFU C
Gjødsbøl et al. 
2006
S. aureus Individual  species  not
specified
CVU C
Citron et al. 2007 S. aureus Gram positive cocci DFU C
Ng et al. 2008 Peptostreptococcus sp. DFU C
Dowd et al. 2008 Stenotrophomonas sp.
S. aureus
Corynebacterium sp.
Enterobacter sp.
Peptoniphilus sp.
Peptoniphilus sp.
CVU
DFU
PU
M
M
M
Frank et al. 2009 S. aureus E. faecalis N/S M
Daltrey et al. 
1981
S. aureus Bacteroides fragilis PU C
The pathological role of P. aeruginosa in chronic wounds is still to be resolved; a
study using peptide nucleic acid (PNA) and fluorescence in-situ hybridization
(FISH) on wound biopsy tissue found that of the samples containing large
bacterial  aggregates,  approximately  70%  of  them  contained  P.  aeruginosa,
compared to only 15% containing  S. aureus (Kirketerp-Moller et al. 2008). An
accurate  interpretation  of  this  data  is  problematic  as  the  analysis  of  the
microscopy was not statistically quantitated. Again the variability of sampling
techniques could be of relevance here;  P. aeruginosa may be associated with
43
deep wound tissue rather than superficially on the wound surface. If swabs are
used they may not collect organisms embedded deeper in the tissue. A study
using cultural techniques identified  S. aureus  in 93.5% of chronic leg ulcers,
71.7% contained  E.  faecalis,  and  52.2% contained  P. aeruginosa.  However,
further interpretation of this work regarding wound demography is difficult  as
even though samples were taken in the form of swabs and biopsies, the origin
of the material in relation to the results was not presented.
A study comparing the microbial diversity of infected and non-infected wounds,
determined by the presence of clinical  signs (exudate, malodour,  erythema4)
found that all wounds were colonized by aerobic bacteria, the most prevalent in
both types of wound being S. aureus, whereas P. aeruginosa had low isolation
rates; 82% of infected wounds contained anaerobes compared to 73% of non-
infected (Bowler and Davies, 1999). The mean number of anaerobes in infected
wounds was significantly higher than the mean number in non-infected wounds
(Bowler and Davies, 1999), the most prevalent being  Peptostreptococcus  sp.
(now known as GPAC, Gram-positive anaerobic cocci) and Prevotella  sp. The
isolation of these two anaerobes has been duplicated by several studies (Wall
et al., 2002). Another interesting finding of this study is that two Candida spp.
(Candida albicans and Candida parapsilosis) were isolated in infected wounds,
but were not isolated in non-infected wounds.
The complex nature of the interaction between a microorganism and its host
needs to be considered when examining how a particular bacterial species may
delay wound healing. Returning to  P. aeruginosa, a small study of ten chronic
venous leg ulcers found that the two patients with ulcers that rapidly enlarged,
compared to the other wounds, had positive antibody titres against exotoxin A
4 Redness of the skin.
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antibody (Danielsen et al. 1996); the remaining eight patients tested negative.
These two patients were colonized with the same strain of P. aeruginosa,  a
strain not isolated in the other patients. This study supports earlier work that
demonstrated  delayed  closure,  in  a  rat  wound  model,  when  wounds  were
treated topically with exotoxin A; the application of antiexotoxin to these wounds
healed at the same rate as the controls (Heggers et al. 1992).
A temporal component may also be of importance; a study monitoring bacterial
community changes in chronic venous leg ulcers over 8 weeks defined resident
bacteria  as  those  bacteria  that  were  isolated  at  all  swabbing  events  and
observed significantly larger wounds in those that had resident  P. aeruginosa
(Gjodsbol et al. 2006). Bacteria secrete many virulence factors and it is beyond
the scope of this chapter to discuss all of those that may play a role in delayed
healing.  However,  to  illustrate  the  point  a  few examples  will  be  presented.
Secreted  factors  may impede  neutrophil  activity;  a  B.  fragilis  culture  filtrate
inhibited phagocytic and killing activity of neutrophils, with evidence suggesting
that short-chain fatty acids may be the factors responsible (Rotstein et al. 1989);
extracellular polysaccharides synthesized by  Streptococcus mutans  appear to
reduce oxygen radical production in neutrophils and provide protection against
phagocytosis (Steinberg et al. 1999). If the presence of a critical bacterial load
in a wound is detrimental to healing then mechanisms to disrupt immune cell
mediated clearance will be an exacerbating factor. Some anaerobic bacteria are
known to excrete hydrolytic enzymes, such as collagenase (Steffen & Hentges,
1981),  which may delay healing by inhibiting the formation of  new tissue,  a
process reliant on collagen formation. If the delay in wound healing is caused by
a secreted factor it is possible that the concentration of the factor in the wound
environment,  and/or  a  critical  exposure  time,  is  a  key  determinant  of  its
pathological role. The effect seen with the B. fragilis filtrate occurred only when
the bacterial population had reached stationary phase of growth (Rotstein et al.
1989) so bacterial population density may be an important factor.
The  key  message  appears  to  be  that  an  effort  to  reduce  the  burden  of
pathological organisms in a wound is an important component of chronic wound
treatment plans. Herein lies a conundrum; a Health Technology Assessment
review of  chronic  wound  care  management  strategies  concluded  that  there
were “no beneficial effects” of topical or systemic antibiotics in the treatment of
diabetic foot ulcers (O'Meara et al. 2000). A later review (Nelson et al. 2006)
concluded  that  the  evidence  for  specific  diagnostic  testing  for  infection  and
antibiotic treatment of diabetic foot ulcers was “weak” and incapable of guiding
clinical practice. It is unfortunate that only a small number of trials satisfied the
review criteria (only two studies in the first review); the heterogeneous nature of
diabetic foot ulcers, and the variability of diagnosis of infection and treatment
options make correlations between infection and wound healing problematic. An
infected  wound  is  never  treated  with  antibiotics  alone;  debridement,
hydrocolloid/antiseptic dressings, patient education, corrective vascular surgery
and glycaemic control  are frequently included in a multidisciplinary approach
(Edmonds. 2006).
A consideration of one component of infection, that appears to be lacking in
most of the studies included so far, is the incidence and implication of antibiotic
resistant bacteria in wounds. A retrospective analysis of the incidence of MRSA
in diabetic foot ulcers found that 30.2% of the patients had MRSA isolated from
their wounds (Dang et al. 2003); in an earlier analysis 40% of S. aureus isolated
from wounds was MRSA, and not surprisingly MRSA was more prevalent in the
wounds  of  patients  who  were  already  being  treated  with  antibiotics.
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Interestingly, the wounds containing MRSA were slower to heal than wounds
containing Methicillin-sensitive S. aureus (Tentolouris et al. 1999). The presence
of MRSA in a DFU is also associated with greater treatment failure (35.3%)
compared to that for DFUs not containing MRSA (23%) (Vardakas et al. 2008).
1.3.3. The presence of fungi in chronic wounds
Studies reporting the presence and diversity of fungi in chronic wounds are few.
An investigation of fungi in DFUs, using microscopy and culture methods as
means of identification (Heald  et al.  2001), found  Candida species to be the
most prevalent with Candida parapsilosis (C. parapsilosis) found in 9 out of 17
wounds  and  Candida  albicans  (C.  albicans)  found  in  5  wounds.  Candida
humicola,  Candida  glabrata and  Candida  tropicalis  (C.  tropicalis)  were  also
identified. Leake et al. (2009) in an investigation of three chronic wounds using
molecular methods, identified three fungal species: C. albicans, C. parapsilosis
and  C. tropicalis.  All  three wounds contained  C. tropicalis,  though in smaller
quantities than either C. albicans or C. parapsilosis. A later, larger study by the
same group (Dowd  et al.  2010),  identified 48 fungal  species in  208 chronic
wounds. Again, the most abundant genus found was Candida and the five most
prevalent species, in terms of the number of wounds in which they were found,
were C. albicans,  C. parapsilosis, Curvularia lunata, Candida orthopsilosis and
Ulocladium botrytis.
1.4. Biofilms
In natural and synthetic environments microorganisms can be found in either
planktonic  or  sessile  form,  the  latter  comprising  a  surface-associated
community of organisms, which, when encased within a matrix of extracellular
polymeric  substances  (EPS),  is  known  as  a  biofilm.  The  components  and
dynamics  of  the  biofilm  microorganism  community  are  as  variable  as  the
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environments in which they are found, from marine ecosystems to the plaque
on  our  teeth.  The  first  stage  of  biofilm  development  is  the  attachment  of
planktonic cells to a surface, a process that is influenced by the presence of a
conditioning film. This is followed by a steady accumulation of cells which start
to aggregate together. Cells then excrete EPS and become enclosed within a
matrix (Fig. 1.2).
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Figure 1.2.  Formation  of  a  biofilm.  Bacterial  and fungal  cells  attach to  a  surface and  then
aggregate  together.  The  cells  secrete  extracellular  polymeric  substances  (EPS)  which
encompasses the microbial community and eventually forms the mature matrix structure.
1.4.1. Biofilm structure
Before  discussing  mature  biofilm  structure  it  is  necessary  to  consider  the
process of cell adhesion to a substratum; this may have particular significance
to the design of medical devices and to the treatment of chronic wounds. The
ability of planktonic cells to adhere to a surface depends on the properties of
both the bacterial strain and the substratum, for example, most bacteria carry a
net negative charge, the magnitude of which is strain dependent; hydrophobicity
will  also  determine  whether  an  organism  will  readily  adhere  to  a  surface
(Dickson & Koohmaraie, 1989).
The  adsorption  of  a  conditioning  film  to  a  substratum  alters  the  surface
properties  and  therefore  adhesion  capabilities  of  bacterial  cells.  Studies
examining biofilms in marine environments have found that conditioning films
can consist of polysaccharides, proteins, lipids, nucleic acids and amino acids,
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proteins  usually  being  the  first  molecules  to  appear  (Bakker et  al. 2004,
Poleunis et al. 2002). The films can be temporally heterogeneous, changing
composition according to the time of year, films formed during spring contain
more protein and organic carbon than winter films, with consequent differences
in marine organism adherence (Bakker et al. 2003).
Silicone urinary catheters have been shown to develop conditioning films during
the  early  stages  of  placement  within  human  bladders  (Tieszer et  al. 1998)
though the effects of films on pathogens in various in vitro situations has been
complex.  A conditioning  film containing fibrinogen and fibronectin  in  silicone
catheter  lumens  decreased  the  number  of  S.  epidermidis adhering,  but
increased the number of  S. aureus (Espersen et al. 1990). In an oral biofilm
model conditioning films formed in the presence of a saliva medium increased
the adherence of some oral bacterial species but slowed down the adherence of
some  Staphylococcus and  Streptococcus species  (Busscher et  al. 1997).
Selectivity  of  adherence  could  occur  due  to  the  presence  of  receptors  for
specific  strains  on  salivary  glycoproteins  (Murray et  al. 1992).  These  were
identified for 8 out of 16 strains of oral  streptococci. The evolution of specific
interactions between oral bacteria and salivary components is logical; there is a
need  for  organisms  to  adhere  rapidly  and  strongly  to  a  surface  in  an
environment of high shear pressure.
Non-specific  interactions  should  not  be  discounted  however,  blood
preconditioning of central venous catheters resulted in increased adherence of
P. aeruginosa, P. agglomerans  and  Enterobacter cloacae (Murga et al. 2001)
and bacterial adherence on a plastic substratum was increased when mussel
juice conditioning film was present (Herrera et al. 2007). A common conclusion
from the  studies  mentioned  is  that  early  surface  colonisers  may  utilise  the
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conditioning  film  as  a  temporary  nutrient  source  though  the  bacterial  cells
themselves may contribute to the film components; a conditioning film on glass
slides  in  situ during  the  stationary  phase  of  Bacillus  cereus  (B.  cereus)
population  growth  contained  DNA,  which  in  turn  appeared  to  contribute  to
adherence (Vilain et al. 2009). Damaged tissue present in chronic wounds may
contain a cocktail of conditioning film components increasing the likelihood of
bacterial adherence at a very early stage of colonisation.
The extracellular matrix has been estimated to be at least 97% water when fully
hydrated (Zhang et al. 1998), other components include bacterial metabolites,
nutrients,  polysaccharides,  proteins,  DNA and  debris  from  the  surrounding
environment  (Sutherland,  2001).  One  of  the  functions  of  the  biofilm  matrix
appears to be a protective one. It  maintains the structure of the biofilm, and
protects cells from dehydration (Ophir & Gutnick, 1994) and ultraviolet radiation
(Elasri & Miller, 1999). Microbial cells usually form a small percentage of the
total mass of the biofilm which is highly heterogeneous regarding pH, density,
components and structure, which are influenced by factors such as nutrient and
oxygen availability,  cell-to-cell  signalling, gene expression and environmental
stressors (such as shear stress) (Puevdorj-Gage  et  al. 2002, Hall-Stoodley et
al. 2004). Biofilms of  P. aeruginosa grown with citrate as a carbon source are
flat,  whereas those grown with glucose have a mushroom-like structure with
water filled channels; further to this is evidence that microcolonies within the
structures are phenotypically different. Non-motile cells have been found in the
stalks of the mushrooms, and motile cells of the same species were localized in
the cap of the mushroom (Klausen et al. 2003).
Physiological activity in P. aeruginosa biofilms has been found to be dependent
on  oxygen  availability;  active  cells  were  visualized  around  the  edge  of  the
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biofilm,  a  layer  which  becomes  thicker  in  the  presence  of  100%  oxygen
compared to 21% (Xu et al. 1998). Gradients for gases and other substances
such  as  nutrients  are  logical  and  probably  account,  in  part,  for  the
heterogeneous nature of the biofilm. However, each biofilm will develop its own
unique physical properties which will influence the interaction between solutes
and matrix; a consensus on diffusion coefficients for molecules within the biofilm
remains elusive. The low diffusivity of biofilms is often postulated as a reason
for  increased  antibiotic  resistance  of  biofilm  cells,  however,  by  fluorescently
tagging solutes of various molecular weights (MW) from 3,000 to 150,000 Da,
and tracking their  penetration into a model  oral  biofilm it  was observed that
solutes reached the centre of cell aggregates within 3 minutes (Takenaka  et al.
2009). Most antibiotics have a MW well  below 3,000 Da so if  their transport
through the biofilm matrix is impaired it is likely that another factor is involved
(Section  1.4.3).  Membrane  vesicles  (MVs)  have  also  been  found  in  biofilm
matrices.  They  are  derived  from the  outer  membranes  of  bacteria  and  the
contents will depend on the parent organism. Isolated MVs from P. aeruginosa
biofilms  demonstrated  proteolytic  activity,  and,  interestingly,  also  bound  the
antibiotic gentamycin (Schooling & Beveridge, 2006).
1.4.2 Planktonic and sessile cells are phenotypically different
The  observation  of  different  phenotypes  among the  same bacterial  species
within a biofilm prompted work to explore the genetic behaviour of these cells.
Multiple stages were uncovered for some species where the extent of protein
expression changes according to the developmental stage of the biofilm. For
example, when P. aeruginosa cells were grown as a biofilm and as planktonic
cells the correlation coefficient for protein expression decreased until day 6 of
biofilm growth (Sauer et al. 2002), during this time more than 50% of proteins
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were  upregulated  in  the  biofilm  cells.  These  proteins  included  membrane
proteins,  oxidative  stress  response  proteins  and  those  necessary  for
biosynthesis.  How  changes  in  protein  expression  affect  cell  behaviour  in
biofilms was demonstrated, again with  P. aeruginosa; bacteria from 5-day old
biofilms  showed  significant  diversity  in  swimming  capability  whereas
planktonically grown cells showed no swimming variability at all  (Boles  et al.
2004).  The degree of  variability indicated that  multiple  genetic  changes had
been initiated rather than a single mutation event.
These phenotypic changes may contribute to the heterogeneity of biofilms and
the formation of  environmental  niches within  the biofilm structure, facilitating
survival and mutual co-operation within and between species. The example of
mushroom formation by  P. aeruginosa and the generation of water channels
facilitate  the  dissemination  of  oxygen  and  nutrients  deeper  into  the  biofilm,
benefitting other members of the biofilm community. This structural feature of
biofilms  is  not  confined  to P.  aeruginosa;  mushroom  morphology  has  been
observed  in  the  biofilms  of  Caulobacter  crescentus (Kirkpatrick  and  Viollier.
2010).
1.4.3. Biofilms and antibiotic resistance
Numerous studies have now demonstrated an inherent resistance of biofilms to
antibiotics;  minimum  inhibitory  concentrations  (MICs)  of  tobramycin  against
P. aeruginosa  biofilms  are  1000  fold  higher  than  those  for  planktonic  cells
(Nickel et al. 1985), ciprofloxacin fared better against P. aeruginosa biofilms with
eradication occurring at 16 fold higher than the MIC for planktonic cells (Abdi-Ali
et al. 2006). Different antibiotics have different responses and there are many
factors that influence this: (i) the ability of the drug to diffuse through the matrix
and actually reach the bacterial cells; (ii) the extent of binding and/or antibiotic
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deactivation within the matrix; (iii) target cells may be phenotypically different to
planktonic cells; and (iv) nutrient and oxygen gradients in the matrix may result
in a heterogeneous physiological response. An important point to note, before
discussing  these mechanisms of  biofilm resistance,  is  that  the  methodology
chosen to quantify bacterial inhibition/killing and any reduction in biofilm mass
needs to be scrutinized whilst  interpreting the data as this will  influence the
analysis.  For example, measuring viable cell  counts may give a significantly
different  result  compared  to  measuring  bacterial  respiratory  activity;  studies
need  to  differentiate  between  biofilm  matrix  mass  and  cellular  mass  when
quantifying reduction, or make it clear that they are measuring the whole biofilm
mass.
It has long been hypothesized that the gelatinous nature of the biofilm matrix
will impede the diffusion of antibiotics, either via physical properties such as the
presence of macromolecules and charge interactions, or by directly binding to a
matrix component, but what is the evidence for this? The antibiotic ciprofloxacin
penetrated Klebsiella pneumonia (K. pneumonia) biofilm to MIC concentrations
within  20  minutes,  demonstrating  no  significant  impairment  of  diffusion.
However,  ampicillin  was  able  to  penetrate  a  β-lactamase  negative  mutant
K. pneumonia,  but not the β-lactamase positive wild-type strain (Anderl et al.
2000), providing evidence that extracellular deactivating enzymes may play a
role in resistance. An interesting observation from this particular study was that
the  increased resistance noted for  this  organism (including  the  β-lactamase
positive  strain)  to  both  antibiotics,  indicates  that  a  separate  mechanism  of
resistance  is  occurring  here.  Penetration  of  rifampin  through  S.  epidermidis
biofilms  (Zheng  &  Stewart,  2002),  vancomycin  through  S.  aureus  biofilms
(Jefferson et  al. 2005) and tetracycline through  E .coli biofilms (Stone et  al.
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2002) have all been observed. In some cases penetration was slow but target
concentrations were achieved. However, despite this, killing was still impaired.
Slow penetration  of  drugs may allow time  for  biofilm  cell  mass to  increase
before a cidal or inhibitory concentration is reached, but this is probably not
sufficient to explain the levels of resistance seen.
The addition of slime, removed from a biofilm-positive strain of S. epidermidis,
to  a  MIC  assay,  decreased  killing  of  clinical  Staphylococcal isolates  by
vancomycin; the slime had no effect on the MICs of rifampicin (Mathur  et al.
2005). This study illustrates the heterogeneous nature of antibiotic resistance;
both drugs are glycopeptides but have a differential response in the presence of
biofilm  slime.  Vancomycin  is  hydrophilic;  rifampicin  is  lipophillic,  properties
which may influence the nature of their  interactions with  components of  the
biofilm matrix. A criticism of this study is that they performed MIC assays on
planktonic  cells,  to  which they then added slime;  evidence of  differences in
phenotype between planktonic and biofilm cells has been discussed (Section
1.4.2) and needs to be considered; upregulated proteins during biofilm growth
may modify the level of resistance to either antibiotic.
The presence of genetic material in the biofilm matrix has been considered to
be  a  non-significant  by-product  of  cell  lysis;  however,  evidence  is  now
accumulating that supports a more active role for nucleic acids. Apart from a
structural role (Allesen-Holm et al. 2006) extracellular DNA has been shown to
chelate  cations  in  P.  aeruginosa  biofilms,  resulting  in  the  induction  of  an
antibiotic  resistance  operon  which  increased  MICs  for  cationic  antimicrobial
peptides and aminoglycosides (Mulcahy et al. 2008). In support of this Tetz et
al. (2009) observed that DNase treated biofilms were structurally altered and
allowed  increased  antibiotic  penetration.  There  is  evidence  to  support  a
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regulatory role of QS in DNA release into the biofilm matrix (Nakamura  et al.
2008) supported by the observation that a  P.aeruginosa QS mutant that has
reduced extracellular DNA was more susceptible to aminoglycoside antibiotics
than the wild-type organism (Chiang et al. 2013).
Evidence for the presence of antibiotic deactivating enzymes in biofilm matrices
was discussed previously in this section (Anderl et al. 2000), however a picture
of heterogeneous distribution of the induced enzyme is emerging. A reporter
plasmid  carrying  an  unstable  green  fluorescent  protein  (GFP)  was  used  to
discern the induction pattern of β-lactamase within P. aeruginosa biofilms when
sub-MICs of two β-lactams were introduced; induction occurred primarily around
the periphery of the biofilm, with no induction occurring in microcolonies in the
centre of the biofilm (Bagge et al. 2004). The authors of the study admit that
their method of detection may not be sensitive enough to detect low levels of
induction  in  the  central  colonies;  however  a  differential  in  induction  is  still
evident. A suggestion that the central cells response is due to a slower growth
rate due to nutrient and oxygen limitation is postulated, a theory supported by
other  studies  (see  later  in  this  Section),  though  it  is  also  possible  that
extracellular β-lactamase (perhaps circulated and stored in MVs) is sufficient to
reduce the concentration of antibiotic reaching the centre of the biofilm to sub-
induction levels.
Many  antibiotics,  including  the  β-lactams  are  only  effective  against  actively
growing cells, and this is as true for biofilm cells as it is for planktonic cells.
Gradients for nutrients and oxygen develop due to the physical structure of the
biofilm in relation to the environmental interface (de Beer et al. 1994), and to
local  depletion  by  microcolonies  and  accretion  due  to  cell  lysis.  This
phenomenon has been modelled mathematically (Roberts & Stewart, 2004) and
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demonstrated  in  vitro;  only  cells  in  an  oxygenated  region  adjacent  to  a
P. aeruginosa biofilm  interface  were  able  to  express  a  GFP,  cells  near  the
centre  did  not  (Borriello et  al. 2004).  Oxygen  measurements  in  the  biofilm
demonstrated a rapid fall in oxygen concentration from the biofilm surface to a
depth of 50 µm so it was suggested that the core of the biofilm was anaerobic
and therefore cell growth was minimal. The use of GFP in biofilm studies is very
common but it does require oxygen in order to produce the fluorophore5, it is
also sensitive to low pH, being undetectable at pH 4.5 and below (Hansen et al.
2001). Cells in anaerobic, acidic conditions in localised pockets of a biofilm may
be non-growing but if these conditions are suspected then an alternative means
of measuring physiological activity may be preferential.
Comparisons between biofilm cells and stationary phase planktonic cells have
been made to illustrate the similarities between limited nutrient availability and
the  organism’s  resistance  to  antibiotics;  resistance  is  increased  in  both
situations, and again is linked to slow growth (Anderl et al. 2003). One study
confirmed the link by exposing both types of cells to a fluoroquinolone antibiotic
(which does not depend on cell growth to exert its bactericidal action) and β-
lactams; the P. aeruginosa stationary phase and biofilm cells were susceptible
to  killing  by  the  fluoroquinolone  but  not  the  β-lactam  antibiotic,  logarithmic
phase cells were vulnerable to killing by both antibiotics (Spoering & Lewis,
2001).
The effect of biofilm age on antibiotic resistance also has implications for wound
treatment  protocols.  Mature  biofilms  have  been  shown  to  produce  more  β-
lactamase than young biofilms when exposed to antibiotics (Bowler et al. 2012),
though even biofilms not exposed to antibiotics can evolve increased resistance
5 A component of a molecule that is fluorescent.
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with the maturation of the biofilm (Tyerman et al. 2013). Evidence suggests that
increasing oxidative stress in a maturing biofilm results in increased mutation
conferring greater antibiotic resistance (Ryder et al. 2012, Bernier et al. 2013).
The characterisation of the cells that survive cidal concentrations of antibiotics
is an area of research that has led to a theory that was, for a long time ignored
but is now much debated; the cells, which have been labelled “persisters”, do
not demonstrate antibiotic resistance, but rather tolerance, they “neither grow
nor die” (Keren et al. 2004). It has been argued that these cells are senescent
(Klapper et al. 2007) possibly as a result of asymmetric binary fission which,
over time, leads to the altered phenotype of an aged cell (Lindner et al. 2008,
Stewart et al. 2005). This is a fascinating area of research and there is not the
space to discuss the topic fully here, but factors other than aging do seem to be
involved;  the  identification  of  a  persister  related  gene  hipB/hipA  which  is  a
toxin/antitoxin module may only be part of the story and the reader is directed to
a  review  for  more  details  (Jayaraman,  2008).  The  main  weakness  of  the
senescence  argument  is  that  any  genetic  component  conferring  antibiotic
resistance should be passed on to daughter cells, however, daughter cells of
persisters are susceptible to antibiotics (Bigger, 1944).
Whatever the nature of persister cells the important property of relevance to this
work is their multidrug tolerance. Whichever antibiotic is administered it will only
be effective if it corrupts a target within the bacterium, the unique property of
persister cells seem to be their dormancy-like state where all cellular functions
shut down conferring on them a physiological  ambivalence to antimicrobials.
The fact that these cells are found in biofilms (Brooun et al. 2000), where they
benefit  from  the  protection  of  the  matrix,  is  a  cause  for  concern  and  may
account  for  the multidrug resistance and virtual  incurability of  certain biofilm
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related infections, e.g. P. aeruginosa in the lungs of cystic fibrosis patients. All of
the  above  studies  have  investigated  mono-species  biofilms,  a  situation  that
rarely occurs in natural environments, including wounds (Section 1.3). It is of
concern then that multispecies biofilms show increased biofilm mass and an
increase in antibiotic resistance compared to mono-species biofilms (Burmølle
et al. 2006).
1.4.4. Biofilms and the immune response
It is probably fair to say that the mechanisms of interaction between biofilms
and immune cells have come predominantly from work with P. aeruginosa, and
the overall consensus seems to be that the exopolysaccharide component of
the biofilm EPS is responsible for a degree of protection for biofilm enclosed
bacterial cells. Using confocal laser scanning microscopy (CLSM) to monitor the
interaction between P. aeruginosa biofilms and neutrophils, on contact with the
biofilm neutrophils appeared to become immobile and retain an unstimulated
rounded  morphology;  despite  evidence  of  the  presence  of  oxidative  burst
products and phagocytosis  of  bacterial  cells  their  immobility resulted in  only
localised  clearance  (Jesaitis et  al. 2003).  Evidence  suggests  that  alginate
production  is  a  key  factor  in  protection;  alginate  negative  strains  of
P. aeruginosa  were  susceptible  to  leukocyte  killing,  a  situation  that  was
reversed on the addition of exogenous alginate to the culture (Leid et al. 2005).
Despite  the  observation  that  some  biofilm  cells  are  phagocytosed  and  an
oxidative burst occurs, evidence suggests that immune cell function may still be
compromised. Slime producing  Enterococcus  sp. survived for 48 hours within
rat  peritoneal  macrophages  compared  to  24  hours  for  non-slime
producingstrains (Baldassarri et al. 2001). Antibody-mediated phagocytic killing
of  cells  may  also  be  compromised  in  a  biofilm  environment;  the
59
exopolysaccharide  poly-N-acetylglucosamine  (PNAG)  normally  elicits  an
opsonic antibody response when secreted by  S. aureus  and  S. epidermidis,
however, in a biofilm model bacterial cells were more resistant to this mode of
killing than planktonic cells (Cerca et al. 2006). The results indicated that large
amounts  of  PNAG  had  accumulated  in  the  biofilm  environment  which
overwhelmed  the  antibody  response  conferring  a  degree  of  protection  to
bacterial cells.
1.4.5. Biofilms in wounds
Chronic wounds, particularly before cleaning, are often covered in a sloughy
material that has the appearance of a biofilm, and it has long been suspected
that this is the case, but what is the evidence that biofilms do actually develop in
wounds?  Bacterial  cell  aggregations  surrounded  by  EPS were  visualised  in
tissue biopsies from 60% of chronic wounds included in a study (James et al.
2008), this is fairly diagnostic of biofilm presence. Only 6% of acute wounds
contained evidence of biofilms which suggests that the environment in a chronic
wound may be particularly conducive to biofilm production.  The presence of
biofilm producing strains in clinical isolates has been demonstrated (Sanchez et
al. 2013); and an isolate from a burn wound developed an EPS coating within 5
hours  of  in  vitro  growth,  and had grown into  a  mature  biofilm  by 10 hours
(Harrison-Balestra et al. 2003). Many bacteria certainly express the virulence
factors necessary for attachment to a wound surface, e.g. S. aureus expresses
cell-wall  bound adhesion which are able to bind to collagen, fibronectin and
fibrinogen  (Foster  &  Hook,  1998).  A wound  provides  substrates  for  biofilm
growth in the form of plasma and lysed cells; poorly controlled diabetic patients
are  likely  to  have  glucose  rich  fluids  in  a  wound  environment  though  no
evidence has been found to support this hypothesis.
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The presence of  vascular  disease in  diabetic  patients  results  in  poor  tissue
perfusion  and  a  consequence  of  this  could  be  a  reduction  in  the  local
concentration  of  antibiotics  in  a  wound environment.  Apart  from inadequate
inhibitory or cidal effects, low levels of antibiotics may induce DNA release. This
has been observed, concurrent with increased biofilm formation, in  S. aureus
(Kaplan et al. 2012), a prominent organism found in non-healing wounds.
One aspect of the polymicrobial character of biofilms, that may have an impact
on wound pathology, is the interaction between bacterial and fungal species.
The presence of fungi in dual-species biofilms can result in enhanced biofilm
growth; this has been seen for  C. albicans and  S. epidermidis (Adam  et al.
2002) and Candida lusitaniae and E. faecalis (van Merode et al. 2007). Of equal
concern is the evidence that S. aureus is able to physically associate itself with
the  hyphae  of  C.  albicans in  dual-species  biofilms  (Peters  et  al.  2010),
potentially  giving  the  bacteria  a  means  of  colonising  deeper  tissue.  Any
increased pathology, however, may also be due to a differential in  S. aureus
protein expression between single and dual-species biofilm cells which could
increase survival and virulence (Peters  et al. 2010). The relationship between
species in a biofilm may also be antagonistic; the P. aeruginosa QS signalling
molecule,  O-C12-HSL,  has  been  shown  to  inhibit  filamentous  growth  of  C.
albicans (Hogan et al. 2004).
Despite the paucity of  in  vivo evidence for the presence and significance of
biofilms in chronic wounds there is much support for the theory that biofilms,
particularly  multi-species  biofilms  (Seth  et  al.  2012)  contribute  to  the  non-
healing  pathology.  If  chronic  wounds  are  colonised  exclusively  by  antibiotic
sensitive planktonic cells then antibiotics should reduce their number sufficiently
to a level that can be cleared by the hosts’ immune response, though this may
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not be the case if they are predominantly persister cells. It could be argued that
patients who develop chronic wounds often have impaired immune systems,
and this may be a factor but not all patients do, yet they still may have a non-
healing pathology and recalcitrant infection. Biofilms provide a constant source
of inoculating bacterial cells, and coupled with increased antibiotic resistance
and  various  strategies  to  evade  or  impair  an  immune  response  it  is  now
accepted that procedures to facilitate the removal of biofilms in a chronic wound
treatment  regimen  is  crucial  for  a  successful  outcome  (Wolcott  &  Rhoads,
2008).
1.5. Quorum sensing
First  described in  1970,  in  Vibrio  fischeri  (V. fischeri)  (Nealson et  al. 1970),
quorum sensing (QS) is a complex and diverse system of genetic expression
co-ordination. Utilised by multiple bacterial species, the common components of
QS are small secreted molecules, receptor proteins and down-stream effectors.
The signalling molecules, initially designated autoinducers, broadly fall into two
groups: acyl-homoserine lactones (AHLs) secreted by Gram-negative bacteria
(Eberhard et al. 1981) and small peptides, secreted by Gram-positive bacteria
(Camilli & Bassler, 2006). Quorum sensing is a density-dependent mechanism
of bacterial cell to cell communication. A wide range of functions are regulated
by QS, perhaps the most important of which, in the context of pathogenesis, are
virulence and biofilm  formation  (Camara et  al. 2002).  Biofilm  formation  and
maturation have been shown to be regulated by QS (Sakuragi & Kolter, 2007)
along with other virulence mechanisms that may contribute to non-healing of
chronic wounds. QS is seen as a potential target for interference, triggering the
search for viable therapeutic options.
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1.5.1. Quorum sensing in Gram-negative bacteria
The ability of bacterial cells to communicate with each other in order to modify
the  expression  of  bioluminescence was  demonstrated  in  V.  fischeri  in  1970
(Nealson et al. 1970), when it was proposed that this mechanism of  lux gene
autoinduction was density-dependent. It soon became clear that this form of co-
ordinated  genetic  expression  was  neither  confined  to  luminescence,  nor
V. fischeri.  The  biosynthesis  of  the  antibiotic  carbapenem,  in  Erwinia
carotovora, was also found to be regulated in this manner (Bainton et al. 1992).
Homologues of the lux gene have now been documented for numerous Gram-
negative bacteria, including SdiA in E. coli (Sitnikov et al. 1996), and lasR/lasI in
P.  aeruginosa  (Gambello  &  Iglewski,  1991,  Passador  et  al.  1993),  two
organisms found in chronic wounds.
Structural  analyses  of  autoinducers  from  various  Gram-negative  bacteria
sources uncovered a group of  related small  molecules,  the acyl-homoserine
lactones (Eberhard  et  al.  1981,  Pearson et  al. 1994).  The core  structure  of
AHLs consists  of  a  homoserine  lactone (HSL)  ring  with  acyl  side  chains  of
between 4 to 18 carbons long attached via an amide bond (Fig. 1.3.).
The third carbon in the chain may carry an oxo or hydroxyl substitution. The
side  chain  length  and substitution  determine  the  specificity  of  the  AHL,  the
different  types  of  which  are  directed  by  different  lux homologues  (Taga  &
Bassler,  2003).  The  majority  of  AHLs  identified  are  products  of  fatty  acid
biosynthesis, thus the acyl side chains, (Schaefer et al. 1996), however, a soil
bacterium Rhodopseudomonas palustris utilises environmental p-coumaric acid
to synthesise p-coumaroyl-HSL (Schaefer et al. 2008).
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Figure 1.3. Structures of representative AHLs. AHL, acyl-homoserine lactone. The homoserine
lactone ring (indicated) is a common feature of AHLs. The chain length can be between 4 and
18 carbons and the third carbon in the chain may carry an oxygen or a hydroxyl substitute.
Probably because  it  is  such  a  widely  studied  bacterium,  a  second class  of
signalling molecule has been identified in  P. aeruginosa  (Pesci et al. 1999); it
belongs to the 2-alkyl-4-quinolone family of compounds and is known as the
Pseudomonas quinolone signal (PQS). It is synthesised from anthranilate and
β-keto-(do)decanoic  acids  (Bredenbruch et  al. 2005)  and  is  involved  in  rhl
regulation, a QS system which produces virulence factors such as rhamnolipid
(a lipid biosurfactant), elastase, cyanide and lectins (Diggle et al. 2006). Further
details of QS specific to P. aeruginosa can be found in Chapter 5, Section 5.1.1
and Figure 5.1. In some bacteria the degradation of tryptophan leads to the
production  of  indole,  which  is  now recognised  as  an  interspecies  signalling
molecule (Lee et al. 2007). In E. coli the formation of biofilms has been shown
to be regulated by the presence of indole and subsequent modification of SdiA,
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which interestingly responds to AHLs even though E. coli does not synthesise
these (Yao et al. 2006).
Within  the  cell  LuxI  or  its  homologues  are  responsible  for  the  synthesis  of
autoinducers which readily diffuse out of the cell. With increasing cell population
density an AHL concentration gradient,  between the extra-cellular  and intra-
cellular  environment,  develops  over  time  leading  to  a  net  movement  into
bacterial cells; once a threshold level is reached the signalling molecules bind to
their cognate receptor, LuxR or its homologues, which show high specificity for
their ligands. LuxR then binds to the promoter region of a target gene initiating
gene expression (Fig 1.4.) (Schauder & Bassler, 2001).
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Figure 1.4. LuxI/LuxR QS system of Gram-negative bacteria. LuxI, autoinducer synthase; LuxR,
autoinducer  regulator,    autoinducer.  With  increasing  cell  population  density  an  AHL
concentration gradient develops leading to a net movement into bacterial cells; once a threshold
level is reached the signalling molecules bind to their cognate receptor, LuxR or its homologues.
LuxR then binds to the promoter region of a target gene initiating gene expression.
The products of QS induced genetic expression vary between species (Table
1.5), though the production of virulence factors is a common theme. It must be
noted that the net effect of QS is complex and different signalling molecules
may have opposing effects; biofilm formation may depend on a combination of
both  positive  and  negative  effects  and  a  signalling  molecule  may induce  a
biofilm phenotype in one organism and inhibit it in another (Lee et al. 2007).
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Table  1.5. Gram-negative  bacteria  and  their  LuxI/LuxR  homologue,  AHL,  and  phenotypic
products.  LuxI,  autoinducer  synthase;  LuxR,  autoinducer  regulator;  AHL.  Acyl-homoserine
lactone; HSL, homoserine lactone.
Organism LuxI/LuxR
Homologue
AHL Phenotype Reference
Burkholderia
cepacia
CepI/CepR C8-HSL Protease
Siderophore
Lewenza et  al.
1999
E. coli SdiA Unknown
Indole
Cell division
Biofilm
formation
Sitnikov  et  al.
1996
Lee et al. 2007
P. aeruginosa LasI/LasR 3-oxo-C12-HSL Exoenzymes
Biofilm
formation
RhlR
Gambello  and
Iglewski, 1991
RhlI/RhlR C4-HSL Exoenzymes
Cyanide
Lectins
Pyocyanin
Latifi et  al.
1996
1.5.2. Quorum sensing in Gram-positive bacteria
To date, Gram-positive bacteria are not known to synthesise AHLs. Their QS
signalling  system  is  based  on  autoinducing  peptides  (AIP),  cleaved  from
precursor peptides, which undergo further post-translational modification (Ji et
al. 1995).  The  mechanism leading  to  gene  expression  is  a  two-component
system  (Fig.  1.5);  a  membrane  bound  histidine  kinase-associated  receptor
autophosphorylates on binding of the AIP to the sensor domain. This results in
the phosphorylation of a regulator molecule, which in turn, activates a specific
gene locus. Signal synthesis genes initiate the synthesis of precursor proteins
which  are  post-translationally  modified  to  signal  proteins  (AIPs).  These  are
exported via membrane bound ATP-binding cassette transporters (ABCs).
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As for the Gram-negative system, QS signalling in Gram-positive bacteria is,
primarily, density dependent, and involves the production of virulence factors,
such as proteases, hemolysins, enterotoxins, and biofilm formation. These are
under the regulation of the accessory gene regulator (agr) in S. aureus (Peng et
al. 1988, Recsei et al. 1986)
Figure 1.5.  Two-component QS system in Gram-positive bacteria. ABC, ATP-binding cassette
exporter;  MASP,  membrane associated  sensor protein;      ,  autoinducer  peptide  (AIP).  An
increasing AIP concentration gradient results in binding of AIP to the membrane bound histidine
kinase-associated  receptor  (MASP)  which  then  autophosphorylates.  This  leads  to  the
phosphorylation of a response regulator, which in turn, activates target genes. Signal synthesis
genes initiate  the  synthesis  of  precursor  proteins  which  are  post-translationally  modified  to
signal proteins (AIPs). These are exported via membrane bound ABCs.
Many QS systems in Gram-positive bacteria have now been studied; a diverse
range of AIPs have been identified, and more is now known about how they
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achieve specificity.  To take a commonly found bacterium in chronic wounds,
S. aureus,  as an example, an interesting picture of self-induction and cross-
communication  emerges.  In  common  with  S.  epidermidis, sub-groups  of
S. aureus produce unique AIPs that induce self, but inhibit non-self sub-groups;
concurrently,  AIPs  that  self-induce  in  one  species  of  a  genus  will  inhibit  a
different species within that same genus (Wright et al. 2004). Despite having a
thiolactone  ring  with  a  highly  conserved  cysteine,  AIPs  have  amino  acid
extensions of varying sequence and length, which are proposed as determining
specificity.
1.5.3. The role of quorum sensing in chronic wounds
The  previous  two  sections  have  touched  briefly  on  the  mechanism  of  QS.
Signalling molecules continue to be discovered, but what role do they play in
the pathogenesis and recalcitrant nature of chronic wounds? The role of QS in
the development and maintenance of infection in chronic wounds is gradually
being ascertained. An undisturbed wound provides a warm, moist environment,
conducive for an increase in bacterial populations that would generate threshold
QS signalling molecule concentration.  This  could result  in the expression of
virulence factors that prolong the inflammatory response, or reduce the efficacy
of  polymorphonuclear  monocytes  (Jensen et  al. 2007).  Exotoxin  release
(particularly  proteases),  coupled  with  hypoxia,  may  result  in  damaged  host
tissue; further enriching the environment for bacterial survival. Arguably one of
the most important QS-mediated mechanisms involved in wound pathology is
the formation of biofilms.
1.5.4. Quorum sensing and biofilms
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The role  of  QS in  the formation of  biofilms appears to  be diverse. Different
studies have observed conflicting results, illustrating the complexity of bacterial
signalling  and  the  processes  of  biofilm  formation.  Some researchers,  using
imaging techniques such as CLSM have demonstrated differences in biofilm
architecture  between  wild-type  organisms  and  their  QS  mutant  equivalents
(Davies et  al. 1998);  wild-type  P.  aeruginosa developing  mushroom-like
structures with water channels, whereas QS mutant biofilms were flat. It has
been suggested that this type of biofilm morphology may be determined by QS
controlled biosurfactant  production (Pamp & Tolker-Nielson,  2007).  However,
others have found no differences in  biofilm structure  between wild-type and
mutant strains of  P. aeruginosa (Heydorn et al. 2002). Purevdorj et al  (2002)
demonstrated that laminar and turbulent flow shear can affect biofilm structure
and  that  QS signalling  is  not  essential  for  biofilm  adhesion.  The  growth  of
biofilms has been shown to be dependent on many variables, including nutrient
availability, carbon source and flow conditions (Purevdorj et al. 2002, Kirisits &
Parsek,  2006)  so  it  is  possible  that  the  varied  results  are  due  to  protocol
differences.
Despite differences in biofilm morphology there is abundant evidence that QS
has a significant role to play in biofilm formation in a wide spectrum of bacterial
species, including those of clinical importance, such as P. aeruginosa (Davies et
al. 1998),  Acinetobacter  spp.  (Anbazhagan  et  al.  2012),  Burkholderia  sp.
(Inhϋlsen  et  al.2012),  Streptococcus  pneumonia (Vidal  et  al.  2011),
Enterobacter  cloacae (dos  Reis  Ponce  et  al.  2012),  Serratia  marcescens
(Bakkiyaraj et al. 2012) and S. aureus (Periasamy et al. 2012). The importance
of this in clinical applications is of particular significance due to the finding by
some  studies  that  flat,  undifferentiated  biofilms  are  more  susceptible  to
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antibiotics (Bjarnsholt et al. 2005) and biocides (Davies et al. 1998). Though not
necessarily involving the same mechanism this is supported by the observation
that  the  presence  of  a  lactonase  (Kiran  et  al.  2011)  and  QS  inhibitors
(Brackman  et al. 2011) increased the antibiotic susceptibility of  P. aeruginosa
biofilms.
A complex picture of biofilm regulation, by agr QS in S. aureus is also emerging.
An  active  agr system,  rather  than  leading  to  enhanced  biofilm  formation,
instead,  induces the  formation  of  biofilm  channels  and the  dissemination  of
bacterial  cells  from the biofilm (Periasamy  et  al.  2012)  by the action of  agr
regulated  proteases  (Boles  &  Horswill,  2008).  This  has  implications  for  the
pathogenicity of  the biofilms as cell  detachment could lead to the spread of
colonisation within and beyond a wound environment. Populations of both wild-
type  and  mutant  agr genotypes  have  been  identified  in  S.  aureus biofilms
(Savage  et  al.  2013),  suggesting  that  both  may  be  necessary  to  maintain
infection. 
1.5.5. Quorum sensing interference
A means of interfering with QS signalling is beneficial for several reasons, and
one way this may be achieved is via inactivation of signalling molecules. Unless
secreted into conditions that favour deactivation AHLs are stable for some time
(Schaefer et al. 2000), which will serve to maintain concentration levels when a
response  is  no  longer  required,  wasting  valuable  resources.  Agrobacterium
tumefaciens  produces at  least  two degradative enzymes,  one of  which is  a
lactonase  whose  expression  is  suppressed  during  logarithmic  growth  and
increased when stationary phase has been reached (Zhang et al. 2004). This
enzyme catalyzes the hydrolysis of the lactone ring of the AHL. The amide bond
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can be cleaved by acylases, an action sufficient to attenuate QS phenotypic
changes (Lin et al. 2003).
AHLs with a oxo substitute on the third carbon have also been shown to be
inactivated by oxidised halogens, such as hypochlorous acid, and hypobromous
acid  (Borchardt et  al. 2001).  This  suggests  that  as  well  as  an  intracellular
bactericidal effect, phagocyte-derived oxidants in the extracellular environment
could interfere with QS.
Vulnerability to inactivation is not restricted to QS signalling molecules released
by Gram-negative  bacteria;  a  Type I  AIP,  from the  Gram-positive  bacterium
S. aureus,  has  also  been  shown  to  be  deactivated  by  phagocyte-derived
oxidants  (Rothfork et  al. 2004).  Rothfork  also  postulated  that  the  in  vivo
attenuation of virulence was due to impaired interaction between the AIP and
the receptor, rather than the oxidised molecule acting as a competitive receptor
antagonist,  though  it  cannot  be  concluded  that  this  is  the  case  for  other
signalling molecule inactivation.
QS inhibition is also a necessary strategy for hosts to protect themselves from
the damaging effects of invading bacteria; evidence as to how they may do this
comes from the Australian red alga  Delisea pulchra.  This seaweed produces
halogenated  furanones,  molecules  with  some  structural  similarities  to  AHLs
which  have  been  shown  to  inhibit  QS-induced  mechanisms  in  Serratia
liquefaciens  (Givskov et al.  1996). These AHL analogues interact with LuxR-
type protein,  resulting in  increased degradation;  a  concurrent  reduction of  a
downstream virulence product supports their roles as QS inhibitors (Manefield
et al. 2001). Evidence suggests that higher order eukaryotes may also benefit
from this type of QS interference; synthetic furanones decreased QS-induced
bacterial virulence in a mouse model (Wu et al. 2004). These are examples of
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how,  both  natural  and  synthetic  analogues  may  compete  with  endogenous
signalling molecules for receptor binding.
The  complexity  of  QS  systems  in  multi-community  populations  is  evident,
making research in this area challenging. Blocking the pathway of one species
may serve to facilitate the pathway in another species, shifting the balance of
competition to favour one species over another, and as discussed in Section
1.5.4.  inhibition  of  the  agr QS  system  in  S.  aureus  may  result  in  the
dissemination of detached biofilm cells to other parts of a wound. The dynamic
of  chronic  wound  bacterial  populations  is  still  too  incomplete  to  predict  the
outcome  of  manipulation  of  this  kind.  However,  the  ability  to  inhibit  the
production of virulence factors and the formation of biofilms could augment the
effects of conventional antibacterial drugs. 
1.6. Hyperbaric oxygen therapy
HBO therapy (HBOT) is now accepted as a treatment option for several non-
diving  related  disorders,  including  carbon  monoxide  poisoning,  soft  tissue
trauma, osteomyelitis, radionecrosis, and chronic wounds (Wattel, 2004). HBO
is defined as breathing oxygen at  a  pressure higher  than local  atmospheric
pressure;  treatment  regimens  vary  according  to  clinical  assessment  but  for
chronic wounds usually involve breathing 100% oxygen at pressures of around
2.4 atmospheres absolute (ATA), for 1-2 hours daily, for several weeks (Roeckl-
Wiedmann et al. 2005). At the Diving Diseases Research Centre (DDRC) in
Plymouth the standard treatment programme lasts until the wound is healed or
up to 8 weeks, at which point the wound is reassessed. HBO is administered in
either a multiplace chamber, which can accommodate several patients, or in a
monoplace chamber which is designed for a single person only.
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HBO is still seen as a controversial treatment choice; strong evidence, based on
well  designed trials  incorporating randomised double  blind conditions with  a
statistically viable number of participants is rare. This is partly due to the ethical
issues involved with randomising treatments; it would be ethically questionable
to deny a patient HBOT. Ironically the lack of referrals to HBO centres, due to
the paucity of evidence, perpetuates the limited pool of potential participants for
trials.  The  various  studies  that  have  been  published  do  not  provide  a
homogeneous and comparable set of results, mainly due to: (i) the variability of
ulcer types, (ii) different end-point criteria, e.g. wound fully closed, 80% closure
or reduced risk of amputation, (iii) lack of suitable controls, and (iv) different
treatment  regimens.  However,  a  Cochrane  Database  systematic  review
concluded  that  HBO  significantly  reduced  the  risk  of  major  amputation  in
diabetic foot ulcers (Kranke et al. 2004). A second review that came to the same
conclusion  (Roeckl-Wiedmann  et  al.  2005)  also  conceded  that  evidence for
HBO efficacy was lacking for venous or pressure ulcers.
1.6.1. Tissue oxygenation
The rationale for the effectiveness of HBOT is based on Henry’s Law, which
states:  “The  amount  of  gas  that  will  dissolve  into  a  solution  is  directly
proportional to the partial pressure of that gas and inversely proportional to the
absolute  temperature”  (Bove,  1997).  Haemoglobin  in  human  blood  is
approximately  97%  saturated  at  normobaric  pressure  and  blood  plasma
contains 0.3 ml of oxygen per 100 ml (Lambertsen et al. 1953); at rest tissues
require approximately 6 ml of oxygen per 100 ml of plasma which is supplied
primarily from that bound to haemoglobin.
The  amount  of  oxygen  dissolved  in  plasma  is  proportional  to  the  partial
pressure of oxygen (pO2); this increases to 1.5 ml per 100 ml when breathing
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100%  oxygen  at  normobaric  pressure,  and  to  6  ml  per  100  ml  at  3  ATA
(Lambertsen  et  al.  1953).  This  higher  concentration  of  plasma  oxygen  can
improve  tissue  oxygenation  in  two  ways:  (i)  plasma  can  reach  tissue  with
restricted  microcirculation  as  it  can  flow  through  vessels  too  narrowed  or
inflexible to allow the passage of red blood cells, and (ii) an increased oxygen
concentration  gradient  between  plasma  and  tissue  means  that  oxygen  can
diffuse further into tissue.
Tissue  oxygen  tension  when  breathing  normobaric  air  is  approximately
55 mm Hg (Tibbles & Edelsberg, 1996); HBO can increase this to greater than
900 mm Hg at 2.5 ATA (Fife et al. 2002), though this will be influenced by any
underlying pathology. It is important to note that wound tissue is usually hypoxic
in relation to healthy tissue; a rat wound model demonstrated tissue oxygen
tension as low as 7 mm Hg in the acute stages of a wound, gradually increasing
to 30 mm Hg by the 30th day of healing, however, the oxygen tension in an
infected wound fell to 0 mm Hg and remained so for the 30 days of the study
(Niinikoski et al. 1972). Hypoxia has also been measured, using transcutaneous
oxygen tension monitoring (TCOM), in human chronic wounds, with levels as
low as  3  mm Hg in  the  skin  area  adjacent  to  a  wound  (Fife et  al. 2002).
Significant improvement in tissue oxygenation is required in order for healing to
occur;  90%  of  chronic  wounds  failed  to  heal  if  their  in-chamber  TCOM
measurements  stayed  below  100  mm  Hg;  for  wounds  achieving  600-
699 mm Hg during each treatment session the failure rate dropped to 14.3%
(Fife et al. 2002). This highlights the detrimental effect of severely impaired limb
vascular function on the efficacy of HBO.
TCOM  has  become  a  useful  predictive  tool;  sea  level  measurements  can
confirm tissue hypoxia around the wound site and in-chamber measurements
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with an oxygen challenge (breathing 100 % O2  at 2.2 ATA) has been shown to
be the best indicator as to whether a wound will respond favourably to HBO.
Fife  et al. (2002), concluded that an in-chamber TcPO2  < 400 mmHg indicates
that HBO will fail to result in healing, with a reliability of 75.8%.
1.6.2. Production of ROS/RNS
Phagocytes require oxygen for the “respiratory burst”, an important mechanism
for bacterial killing (Allen et al. 1997). Figure 1.6 illustrates some of the reactive
oxygen  species  (ROS)  and  reactive  nitrogen  species  (RNS)  that  may  be
produced by phagocytes during this process (Halliwell, 2006).
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Figure  1.6.  A schematic  of  how some  ROS  and  RNS  are  generated  by  phagocytes.  The
membrane bound NADPH oxidase catalyses the production of O2•- which dismutates to H2O2.
The enzyme myeloperoxidase (MPO) catalyses the oxidation of Cl - to produce HOCl. In the
presence of free Fe2+, HO• is produced via Fenton chemistry. Inducible nitric oxide synthase 2
(NOS2) catalyses the conversion of L-arginine to NO• which reacts with O2•- to produce ONOO-.
The membrane-bound NADPH oxidase catalyses the production of superoxide
(O2•-) which rapidly dismutates to H2O2.  Having relatively low reactivity, H2O2 is
able to diffuse in and out of cells and traverse some distance from its source;
though capable of damaging molecules itself, in the presence of free iron the
highly reactive hydroxyl radical (OH•) is produced via Fenton chemistry.
             Fe2+ + H2O2                         Fe3+ + OH• + OH-       
                                                                                
Increased  levels  of  iron-binding  proteins  have  been  found  in  chronic  non-
healing  wounds  (Yeoh-Ellerton  &  Stacey,  2003),  though  the  potential  for
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microbial  products,  such  as  elastases,  to  modify  their  function  has  been
demonstrated  (Britigan  &  Edeker,  1991);  OH• radicals  were  produced  when
diferrictransferrin  was  exposed  to  Pseudomonas elastase.  It  is  not  known
whether free iron exists  in vivo  in chronic wounds or whether it contributes to
Fenton chemistry to generate OH•.
Myeloperoxidase (MPO) is a mammalian haem-containing oxidoreductase and
is  the  main  component  of  neutrophil  azurophilic  granules.  It  uses  H2O2 to
oxidise halides, the rate and preference of which is dependent on physiological
concentrations  and  pH  (Senthilmohan  &  Kettle,  2006).  It  has  been
demonstrated that at pH 5-7, 90% of H2O2 oxidises chloride (Cl-  ) to produce
hypochlorous  acid  (HOCl)  and  10%  oxidises  bromide  (Br-)  to  produce
hypobromous acid (HOBr); at pH 7.8 the amount of H2O2 oxidising Br- rises to
40%.  Plasma  concentrations  of  Cl-  are  approximately  100  mM and  plasma
concentrations of Br-, being in the region of 20-100 µM, are 1,000-fold lower
(Harrison  &  Schultz,  1976)  which  probably  accounts  for  the  perceived
preferential affinity for Cl- as a substrate for MPO. Evidence for the production of
brominating intermediates in vivo has been demonstrated in a mouse model of
polymicrobial  sepsis  where  levels  of  3-bromotyrosine  were  elevated  in
peritoneal fluid (Gaut et al. 2001).
MPO-generated  HOCl  is  responsible  for  both  oxidation  and  chlorination
reactions  (Winterbourn,  2002)  and  will  affect  a  wide  range  of  biological
molecules.  Chloramines,  a  product  of  amine  chlorination  by  HOCl,  is  itself
reactive;  both  HOCl  and chloramines are particularly reactive  towards thiols
(Peskin & Winterbourn, 2001) which makes thiol-containing amino acids, such
as  cysteine,  particularly  vulnerable  to  modification.  Methionine,  histidine,
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tryptophan, tyrosine and various lipid components have all been identified as
potential targets (Malle et al. 2006).
The role of RNS in the bactericidal activity of human phagocytes remains to be
elucidated,  but  they  could  also  play  a  role  in  the  nitration  and  possible
modification of  molecules implicated in antibiotic  resistance.  It  is  known that
nitric oxide synthase 2 (NOS2 or iNOS) is expressed in tissue macrophages in
infectious or inflammatory conditions, which results in a steady production of
nitric  oxide  (NO•)  (Coleman,  2002).  Cellular  nitric  oxide  and  oxygen
concentrations  are  interdependent;  higher  concentrations  of  oxygen  will
increase NOS activity and increased nitric  oxide will  in  turn further increase
oxygen levels. Concurrently, increased oxygen also increases the rate of nitric
oxide consumption (Thomas et al. 2008). Being an uncharged molecule, NO•
can diffuse readily in and out of cells and though having a relatively short half-
life, reacts readily with O2•- to produce peroxynitrite (ONOO-). Peroxynitrite is a
highly reactive molecule in its own right but is readily protonated at physiological
pH to peroxynitrous acid (ONOOH) which can split into two radicals.
The generation of RNS, with a metabolic product of nitric oxide, has also been
demonstrated in  an MPO-catalysed reaction;  nitrite  (NO2-)  when oxidised by
MPO and H2O2 went on to form nitrotyrosine (van der Vliet et al. 1997). Whether
this  system is  of  physiological  importance is  put  into  doubt  by a study that
carried out mass spectrometric analysis of  bacterial  proteins recovered from
neutrophils; proteins were chlorinated rather than nitrated. However, they did
generate  nitrated  proteins  when the  test  medium contained 1  mM of  nitrite
(Rosen et al. 2002). This failed to decrease protein chlorination, a finding at
odds with another study, which found a significant inhibitory effect of nitrite on
the activity of MPO (van Dalen et al. 2000).
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Accepting that various components of  antibiotic resistance mechanisms may
find themselves within a cocktail of reactive molecules, what evidence is there
that  they undergo  modification?  It  has  already been  demonstrated  that  QS
signalling molecules are vulnerable to oxidised halogens (Borchardt et al. 2001;
Rothfork  et al.  2004) (Section 1.5.5), so it is feasible that phagocyte-derived,
and  extracellular  oxidants,  could  exert  similar  effects.  Beta-lactamases  and
other  antibiotic  deactivating  enzymes  are  proteins  and  therefore  potentially
vulnerable to oxidative damage, the degree of which will  depend on enzyme
structure and accessibility of target amino acids.
As previously discussed the heterogeneous biofilm matrix contains numerous
components that could be vulnerable to oxidative damage, e.g. DNA, proteins
and  lipids,  though  this  would  depend  on  the  ability  of  ROS  and  RNS  to
penetrate the EPS. However, quenching of reactive molecules may occur by
sacrificial  matrix  components  with  limited  effect  on  biofilm  function;
P. aeruginosa alginate has been shown to scavenge hypochlorite,  conferring
protection to the organism from this compound (Learn et al. 1987).
It  is necessary to consider the role of antioxidants in an environment that is
normoxic or hyperoxic; aerobic and facultative anaerobic bacteria have a range
of  endogenous  antioxidant  compounds  that  they  may  utilise  as  protection
against oxidative damage (Hassett & Cohen, 1989). They vary from organism to
organism but  may include superoxide dismutase (SOD) which catalyses the
dismutation of O2•- to H2O2, and catalase, which catalyses the decomposition of
H2O2 to O2 and H2O. Glutathione (GSH), a potent antioxidant, does not seem to
be as widely distributed in bacteria,  and expression is dependent on growth
conditions  and growth  stage  (Fahey et  al. 1978);  many bacteria  upregulate
antioxidant defences in the stationary phase of growth. Other thiol-containing
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molecules such as thioredoxin may play a part in bacterial antioxidant defences.
The effectiveness of GSH as a defence against  HOCl and chloramines has
been  demonstrated  in  E.  coli,  both  from endogenously  produced  GSH and
when  GSH  was  added  to  the  extracellular  environment  of  GSH-deficient
organisms (Chesney et al. 1996).
It  appears logical that improved tissue oxygenation and facilitated phagocyte
function could contribute to the bactericidal actions of HBO. A secondary effect
of  phagocyte  production  of  oxidative  products  is  the  release  of  hydrogen
peroxide (H2O2) and myeloperoxidase (MPO) into the extracellular environment
(Test & Weiss, 1984), a process possibly facilitated by HBO; it  is within this
environment that molecules secreted by bacteria to enable antibiotic resistance,
e.g. β-lactamases, QS signalling molecules and biofilm components, could be
vulnerable to oxidative damage.
1.6.3. HBO and antibiotics
Several studies have demonstrated a synergistic relationship between HBO and
antibiotics (Bornside, 1967, Muhvich et al. 1989, Park et al. 1991); hyperoxia at
atmospheric pressure achieves similar results (Brown et al. 1968). The main
effect  is  seen as a reduction in  MICs for a range of,  but  not all,  antibiotics
tested. It has been postulated that the effect is additive rather than synergistic;
in the case of S. aureus, population growth was inhibited by hyperoxia alone, to
the extent that a gradient of growth was dependent upon the volume of medium
used,  indicating  that  the diffusion  of  oxygen into the growth  medium was a
limiting factor for growth inhibition (Bornside, 1967).
HBO and hyperoxia have also been shown to prolong the post-antibiotic effect6
of antibiotics in P. aeruginosa (Park et al. 1991), an organism which, contrary to
6 The time taken for the number of antibiotic treated bacteria to increase by 1 log10 CFU ml-1 after 
antibiotics have been removed.
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S.  aureus,  showed enhanced population  growth  in  hyperoxia.  These results
illustrate  that  the  relationship  between  oxygen  tension  and  antibiotics  is
complex and must involve more than an additive effect. Different organisms will
have  different  responses  to  hyperoxia,  which  will  be  dependent  on  the
effectiveness of their antioxidant defences and their metabolic state; these have
to be considered alongside the effects of hyperoxia on the mode of action of the
antibiotic and the method of entry into the bacterium.
Though various hypotheses have been expressed to explain the above results,
such as an altered redox state as a result of hyperoxia or that antibiotics may
inhibit  induction  of  antioxidants  such  as  GSH  (Park et  al. 1993),  literature
searches  have  failed  to  identify  studies  that  explore  further  the  relationship
between  HBO/hyperoxia  and  antibiotic  efficacy,  and  arguably  of  more
importance  in  present  times,  whether  there  is  an  interaction  between
HBO/hyperoxia and the mechanisms of antibiotic resistance. It is notable that all
the organisms used in the above studies are antibiotic sensitive strains.
1.6.4. The safety of HBO
Provided  that  HBO  therapy  is  administered  in  accordance  with  standard
protocols  to  patients  who  have undergone a  pre-treatment  assessment  it  is
considered  a  safe  procedure.  Mild  adverse  effects,  mainly  as  a  result  of
barotrauma, can be experienced by some patients; these can include ear pain,
toothache  and  sinus  pain  (Tibbles  &  Edelsberg,  1996).  Oxygen  toxicity  is
minimised by inserting regular breaks in the programme where air rather than
100% oxygen is  breathed.  DNA damage is  considered to  be physiologically
insignificant as damage occurring during treatment is rapidly repaired (Speit et
al. 1998).  Evidence also suggests that  antioxidant  defence mechanisms are
upregulated during HBO (Benedetti et al. 2004, Gurdol et al. 2008). Beneficial
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for  a  toxicity  issue,  but  not  for  a  therapeutic  issue  is  that  raised  tissue
oxygenation is only maintained for a short period of time following each HBO
session (Siddiqui et al. 1997) (Fig.3.18).
1.7. Conclusion, hypotheses and aims
Chronic wounds carry a personal and financial burden; evidence suggests that
infection plays an important role in maintaining the non-healing pathology. The
ability  of  bacteria  to  resist  antibiotics  hinders  the  healing  process  as
chemotherapeutic options to clear the wound of infection become limited. The
ability of organisms to survive in a wound biofilm, co-ordinated in part by QS, is
one of several mechanisms that bacteria utilise to resist antibiotics.
Oxidative  damage  to  biological  molecules  may lead  to  modified  activity,  as
demonstrated in the interference of QS, which offers exciting possibilities for
novel methods of infection control and the attenuation of virulence. HBOT has
been shown to reduce the incidence of major amputation for diabetic patients
with foot ulcers which may be due to a reduction in bacterial load. In providing
conditions for the potentiation of oxidative damage HBO can be considered as a
treatment adjunct in the management of antibiotic resistant bacteria in chronic
wounds, however, this appears to be an area as yet unexplored.
The overall  aim of the  in vitro work in this study was to investigate whether
oxidants were able to modify three components related to antibiotic resistance,
the action of penicillinase (Chapter 2),  the signalling ability of QS molecules
(Chapter  3)  and  the  reduction  in  live  cells  within  biofilms  (Chapter  4).  An
overview of  how these  modifications  may  facilitate  wound  healing  during  a
course of HBOT is presented in Figure 1.7.
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Figure  1.7.  Schematic  representation  of  how  HBO  could  facilitate  wound  healing  by  the
modification of antibiotic delivery and efficacy. HBO increases pO2 which results in increased
neoangiogenesis, facilitating improved delivery of antibiotics to the wound. Increased pO2 also
facilitates ROS/RNS production by immune cells which results in damage to the QS signalling
molecules that influence biofilm formation. The combination of ROS and antibiotics results in
increased killing of biofilm cells and ROS/RNS damages β-lactamase enzymes. Together these
effects  increase  antibiotic  efficacy,  which,  along  with  improved  delivery,  leads  to  improved
wound healing.
In order to gain some insight into whether an environment of increased oxidant
generation (i.e. during a course of HBOT) resulted in changes to chronic wound
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microflora populations, a clinical study investigating non-healing DFUs during a
course of HBOT was carried out using the molecular techniques of PCR-DGGE
(polymerase chain reaction-denaturing gradient gel electrophoresis) and cloning
(Chapter 5).
The hypotheses for this thesis are:
i. Oxidative damage to penicillinase results in a significant reduction of
enzyme activity compared to a control.
ii. Oxidative  damage to  QS signalling  molecules  (AHLs)  results  in  a
reduction in the QS signalling activity in bacteria, in vitro and in vivo.
iii. An increase in oxygen concentration in growth conditions that contain
an oxidant generating system results in an increase in bacterial cell
death in biofilms.
iv. HBOT  results  in  changes  to  chronic  wound  microbiological
communities that will influence wound healing.
The aims of this thesis are:
i. to demonstrate that ROS/RNS damage to penicillinase results in a
reduction in enzyme activity.
ii. to determine the effect of oxidants on the strength of QS signalling in
mono-species, planktonic, bacterial cultures
iii. to determine the effect of oxidants on the strength of QS signalling in,
planktonic,  bacterial  cultures  of  mono-species  containing  gene
fusions.
iv. to  determine  the  effect  of  oxygen  concentration  on  MICs  in  both
antibiotic  sensitive  and  antibiotic  resistant  strains  of  bacteria  in
planktonic culture conditions.
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v. to determine the effect of oxygen concentration on the formation of
biofilms in antibiotic sensitive and resistant strains of P. aeruginosa
and S. aureus.
vi. to determine the effect of oxygen concentration on the ability of an
oxidant generating system to kill bacteria in mono-species biofilms.
vii. to complete a molecular analysis of the microbiological communities
in non-healing diabetic foot ulcers during a course of HBOT.
viii. to investigate the presence of fungi in non-healing diabetic foot ulcers
before and during a course of HBOT.
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Chapter 2
The effects of ROS/RNS on the activity of penicillinase
2.1. Introduction
Penicillinase is an antibiotic deactivating enzyme (Section 1.2.1), comprised of
β-lactamases, with specific affinity for the penicillins. It catalyses the hydrolysis
of  the  amide  bond  in  a  β-lactam ring,  a  structural  feature  of  all  penicillins,
rendering the drug ineffective against bacteria that produce this enzyme. The
number of known β-lactamase inhibitors is limited, clavulanic acid, tazobactam
and sulbactam, being the most commonly used adducts to antibiotic therapy
(Bebrone  et  al.  2010).  However,  these  compounds  do  not  inhibit
metalloenzymes and there is evidence of reduced sensitivity amongst naturally
occurring mutant forms of previously vulnerable, β-lactamases (Schroeder et al.
2002) and for this reason the search for new methods of inhibition is ongoing. 
The aim of this study was to investigate whether H2O2, HOCl, ONOO-, and MPO
generated oxidants were able to significantly reduce the activity of penicillinase.
These  ROS/RNS  were  chosen  because  it  is  feasible  that  they  occur
extracellularly in a chronic wound environment where secreted β-lactamases
could accumulate. Though the measurement of ROS in wounds is problematic it
is known that immune cells such as neutrophils release their contents (Section
1.6.2.) via degranulation (Amulic et al. 2012) and the production of extracellular
traps, a netwok of strands with bound MPO (Parker & Winterbourn, 2013) that
have been detected in vivo in gingival pockets (Vitkov et al. 2009). H2O2 readily
diffuses out of cells and could act as a substrate for the net-bound MPO to
produce extracellular HOCl. Levels of these ROS, associated with neutrophil
extracellular traps, have been found to be sufficient for bacterial (Brinkmann et
al. 2004) and fungal killing (Urban et al.2006).
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The choice of ROS concentration was based on those measured in vivo; HOCl
concentrations have been estimated to vary between 25 and 200 μM (McCall et
al, 2001), reaching the upper level in pathological conditions. H2O2  levels have
been measured in several human tissues and systems, including up to around
100 μM in urine (Long et al, 1999) and ocular tissue (Spector et al,1998), and
very  low  μM  levels  in  human  plasma  (Halliwell  et  al,  2000).  A  range  of
concentrations  was  used  for  each  ROS,  apart  from  ONOO -,  which  was
determined by the limited volume synthesised.
The penicillinase used in this study was from Bacillus cereus (B. cereus) and
comprised two β-lactamases (Section 1.2.1); one had a serine at its active site,
the other was a metalloenzyme that utilised two zinc ions as cofactors. In order
to  determine  whether  supplemental  zinc  was  necessary  for  metalloenzyme
function an assay was performed of enzyme activity with various concentrations
of ZnSO4. It was also beneficial to determine what proportion of activity was due
to each β-lactamase, so a further assay of penillinase activity was carried out
with the addition of various concentrations of EDTA, a chelating agent. EDTA
should reduce the activity of the metalloenzyme, but not the serine containing
enzyme,  if  the  EDTA bound  the  active  site  zinc  ions  sufficiently  to  disrupt
function.
Trace amounts of catalytic transition metals in buffer may result  in oxidative
reactions,  such as that  produced via  Fenton chemistry (Section 1.6.2.),  that
affect the interpretation of data from assays. It was therefore desirable to treat
all buffers with a chelating agent prior to use. Chelex, an ion-exchange resin,
was used to treat all vulnerable solutions. An ascorbate assay was performed to
check that  Chelex had successfully removed trace metals from a sample of
treated buffer.
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The penicillinase was exposed to ROS/RNS, and modification of activity was
determined using a colorimetric assay with CENTA as a substrate. CENTA is a
chromogenic  cephalosporin  which  is  readily  hydrolysed  by  β-lactamases
(Bebrone  et  al.  2001).  It  undergoes  a  colour  change  from  light  yellow  (λ
maximum  340  nm)  to  chrome  yellow  (λ  maximum  405  nm)  making  it
measurable with  a spectrophotometer.  Due to  the possibility  that  ROS were
able to bleach CENTA the absorbance of CENTA was measured following the
addition of various concentrations of ROS.
In addition to looking at the direct effect of ROS on penicillinase activity a ROS
generating model  was also  investigated.  Initially,  lactoperoxidase (LPO) was
used as an oxidant generating model as it was cheaper to purchase than MPO.
LPO is a haem-containing peroxidase which catalyses the oxidation of halides
or pseudohalides, particularly iodide and thiocyanate, by hydrogen peroxide. In
mammals it is found in milk, saliva and tears (Morrison et al. 1965, Thomas et
al. 1994). The products of oxidation, iodine and thiocyanous acid, are known to
be  antimicrobial  (Welk  et  al.  2009)  as  well  as  potential  oxidising  agents.
However, this model was unsuccessful and it was decided to use MPO.
MPO  is  a  haem-containing  peroxidase  found,  predominantly,  in  neutrophils
(Section 1.6.2.). When stimulated, neutrophils generate O2•- and H2O2 during the
“respiratory burst”  and MPO utilises  H2O2  and a  halide,  or  pseudohalide,  to
produce other ROS, however, it is unique amongst the peroxidases for being
able to utilise chloride as a substrate (Winterbourn, 2002) to produce HOCl:
                           H2O2 + Cl- →H2O + HOCl
As H2O2 is a substrate of MPO it was necessary to include H2O2 alone as a
control  to determine how much of the reduction in penicillinase activity may
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have  been  due  to  H2O2 directly.  Catalase  was  used  to  quench  H2O2 and
reduced glutathione was used to quench HOCl, in order to control the time that
penicillinase was exposed to the oxidants. In order to estimate whether residual
activity, following ROS exposure, was that of the metalloenzyme, assays were
carried out with the addition of EDTA just prior to the determination of enzyme
activity. 
To summarise, the aim of this study was to demonstrate that ROS/RNS damage
penicillinase and result in a reduction in enzyme activity. The objective was to
measure  penicillinase  activity  following  exposure  to  various  RS.  This  study
found that the penicillinase used was vulnerable to H2O2, HOCl, ONOO-, and
possibly, MPO generated oxidants. 
2.2. Materials and methods
2.2.1. Chemicals
CENTA and myeloperoxidase (Cat# 475911) were obtained from Calbiochem
(Merck  Serono  Ltd,  Feltham,  Middlesex,  UK).  Ethanol,  glacial  acetic  acid,
hydrochloric  acid,  L-  ascorbic  acid  (sodium  salt)  and  sodium  iodide  were
obtained  from  BDH  Biochemical  (VWR,  BDH  Prolabo,  Lutterworth,
Leicestershire, UK). Catalase (Cat# 60635), Chelex 100 (sodium form, 200-400
mesh)  DMF,  DTPA,  EDTA,  glutathione,  guaiacol,  hydrogen  peroxide  (30%),
lactoperoxidase  (from  bovine  milk,  Cat#  61328),  penicillinase,  sodium
thiocyanate, TMB, taurine and all  inorganic salts were obtained from Sigma-
Aldrich (Poole, Dorset, UK). Bleach was obtained from J Sainsbury plc (London,
UK). Potassium permanganate was kindly donated by Nick Crocker (University
of Plymouth, Plymouth, UK). All water used was prepared in a Milli-Q system
(resistivity = 18 MΩ·cm-1).
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2.2.2. Preparation of Chelex-treated potassium phosphate buffer
Stock  solutions  of  1  M  potassium  phosphate  (monobasic)  and  potassium
phosphate (dibasic) were prepared. Appropriate volumes of each solution were
combined  and  then  diluted  with  ultrapure  water.  The  pH  was  checked  and
adjusted before making up to the final volume.
Dialysis tubing (20 mm wide) was prepared by cutting a length 10 cm long and
boiling it for 5 min in 1 mM EDTA, pH 8. Once cool, the tubing was rinsed well
with dH2O. For each 500 ml of buffer 2.5 g of Chelex was placed in the prepared
dialysis tubing. Each end of the tubing was knotted after squeezing out any air.
The tube containing the Chelex was placed in a bottle of buffer and shaken
overnight, on an orbital shaker at 100 rpm. The Chelex was left in the buffer.
Unless  otherwise  stated  all  buffer  used in  work  involving  penicillinase was  
50 mM potassium phosphate buffer, pH 7 and was stored at 4 °C.
2.2.3. Ascorbate assay for trace metal contamination of buffer
An assay, based on the method by Buettner (1988), was carried out to check
the efficiency of Chelex in the removal of trace metals. Briefly, 1 ml of untreated
potassium phosphate buffer was placed in a 1.6 ml volume cuvette (disposable
plastic, UV – 220-900 nm, Fisher Scientific, Loughborough, Leicestershire, UK).
The  cuvette  was  placed  in  a  UV spectrophotometer  (Perkin  Elmer  UV/VIS,
Lambda Bio 20, with UV WinLab Software, Cambridge, UK) with a circulating
water bath at 25 °C. One microlitre of 100 mM sodium ascorbate solution was
added  to  the  cuvette  and  stirred  thoroughly  after  which  absorbance  was
measured  at  265  nm for  15  min.  The  data  was  plotted  (SigmaPlot,  Systat
Software Inc. Hounslow, London, UK) and using linear regression analysis, the
mean reaction rate % change min-1 was calculated (Table 2.1).
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Table 2.1. Mean rate of ascorbate loss in treated and untreated buffer, n = 4
Buffer % loss of ascorbate in 15 min
Untreated buffer 13.95
Chelex treated buffer 0.43
The lower percent loss of ascorbate from the treated buffer indicated that the
Chelex was successfully removing transition metals from the buffer,  and fell
below the upper limit of 0.5 % loss of ascorbate in 15 min, which indicated non-
significant metal contamination (Buettner, 1988).
2.2.4. Penicillinase activity with CENTA as substrate 
In order to determine the optimal concentration of penicillinase and its substrate
to use for all  enzyme activity assays following ROS exposure, a colorimetric
assay was carried out using CENTA as a substrate.  Purchased CENTA was
reconstituted in buffer and stored in 1 ml aliquots of  0.4 mg ml-1 at  -20 °C.
Penicillinase  (from  B cereus,  1,500-3000  U  mg-1 protein7)  was  dissolved  in
buffer and stored in 500 µl aliquots of 500 U ml-1 at -20 °C. All solutions were
thawed on ice immediately prior to use.
For the assay, CENTA (0.4 mg ml-1) was diluted with buffer to make 5 ml of 0.02
mg  ml-1;  stock  penicillinase  was  diluted  with  buffer  to  make  5  different
concentrations. Three hundred microlitres of buffer was added to a 1 ml plastic
cuvette (1 cm path length) which was placed in a spectrophotometer with a
circulating water bath at 30 °C; 450 µl of CENTA (0.02 mg ml-1) was then added
and stirred. Continuous readings were commenced at 405 nm and 150 µl of
penicillinase (13.8 U ml-) was added to the cuvette and stirred thoroughly for
approximately  10  s.  Absorbance  was  read  for  10  min.  This  procedure  was
repeated  for  all  concentrations  of  penicillinase.  The  spectrophotometer  was
blanked  with  1  ml  buffer  prior  to  all  samples  being  read.  This  assay  was
7 One unit will catalyse the hydrolysis of 1.0 µmol of substrate (benzylpenicillin) per min at pH7, at 25 °C.
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repeated  for  all  new  batches  of  penicillinase  or  CENTA and  the  optimum
concentrations  were  deemed  as  those  that  gave  good  absorbance  values  
(> 0.05) with a reaction rate that did not level off too soon. Although it would
have  been  preferable  to  obtain  a  linear  rate  of  increase  in  absorbance  for
several minutes this was not always achieved. 
2.2.5. Effect of EDTA on penicillinase activity 
The  basic  penicillinase  and  CENTA  assay  was  repeated  with  various
concentrations of EDTA; a 900 µl volume in each cuvette consisting of 446 µl of
50 mM potassium phosphate buffer, pH 7, 450 µl of CENTA (0.04 mg ml -1), and
2  µl  of  EDTA  (various  concentrations).  Two  microlitres  of  penicillinase  
(81 U ml-1) were added to initiate the reaction and the contents were read at  
405 nm for 10 min. 
2.2.6. Effect of zinc supplementation on penicillinase activity
The  basic  penicillinase  and  CENTA  assay  was  repeated  with  various
concentrations of ZnSO4; a 900 µl volume in each cuvette consisting of 430 µl
of 50 mM potassium phosphate buffer, pH 7,450 µl of CENTA (0.04 mg ml -1),
and 10 µl of ZnSO4 (various concentrations). Ten microlitres of penicillinase  
(225 U ml-1) was added to initiate the reaction and the contents were read at 
405 nm for 10 min. 
2.2.7. Catalase assay
The enzyme catalase  was  used  for  the  quenching  of  H2O2 in  some of  the
following assays:         2 H2O2     Catalase      2 H2O + O2 
An assay of catalase activity was carried out based on the decomposition of
H2O2 (Sigma-Aldrich, 2008). The spectrophotometer (with circulating water bath
at 25 °C) was blanked with 1.5 ml of 50 mM potassium phosphate buffer, pH 7.
A cuvette (UV range, plastic) containing 1.45 ml of 0.036 % H2O2 was placed in
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the  spectrophotometer  and  recording  was  commenced  at  240  nm.  Fifty
microlitres  of  suspension  (100  U  ml-1)  was  added  to  the  cuvette  and  the
contents stirred well for 5-10 s; recording was continued for a further 10 min.
The calculation used to determine activity can be found in Appendix 1.
2.2.8. General protocol for the exposure of penicillinase to ROS
The assay carried out for each exposure of penicillinase to ROS had the same
basic structure, but as solutions and concentrations varied the assay will  be
described in detail in each appropriate section. Briefly, the core of the assay
involved exposing penicillinase to ROS for up to 60 min with samples being
removed  at  10  min  intervals  from  time  zero.  The  oxidative  reaction  was
quenched for each sample removed and the samples were stored on ice. At the
end of sampling three replicates of each time point were placed in a 96-well
plate (clear, plastic, flat-bottom) and the plate was read at 405 nm immediately
following the addition of CENTA. Details of controls used will be given in each
section. All  data were plotted with SigmaPlot and either linear,  or non-linear
(exponential  rise  to  maximum,  single,  3  parameter)  regression  analysis
performed to determine the initial reaction rate. The equation to determine initial
rate can be found in Appendix 2.
Concentrations  of  penicillinase  varied  throughout  the  study  due  to  batch
differences  in  enzyme  activity.  The  concentration  used  for  exposure  was
determined.  Alongside  that  of  CENTA,  from  the  enzyme  activity  assay
described in Section 2.2.4. Prior to starting the assay penicillinase and CENTA
were thawed, diluted with buffer to appropriate concentrations and stored on
ice.  All  other  solutions  used  were  prepared  as  required  and  stored  on  ice.
Details  of  these  solutions  will  be  given  in  the  appropriate  sections  of  this
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chapter.  All  assays  were  carried  out  at  least  three  times  unless  otherwise
stated.
2.3. Exposure of penicillinase to lactoperoxidase generated oxidant
2.3.1. Lactoperoxidase activity assay
An  assay  to  determine  lactoperoxidase  activity  was  based  on  that  in  the
Worthington Enzyme Manual (Worthington & Worthington 2007), which was a
modification  of  that  of  Morrison  (1970).  The  rate  of  oxidation  of  iodide  to
triiodide is measured spectrophotometrically. It was observed, however, that a
fall in the rate of reaction occurred after only 30 s; after consulting the original
paper it was noted that different concentrations of H2O2 had been used in the
two assays and as it has been suggested that an excess of H2O2 may inhibit
enzyme activity (Galijasevic et al. 2004) it was decided to investigate the effect
of H2O2 concentration on LPO activity.
A reaction mixture was prepared containing 50 mM potassium buffer, pH 7,  
5 mM potassium iodide (KI) and 0.45 mM H2O2. One millilitre of reaction mixture
was placed in a cuvette and a blank rate established at 350 nm, at 25 °C. LPO
(3 μl  of  66.3  U ml-1)  was  then added to  the  cuvette  and stirred  vigorously.
Absorbance was read at 1 s intervals for 5 min. The above was repeated with
the reaction mixture containing 0.3 mM and 0.15 mM H2O2, respectively. The
calculation to determine U mg-1 enzyme can be found in Appendix 3.
2.3.2. Exposure of penicillinase to LPO generated oxidant
Initially an assay using KI as a substrate was used, but data was extremely
inconsistent so a revised protocol using thiocyanate (SCN -) was devised. Four
conditions were prepared (Table 2.2) in 1.5 ml microcentrifuge tubes. At time
zero,  for  each  condition  (this  was  staggered,  with  2  min  intervals),  100  µl
penicillinase (23.5 U ml-1) was added and mixed well; immediately 60 µl was
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transferred  to  a  0.7  ml  microcentrifuge  tube  containing  1  µl  of  catalase8
(20 000 U ml-1). This was mixed well and stored on ice. At 10 min intervals a
further 60 µl of mix was transferred in the same manner, for all conditions. This
was repeated for up to 60 min. The final concentration of penicillinase in each
tube was 4.7 U ml-1.
Table 2.2.  Exposure of penicillinase to LPO-derived oxidants. Volumes and concentrations of
solutions combined for each condition. Values in brackets are final concentrations. At time zero,
100 μl of penicillinase (23.5 U ml-1) was added to each condition. The final concentration of
penicillinase in each tube was 4.7 U ml-1.
Condition Potassium
phosphate buffer
SCN- H2O2 LPO9 H2O
ROS exposed
penicillinase
390 µl 50 mM pH7 5 µl 50 mM
(500 μM)
3 µl 25 mM
(150 μM)
2 µl 78 U ml-1
(0.3 U ml-1)
Penicillinase
activity
control
390 µl 50 mM pH7 10 µl
No enzyme
control
390 µl 50 mM pH7 5 µl 50 mM
(500 μM)
5 µl 15 mM
(150 μM)
No substrate
control
390 µl 50 mM pH7 10 µl 15 U ml-1
(0.3 U ml-1)
When all samples had been collected, 15 µl from each tube was transferred to
each of  three wells  in a  96-well  microplate.  Immediately,  250 µl  of  CENTA  
(0.01 mg ml-1) was added to each well containing samples and also to a further
three wells to provide an absorbance measurement for CENTA. The plate was
read in a platereader (Optimax, Molecular Devices, Wokingham, Berkshire, UK)
at 405 nm for 10 min. Data were acquired with SoftmaxPro software and plotted
with SigmaPlot software.
2.4. Exposure of penicillinase to MPO-generated oxidants
8  2000 U mg-1 protein. One unit will decompose 1.0 μM H2O2 min-1 at pH7 at 25 °C.
9 88 U mg-1 protein, 39 U mg-1 solid. One unit will form 1.0 mg purpurogallin from pyrogallol in 20 s at 
pH 6 at 20 °C.
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2.4.1. Chloramine production by MPO
MPO  activity  with  chloride  as  the  halide  substrate  was  assayed  using  the
method of Dypbukt  et al. (2005).  Briefly,  the chlorination of taurine by HOCl
results in the production of taurine chloramine, which is then detected by iodide
catalysed  oxidation  of  TMB  to  a  blue  product  which  is  proportional  to  the
concentration of taurine chloramine.
2.4.2. MPO assay standard curves
Standard  buffers  were  prepared  with  various  concentrations  of  HOCl  
(Table  2.3).  HOCl  was  prepared  by  diluting  bleach  with  50  mM potassium
phosphate  buffer,  pH  7,  and  reading  absorbance  at  235  nm  to  determine
concentration  (ɛ235 =  100  M-1  cm-1).  The  developing  reagent  was  prepared  
(Table 2.3) immediately before use.
Table 2.3.  Composition and final concentrations of standard buffer and developing reagent for
the formulation of standard curves. * TMB was dissolved in DMF (20 mM TMB) prior to addition
to the developing reagent.
Standard Buffer pH 7.4 Developing Reagent
10 mM phosphate buffer 400 mM acetate buffer, pH 5.4
140 mM NaCl 2 mM TMB* 
10 mM KCl 100 µM NaI
5 mM taurine
HOCl
Two hundred microlitres of each standard was transferred to each of three wells
of a 96 well plate; 50 µl of developing reagent was then added to each well. The
plate was left  at room temperature for 5 min before reading at 650 nm. The
control consisted of standard buffer with ultrapure water in place of HOCl.
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2.4.3. MPO assay
Taurine containing buffer was prepared fresh prior to each run of the assay, the
composition  of  which  is  20  mM  potassium  phosphate  buffer,  pH  6.5,  
100 mM sodium chloride  and 5  mM taurine,  and  6.5  ml  of  this  buffer  was
transferred to a 20 ml universal container. To this was added 5.91 µl of MPO
(594 U ml-1) and the contents of the container were stirred well. Seven hundred
microlitres of this mix was added to each of nine 1.5 ml microcentrifuge tubes
and these were stored on ice. At time zero, 7 µl of 2mM H2O2 was added to one
of  the  microcentrifuge  tubes  followed  immediately  by  3  µl  of  catalase
 (9320 U ml-1). The contents were mixed well and these were stored on ice. This
was repeated for all microcentrifuge tubes containing the taurine-buffer mix but
catalase was added after a different time period for each tube. From each tube,
200  µl  was  transferred  to  each  of  three  wells  in  a  96-well  plate;  50  µl  of
developing reagent (as described in Section 2.4.2.) was added to each well and
the plate was left at room temperature for 5 min after which it was read at 650
nm. The equation for calculating the concentration of HOCl at each time point
can be found in Appendix 4.
2.4.4. Exposure of penicillinase to MPO-derived oxidants
Three 1.5 ml microcentrifuge tubes were prepared (Table 2.4) and left at room
temperature. At time zero, 100 µl of penicillinase (34 U ml -1) was added to one
of the tubes, vortexed briefly, and immediately 60 µl was transferred to a 0.7 ml
microcentrifuge tube containing 1 µl of catalase (2 × 104 U ml-1). This was stored
on ice. This process was repeated for all other tubes. At 10 min, and thereafter,
at 10 min intervals up to a total of 60 min; 60 µl aliquots were transferred from
each  tube  to  fresh  microcentrifuge  tubes  containing  catalase.  The  final
concentration of penicillinase in each tube was 6.8 U ml-1.
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Table  2.4.  Exposure  of  penicillinase  to  MPO-derived  oxidants.  Contents  of  each  1.5  ml
microcentrifuge tube. Penicillinase (100 μl of 34 U ml-1) was added to each tube at time zero
(this  was  staggered  to  allow  time  to  remove  first  sample).  Values  in  brackets  are  final
concentrations in the tube. The final concentration of penicillinase in each tube was 6.8 U ml-1.
ROS exposed
penicillinase
Penicillinase activity
control
No enzyme control
50 mM potassium 
phosphate buffer
365 µl 365 µl 365 µl
150 mM H2O2 5 µl
(1.5 mM)
5 µl
(1.5 mM)
3 M NaCl 25 µl
(150 mM)
25 µl
(150 mM)
135 U ml-1 MPO 5 µl
(1.35 U ml-1)
Ultrapure H2O 35 µl
When all samples had been collected, 15 µl of each sample was placed in each
of  three wells  of  a  96  well  plate.  When all  aliquots  had been transferred,  
250 µl of CENTA (0.01 mg ml-1) was added to each well. The same volume of
CENTA was also added to three wells containing 15 µl of buffer only. The plate
was read at 405 nm for 10 min.
2.5. Exposure of penicillinase to H2O2
As it was observed that H2O2 with no added MPO also reduced the activity of
penicillinase it was decided to investigate this effect in more detail. The method
was  exactly  the  same  as  that  described  in  Section  2.4.4.,  except  for  the
contents of the tubes (Table 2.5).
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Table  2.5.  Contents of  tubes  for  exposure  of  penicillinase  to  H2O2.  At  time zero 100 μl  of
penicillinase  (180  U  ml-1)  was  added  to  each  tube.  The  far  left  column  gives  the  final
concentration of H2O2 that penicillinase was exposed to in the tube. The final concentration of
penicillinase was 36 U ml-1.
Control 370 µl 50 mM potassium phosphate buffer, pH 7 30 µl H2O
15 μM H2O2 370 µl 50 mM potassium phosphate buffer, pH 7 30 µl 250 µM H2O2
150 μM H2O2 370 µl 50 mM potassium phosphate buffer, pH 7 30 µl 2.5 mM H2O2
1.5 mM H2O2 370 µl 50 mM potassium phosphate buffer, pH 7 30 µl 25 mM H2O2
2.5.1. The effect of EDTA on H2O2 exposed penicillinase
A modification of the protocol (Section 2.4.4) was carried out to investigate the
effect of EDTA on H2O2 exposed penicillinase. Two tubes were prepared (Table
2.6) and two samples were taken from each tube at time zero, as previously
described.  Two further  samples  were  taken from each tube after  60  min of
exposure time only.
Table  2.6.  Contents of  tubes  for  exposure  of  penicillinase  to  H2O2.  At  time zero 100 μl  of
penicillinase  (180  U  ml-1)  was  added  to  each  tube.  The  far  left  column  gives  the  final
concentration of H2O2 that penicillinase was exposed to in the tube. The final concentration of
penicillinase was 36 U ml-1.
Control 370 µl 50 mM potassium phosphate buffer, pH 7 30 µl H2O
1.5 mM H2O2 370 µl 50 mM potassium phosphate buffer, pH 7 30 µl 25 mM H2O2
One microlitre of EDTA (6 mM) was added to one sample from each tube, for
the  60 min time point  only.  Catalase was used,  as  previously described,  to
quench the reaction. Samples were left at room temperature for 5 min. Three
replicates of  each sample were  transferred to  a 96 well  plate as previously
described and the plate was read at 405 nm for 10 min following the addition of
CENTA. The final concentration of EDTA in the tubes was 100 µM.
2.5.2. The effect of H2O2 on the absorbance of CENTA
In order to rule out any bleaching effect of H2O2 on CENTA, the absorbance of
CENTA  was  measured  before  and  after  incubation  with  H2O2. Four
concentrations of H2O2 were prepared, which when 50 µl was added to 250 µl of
CENTA resulted in the following concentrations: 10 µM, 100 µM, 1 mM and  
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10 mM. Three replicates of each concentration were transferred to a 96 well
plate  and three wells  were included with  added water  as a control;  CENTA
(250 μl of 0.02 mg ml-1) was added to each well and the absorbance read at  
340 nm. The plate was left at room temperature for 3 min and then read again.
2.6. Exposure of penicillinase to HOCl
The method for this exposure experiment was the same as that described in
Section  2.4.4.  except  for  the  contents  of  the  tubes  (Table  2.7)  and 1  µl  of
reduced glutathione (60 mM) which was added to each 0.7 ml microcentrifuge
tube, instead of catalase, to quench the reaction of HOCl with penicillinase.
Table  2.7.  Contents of  tubes for  exposure of  penicillinase to  HOCl.  At  time zero 100 μl  of
penicillinase  (180  U  ml-1)  was  added  to  each  tube.  The  far  left  column  gives  the  final
concentration of HOCl that penicillinase was exposed to in the tube. The final concentration of
penicillinase was 36 U ml-1.
Control 370 µl 50 mM potassium phosphate buffer, pH 7 30 µl H2O
4 μM HOCl 370 µl 50 mM potassium phosphate buffer, pH 7 30 µl 68 µM HOCl
8 μM HOCl 370 µl 50 mM potassium phosphate buffer, pH 7 30 µl 136 µM HOCl
16 μM HOCl 370 µl 50 mM potassium phosphate buffer, pH 7 30 µl 272 µM HOCl
2.6.1. The effect of HOCl on the absorbance of CENTA
A range of dilutions, from 20 µM to 1.5 mM, of HOCl were prepared and three,
50 µl, replicates of each dilution were placed in a 96 well plate. Fifty microlitres
of 50 mM potassium phosphate buffer, pH 7, were also added to three wells.
Two hundred and fifty microlitres of CENTA (0.024 mg ml -1) was added to each
well and the plate was read at 340 nm.
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2.7. Exposure of penicillinase to peroxynitrite
In order to determine whether reactive nitrogen species were also capable of
reducing the activity of  penicillinase, peroxynitrite (ONOO-)  was synthesised,
based on a method by Robinson and Beckman (2005).
2.7.1. Synthesis of ONOO-
A 250 ml  conical  flask  containing  50 ml  of  0.6 M NaNO2 was placed on a
magnetic  stirring  plate  in  a  fume  cupboard.  Fifty  microlitres,  containing  
30 ml of 1 M HCl, 15 ml of ultrapure H2O and 5 ml of 9.79 M H2O2, was added to
the flask, immediately followed by the addition of 50 ml 1.2 M NaOH. This is a
highly exothermic reaction and great care was taken at all times. Immediately
following the addition of NaOH the contents of the flask were carefully poured
into a 250 ml conical  flask whose base was thinly covered with manganese
dioxide. This flask was placed on ice for 15 min. The suspension was then
filtered through grade No. 5 filter paper (Whatman plc, Maidstone, Kent, UK)
and stored overnight in 20 ml aliquots at -20 °C. The following day, the ONOO -
solutions were removed from storage and the yellow liquid  supernatant  was
aliquoted into 0.7 ml microcentrifuge tubes and stored at -80 °C.
The concentration of  ONOO- was determined by measuring absorbance at  
302 nm, using 0.4 M NaOH as a blank (ε302 = 1670 M-1 cm-1).
2.7.2. Exposure of penicillinase to synthesised ONOO-
Due  to  the  high  pH  of  the  ONOO- solution,  this  exposure  experiment  was
carried out with 50 mM potassium phosphate buffer, pH 4.6, to bring the pH
down  to  that  of  the  control.  Standard  buffer,  pH  7  was  used  for  control
conditions. The contents of each tube are given in Table 2.8.
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Table 2.8. Contents of tubes for exposure of penicillinase to ONOO-.  The final concentration of
ONOO- is given in the far left column. At time zero 100 μl of penicillinase (180 U ml-1) was added
to each tube, giving a final concentration of 36 U ml-1.
Control 370 µl 50 mM potassium phosphate buffer, pH 7 30 µl H2O
104 μM 
ONOO-
370 µl 50 mM potassium phosphate buffer pH 4.62 30 µl 1.77 mM ONOO-
One hundred microlitres of penicillinase (180 U ml-1) were added at time zero.
As there was no effective way to quench the reaction between ONOO - and
penicillinase, 60 µl samples were taken at time zero for the control only and
after 60 min of exposure for all conditions. At the end of exposure all samples
were immediately loaded into a 96 well plate as previously described (Section
2.3.2.) and 250 µl of CENTA (0.02 mg ml-1) were added to each well, including
three wells containing standard buffer only. The plate was read at 405 nm for
10 min.
2.7.3. The effect of ONOO- on the absorbance of CENTA
Fifteen microlitres of 100 µM ONOO- were added to each of three wells in a 96
well  plate; 15 µl of standard buffer was placed in a further three wells. Two
hundred and fifty microlitres of CENTA (0.02 mg ml-1) were added to each well
and the plate was read at 340 nm.
2.8. Results
2.8.1. Penicillinase catalysed the hydrolysis of CENTA
A  scan  to  demonstrate  the  shift  in  λ  maximum  for  CENTA  exposed  to
penicillinase  was  carried  out  based  on  the  method  of  Jones  et  al.  (1982).
Penicillinase  catalysed  the  hydrolysis  of  CENTA  resulting  in  a  product
detectable at 405 nm (Figure 2.1). The measured activity of penicillinase was
dose dependent (Figure 2.2).
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Figure  2.1.  Absorption  spectra  of  CENTA (0.053  mg  ml-1)  before  and  after  exposure  to
penicillinase (4.6 U ml-1). Briefly, CENTA (990 μl of 0.054 mg ml-1) was placed in a 1 ml plastic
UV cuvette. This was scanned in a spectrophotometer (Perkin Elmer) through a wavelength
range of 250-600 nm. Following the scan, penicillinase (10 μl of 230 U ml -1) was added to the
cuvette  and stirred thoroughly.  The CENTA was scanned again through the same range of
wavelengths.
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Figure 2.2. Hydrolysis of CENTA as a measure of penicillinase activity. The concentrations given
are of penicillinase. The initial concentration of CENTA was 0.01 mg ml-1.
2.8.2. Zinc supplementation did not affect penicillinase activity
The addition of zinc sulphate to the buffer, in ten-fold dilutions, did not result in
any significant changes to penicillinase activity (Fig. 2.3); it was concluded that
zinc ion supplementation was unnecessary.
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Figure 2.3. Effect of zinc ions on penicillinase activity. The penicillinase assay, with CENTA as
substrate was performed with zinc sulphate added to buffer and CENTA (0.02 mg ml -1) prior to
addition of penicillinase (2.5 U ml-1). Results are means ± SE, n=3. There was no significant
difference between the activity under any of the conditions, p = 0.101 (One way ANOVA).
2.8.3. EDTA reduced the activity of penicillinase 
As  previously  mentioned  (Section  2.2.6),  part  of  penicillinase  comprises  a
metallo-β-lactamase with  zinc  at  its  active  site;  it  was  optimal,  therefore,  to
determine  whether  a  chelating  agent  such  as  EDTA would  affect  enzyme
activity.  The activity of penicillinase reduced, when exposed to EDTA, before
settling at a level of residual activity of approximately 60% of that of the control
(Fig. 2.4).
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Figure  2.4.  Activity  of  penicillinase  following  exposure  to  various  concentrations  of  EDTA,
expressed as a percentage of that of the control (no EDTA). Penicillinase (0.18 u ml -1) activity
was determined by measuring the hydrolysis of CENTA (0.02 mg ml-1) at 405 nm for 10 min.
These data represent a single experiment only.
2.8.4. Activity of LPO
The concentration of H2O2  (0.15 mM) in the original assay by Morrison (1970)
gave the best curve for analysing the activity of LPO on the oxidation of iodide
(Fig. 2.5).
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Figure 2.5. The effect of H2O2 concentration on LPO activity in the oxidation of iodide. KI 5 mM,
LPO 0.2 U ml-1.
2.8.5. LPO was a poor model enzyme for oxidant production for this assay 
The data from this assay were unexpected; samples containing LPO and both
its substrates showed no penicillinase activity for the first 5 min of the assay, but
thereafter a low rate of absorbance increase was seen (Figure 2.6). The erratic
absorbance  was  most  likely  due  to  small  absorbance  changes.  It  was
concluded that a product of the reaction catalysed by LPO may have resulted in
bleaching of the CENTA, but why this appeared to resolve after 5 min is unclear.
An  exposure  experiment  was  carried  out  which  used  four  different  final
concentrations of LPO, but, the data were too noisy and inconsistent to be of
any value. It was decided to abandon LPO as an oxidant generator and to try
MPO instead.
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Figure 2.6. Penicillinase (4.7 U ml-1) activity following exposure to LPO derived oxidants. Legend
indicates exposure time in minutes. LPO, 4 µg ml-1; H2O2, 150 µM; SCN-, 500 µM; CENTA, 0.01
mg ml-1. Each time course is the mean of 3 replicates.
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2.8.6. Chloramine standard curve
Oxidation of TMB is proportional to concentration of HOCl (Fig. 2.7).
Figure 2.7.  Chloramine standard curve. Iodide catalysed oxidation of TMB (2 mM) by taurine
chloramine. Taurine chloramine was produced by adding the above concentrations of HOCl to
taurine which was incubated, with TMB in the presence of iodide, for 5 minutes. The oxidised
TMB was read at 650 nm. The data are means, n = 3. 
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2.8.7. Catalysis of HOCl production by MPO 
MPO (0.027 U ml-1), with 20 µM H2O2 as a substrate, catalysed the production
of HOCl at a rapid rate for the first 15 s (Fig. 2.8); the rate of production then
decreased until  approximately 60 s when it  then declined to  nothing as the
supply of the substrate hydrogen peroxide ran out.
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Figure 2.8  Time course for HOCl production by MPO. Taurine (5 mM) was exposed to MPO
(0.027 U ml-1) with its substrates H2O2 (20 µM) and NaCl (100 mM). The reaction was stopped
with catalase. Absorbance at 650 nm, representing the production of oxidised TMB, and data
from Figure 2.6 were used to calculate HOCl concentrations. See Appendix 2(iv) for equation.
Data represent means ±SE, n = 3.
112
2.8.8. MPO-generated oxidants reduced the activity of penicillinase
MPO-generated oxidants reduced the activity of penicillinase by approximately
80%, compared to the control at time zero, following 60 min of exposure (Fig.
2.9).
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Figure 2.9. Activity of penicillinase (6.8 U ml-1) exposed to MPO-derived oxidants, expressed as
a percentage of activity of the control at time zero. Exposure time indicates the time (min) that
penicillinase  was  exposed  to  each  condition:  water  (open  circle),  H2O2 and  NaCl  (closed
triangle) and H2O2, NaCl and MPO (closed circle). Concentration of H2O2 was 1.5 mM, NaCl,
150  mM,  and  MPO,  1.35  U  ml-1.  Following  exposure  penicillinase  activity  was  measured
spectrophotometrically at 405 nm for 10 min, using CENTA (0.02 mg ml -1) as a substrate. Data
points are means ± SE, n = 3.
A rapid loss of approximately 60% of activity occurred. A residual activity of
21.4% remained  (Table  2.10).  A similar  loss  of  activity  was  seen  following
exposure  of  penicillinase  to  MPO  substrates,  minus  MPO,  though  the  final
residual activity was 28.9% compared to control.  The rate constant for MPO
was higher than that for substrates minus MPO (Table 2.9).
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Table 2.9. Rate constants and residual activity for loss of activity of penicillinase exposed to 
MPO-derived oxidants. Determined using non-linear regression (exponential decay, single, 3 
parameter).
Rate constant (min l-1) Residual activity (%)
Substrates minus MPO 0.1015 28.9
Substrates plus MPO 0.1463 21.4
2.8.9. H2O2 reduced the activity of penicillinase
H2O2 reduced the activity of  penicillinase in  a  dose-dependent  manner (Fig.
2.10).
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Figure  2.10.  Activity  of  penicillinase  (36.0  U  ml-1  in  the  microplate  well)  exposed  to  H2O2,
expressed as a percentage of activity of the control at time zero. Exposure time indicates the
time (min) that penicillinase was exposed to each concentration of H2O2. Following exposure
penicillinase activity was measured spectrophotometrically at 405 nm for 10 min, using CENTA
(0.02 mg ml-1) as a substrate. Data points are means ± SE, n = 3.
Following  60  min  of  exposure,  15  µM  H2O2 had  reduced  activity  by
approximately  20%,  150  µM H2O2  by  60% and  1.5  mM by  85%.  The  rate
constants for loss of activity are dose-dependent when a constrained fit is used
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(Table 2.11). The highest concentration of H2O2 showed no further reduction in
activity following around 30 min of exposure.
Table 2.10. Rate constants and residual activity for loss of activity of penicillinase exposed to
H2O2.  Determined  using  non-linear  regression  (exponential  decay,  single,  3  parameter).
Constrained fit is to the level of residual activity of 1.5 mM H2O2.
Rate constant (min l-1) Residual activity (%)
15 μM H2O2 Unconstrained fit   0.0239
Constrained fit       0.0037
75.3
150 μM H2O2 Unconstrained fit   0.02
Constrained fit       0.021
9.9
1.5 mM H2O2                     0.0921 12.2
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2.8.10. EDTA did not remove residual penicillinase activity
The exposure of penicillinase to 100 µM EDTA following exposure to H2O2 for
60 min did not remove the residual penicillinase activity (Fig. 2.10).
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Figure 2.11. Penicillinase (36.0 U ml-1) activity compared to control following exposure to H2O2
and EDTA. Penicillinase was exposed to 1.5 mM H2O2  or water for 60 min and then incubated
with  100 µM EDTA for  10 min.  This  data  represents the means ± SE,  n = 3.  There is  no
significant difference between the samples with H2O2, with or without EDTA.
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2.8.11. H2O2 did not cause bleaching of CENTA
Exposure of CENTA to a range of concentrations of H2O2 did not result in a
reduction in absorbance values when measured at 340 nm (Fig. 2.12).
H2O2 (mM)
0 0.01 0.1 1 10
A
bs
or
ba
nc
e 
at
 3
40
 n
m
0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
Figure 2.12.  Absorbance of CENTA (0.02 mg ml-1) when exposed to various concentrations of
H2O2. The bars represent measurements taken immediately following addition of H2O2  (black
bars) and those taken after 3 min incubation with H2O2 (grey bars). Values are means, n = 2.
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2.8.12. HOCl reduced the activity of penicillinase
HOCl reduces the activity of penicillinase in a dose dependent manner (Fig.
2.13).  After  60 min of  exposure to  16 µM HOCl penicillinase activity fell  by
approximately 60%, compared to the control at time zero; the fall in activity was
around 50% for 8 µM HOCl and around 30% for 4 µM HOCl. The rate constants
for loss of activity are dose-dependent when a constrained fit  is used (Table
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2.11).
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Figure 2.13. Activity of penicillinase (36.0 U ml-1) exposed to HOCl. Expressed as a percentage
of activity of the control at time zero. Exposure time indicates the time (min) that penicillinase
was  exposed to  each  concentration  of  HOCl.  Following  exposure  penicillinase  activity  was
measured  spectrophotometrically  at  405  nm  for  10  min,  using  CENTA (0.02  mg  ml -1)  as
substrate. Data points are means ± SE, n = 3.
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Table 2.11. Rate constants and residual activity for loss of activity of penicillinase exposed to
HOCl.  Determined  using  non-linear  regression  (exponential  decay,  single,  3  parameter).
Constrained fit is to the level of residual activity of 16 μM HOCl.
Rate constant (min l-1) Residual activity (%)
4 μM HOCl Unconstrained fit    0.0905
Constrained fit        0.0112
69.2
8 μM HOCl Unconstrained fit    0.0491
Constrained fit        0.0311
43.4
16 μM HOCl                       0.0857 32.6
2.8.13. HOCl bleached CENTA in a dose dependent manner
HOCl bleaches CENTA in a dose-dependent manner (Fig. 2.14). No significant
bleaching effect was detected with 20 µM HOCl, but the absorbance of CENTA
fell  by  approximately  20% with  100  µM HOCl  and  70% with  1  mM HOCl.
Bleaching occurred rapidly after which the remaining absorbance stayed fairly
constant over time. In molar terms the ratio of CENTA to 100 μM HOCl, was
1:27.
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Figure  2.14.  HOCl  bleaching  of  CENTA.  CENTA (0.02  mg  ml-1)  was  exposed  to  various
concentrations of HOCl for 20 min. Absorbance was read at 340 nm. Data are expressed as the
percent absorbance, relative to control (water) at time zero. Error bars denote the range from
the mean, n = 2.
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2.8.14. ONOO- reduced the activity of penicillinase
The  concentration  of  synthesised  ONOO- was  1.77  mM.  Following  60  min
exposure  to  ONOO-,  the  activity  of  penicillinase  fell  by  approximately  40%
compared to that of control at time zero (Fig. 2.15).
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Figure 2.15.  Activity of penicillinase (36.0 U ml-1) after 60 min exposure to ONOO-  (104 μM),
expressed as a percentage of activity of the control (water) at time zero. Following exposure
penicillinase activity was measured spectrophotometrically at 405 nm for 10 min, using CENTA
(0.02 mg ml-1) as a substrate. Data points are means ± SE, n=3.
2.9. Discussion
This study has demonstrated that reactive species (RS) modify penicillinase to
a sufficient degree to significantly reduce its activity compared to controls; to our
knowledge this is the first time that this has been reported. The penicillinase
used in this study comprises two β-lactamases; I, which has a molecular mass
of 27,800 Da (Lloyd & Peacock, 1970) and has a serine at its active site (Hill et
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al. 1980), and II, with a molecular mass of 22,500 Da (Kuwabara & Lloyd, 1971)
and two binding sites for zinc cofactors, of which binding at the highest affinity
site  is  essential  for  enzymic  activity  (Thatcher,  1975).  β-lactamases  are
enzymes  and  numerous  studies  have  demonstrated  that  enzymes,  being
proteins, are vulnerable to modification by RS, including the species used in this
study, hydrogen peroxide (Anjem & Imlay, 2012), hypochlorous acid (Summers
et  al,  2012)  and peroxynitrite  (Hausladen & Fridovich,  1994).  The nature of
enzyme  modification  by  RS  depends  on  the  species  investigated  and  may
involve oxidation, chlorination or nitration reactions, which may be reversible
(Fuentes-Almagro et al, 2012), or result in inactivation of the enzyme (Hurd et
al,  2012).  This  study  did  not  investigate  the  possible  sites  of  enzyme
modification  by  the  species  used  so  the  nature  of  the  damage  caused  is
unknown;  however,  amino  acid  sequences  of  the  two  
β-lactamases (Appendix 5) show the presence of several amino acids that have
been shown to  be  particularly vulnerable  to  RS.  Both  β-lactamases contain
cysteine and the sulphydryl  groups on these amino acid residues are readily
oxidised. In a reducing environment disulphide bonds are unstable, but in an
oxidising environment conditions may be conducive to the formation of these
bonds which may alter the configuration of  an enzyme; Shimizu-Ibuka  et  al
(2004) engineered β-lactamase mutants, with disulphide bridges, which showed
reduced activity for some cephalosporins.
Both  enzymes  contain  several  methionines  which  may  be  vulnerable  to
oxidation; the possibility that this type of modification may lead to significant
changes  to  enzyme  activity  is  supported  by  Hsieh  et  al,  (2012),  who
demonstrated that oxidation of a methionine was a factor in the inactivation of
procaspase-3.  Histidine,  tryptophan  and  tyrosine,  also  present  in  both  β-
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lactamases, are readily attacked by RS (M ller  ӧ et al,  2012; Todorovski,  et al,.
2011; Uchida & Kawakishi, 1994).
It, perhaps, should not be surprising that these amino acids are readily modified
by RS as they are frequently involved in cellular signalling and, as mentioned
above,  the  activation/inactivation  of  enzymes,  and  they  provide  a  possible
mechanism for the reduction in activity seen in penicillinase exposed to RS.
This  effect  may  be  direct,  or  via  a  radical  product  of  amino  acid
oxidation/nitration/chlorination (Alvarez & Radi, 2003; M ller ӧ et al, 2012).
The compositional difference between the two β-lactamases, i.e. zinc ions in the
active  site  of  β-lactamase  II,  presented  an  opportunity  to  explore  whether
modification  was  occurring  to  just  one  or  both  of  the  enzymes  comprising
penicillinase. EDTA, as an effective chelating agent, was used to bind the zinc
ions in β-lactamase II thereby significantly curtailing the enzymes’ activity, as
has been found previously by Davies and Abraham (1974) who observed more
than  99%  loss  of  activity  in  β-lactamase  II  when  zinc  ions  were  removed.
Indeed,  we  found  that  EDTA  (10  and  100  μM)  reduced  the  activity  of
penicillinase by 35–45% (Figs. 2.4 and 2.11), suggesting that at least 50% of
the activity of this particular penicillinase is attributable to β-lactamase I. When
penicillinase was exposed to  both  H2O2 and EDTA there  was  no significant
difference in  the  amount  of  residual  activity (Fig.  2.11),  suggesting that  any
residual activity following exposure to H2O2 can be attributed to β-lactamase I.
One conclusion to be drawn from this observation is that 1.5 mM H2O2 was
sufficient to fully inactivate β-lactamase II, and partially inactivate β-lactamase I.
This  finding  is  of  relevance  due  to  the  inherent  problem,  in  the  clinical
environment,  of  the  paucity  of  drugs  that  are  able  to  inhibit  β-lactamases
(Section 1.2.1). Of particular relevance is that there are, as far as we are aware,
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no inhibitors of metallo-β-lactamases in clinical use at this time, though Mollard
et al  (2001) demonstrated that thiomendelic acid was capable of inhibiting a
broad spectrum of zinc metallo-β-lactamases, including those from  B. cereus,
so, given the lengthy process of clinical trials it  is possible that a drug is in
development. Of interest, from the work of Mollard, is that the active site zinc
ions  are  coordinated  by  three  histidines,  which  are  necessary  for  enzyme
activation, suggesting that RS modification of histidines is a possible pathway.
The concentrations of RS used in this study require further comment; the ability
of  a  RS  to  inhibit  an  enzyme  in  a  clinical  situation  is  only  relevant  if  the
concentration is  likely to  occur  in  vivo,  however,  accurate measurements  of
physiological  levels  of  RS are  challenging and  may be  relevant  only  under
certain conditions. HOCl concentrations have been estimated to vary between 
25 and 200 μM (McCall  et al,  2001), reaching the upper level in pathological
conditions.  This  study found that  penicillinase activity was reduced by more
than  60%  with  just  16  μM  HOCl  and  so  it  is  feasible  that  physiological
concentrations  of  HOCl  would  be sufficient  to  cause significant  reduction  in
penicillinase activity. H2O2 levels have been measured in several human tissues
and systems, including up to around 100 μM in urine (Long  et al,  1999) and
ocular tissue (Spector  et al,1998), and very low μM levels in human plasma
(Halliwell  et  al,  2000),  however,  meaningful  deductions  concerning  the
relevance of these measurements is problematic. Given the ubiquitous nature of
H2O2  production  by  many  human  tissues,  its  role  in  cell  signalling  and  the
presence of quenching systems  in vivo  it was difficult to rationalise a specific
concentration to use for this study. An assumption was made that rapid diffusion
through cell  membranes, and leaking neutrophils could increase extracellular
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levels  of  H2O2  significantly  in  a  wound  environment;  however,  a  range  of
concentrations from μM to mM was used.
Care was taken in the preparation of buffers, and other solutions, to eliminate
as much as possible all trace metals as the study was looking specifically at the
effect of H2O2 on penicillinase. However,  in vivo the environment is unlikely to
be so prescribed and though a loss of approximately 10% after a 60 minute
exposure of penicillinase to 15 μM of H2O2 was seen, in vivo the real risk is that
even very low concentrations of H2O2 will react with transition metal ions to form
the highly reactive and damaging OH• radical via Fenton chemistry. Humans
are well equipped with mechanisms to bind metal ions to reduce the possibility
of  such  reactions,  however,  free  iron  has  been  measured  in  inflammatory
exudate fluid in a rat model, indicating that this may also occur in a chronic
wound environment (Gutteridge et al, 1981).In fact H2O2 itself has been shown
to  degrade  haem proteins  to  free  iron  (Halliwell  et  al,  2000),  as  has  HOCl
(Souza et al, 2011).
In the case of ONOO-, the concentration used (133 μM) was determined by the
limited amount of product synthesised; the equipment necessary to optimise the
synthesis of ONOO- was not readily available. The method used can result in
contamination with Cl-, NO2-, NaOH and H2O2, which has to be considered when
interpreting results,  though the latter  was removed with manganese dioxide.
The reduction in penicillinase activity by ONOO- was much lower than the other
RS examined (possibly supporting the fact that H2O2 was effectively removed),
40% compared to 80-90%. However, we are not able to determine whether this
was due to insufficient concentration or to a fundamental difference in the mode
of  enzyme modification.  Also,  because the synthesis  of  ONOO - results  in  a
solution with a very high pH, it needed to be diluted with a buffer of pH 4.62 to
127
maintain  the  pH  of  the  exposure  conditions.  The  optimal  pH  for  
B. cereus β-lactamase I and II activity is around 7; catalytic activity falls rapidly
at pH 8 (Waley, 1975; Bicknell et al, 1983). It is possible that, at this pH, ONOO-
was rapidly decomposed.  It  is  clear that  there was some component  of  the
solution, that penicillinase was exposed to, that reduced its activity. However, its
true identity cannot be stated with any confidence.
The  failure  to  be  able  to  use  LPO  as  an  oxidant  generating  system  was
disappointing; unfortunately, time constraints meant that determining the causes
of the failure was not possible. Initial thoughts were that some component of the
system was causing bleaching of the CENTA, but the sudden appearance of
activity at 5 min does not support this. The time courses in Figure 2.6 indicate a
lag in enzyme activity for the first 5 min, which could occur if initially, CENTA, or
the product of the hydrolysis of CENTA, is being bleached, but as a component
becomes depleted unbleached product returns.
The MPO system appeared to work, though it could be argued that the fall in
penicillinase activity was due to H2O2, one of the MPO system substrates rather
than HOCl; however, the time course (Fig.2.8) indicates a very rapid production
of  HOCl,  greater  than  20  μM  by  1  min.  When  preparing  the  exposure
experiment, MPO and its substrates would have been combined for at least  
2  min  before  adding  penicillinase,  which  would  have  been  sufficient  for
significant  HOCl  production.  It  is  possible,  however,  that  there  was  still  an
excess of H2O2 in the mix, so an effect of this oxidant cannot be completely
discounted. In hindsight it would have been valuable to have added catalase to
quench excess H2O2 following a period of time allowing for HOCl concentrations
to increase. The higher rate constant and lower residual activity in the presence
of MPO does indicate that greater oxidant damage was occurring under these
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conditions though as Figure 2.14 indicates concentrations of HOCl 100 μM and
above  cause  bleaching  of  CENTA,  the  penicillinase  substrate;  some of  the
effect of the MPO system could have been be due to bleaching if the production
of HOCl was greater than anticipated.
The rate constants for penicillinase exposure to H2O2 and HOCl (Tables 2.10
and 2.11 respectively), when constrained to fit the residual activity of the highest
concentration  showed  dose-dependency.  This  was  not  the  case  for
unconstrained fits.
This study demonstrated that three RS are capable of modifying the activity of
penicillinase from B. cereus. It was not able to provide evidence to identify the
site or nature of the modification, e.g. oxidation, chlorination or nitration, so any
further  work  in  this  area  should  address  this  omission.  The  use  of  mass
spectroscopy to identify molecular changes to damaged penicillinase, following
exposure to each of the RS, would be valuable. Using a method which first
separates  the  two  β-lactamases would  also  provide  further  insights  into  the
differential activity, and vulnerability of the two enzymes. Repeating exposure
with ONOO- would be advantageous if more appropriate equipment could be
used for synthesis, resulting in a purer product; though there still remains the
problem  of  maintaining  a  suitable  pH.  Extending  the  work  to  include
β-lactamases from other classes and from other bacterial species would also be
beneficial 
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Chapter 3
The effects of reactive oxygen species on acyl-homoserine lactones
3.1. Introduction
Due to its role in the formation of biofilms (Section 1.5.4), QS can be regarded
as  a  component  of  antibiotic  resistance,  with  evidence  suggesting  that
interfering with QS results in a reduction in biofilm with an inherent increased
vulnerability to antibiotics. 
3.1.1. Quorum sensing molecules in P. aeruginosa
As discussed in Chapter 1, QS molecules are numerous and diverse; those
pertinent  to  this  study  are  the  AHLs,  particularly  those  produced  by  
P. aeruginosa. The 5 membered lactone ring is a common feature of all AHLs,
with  specificity being determined by the length of  an amide linked acyl  side
chain, and presence or absence of a side group, (usually oxo or hydroxyl) on
the C3 carbon of the acyl chain (Figure 1.3.), (Fuqua et al. 2001). P. aeruginosa
possesses two AHL QS regulatory circuits,  termed LasI/R,  with  the cognate
signal molecule O-C12-HSL and RhII/R, with the cognate signal molecule C4-
HSL. These AHLs do not function in isolation; the QS system in P. aeruginosa is
hierarchical with the las regulon playing a role in the positive activation of the rhl
regulon  (Figure  3.1.).  With  increasing  population  density  (or  conditions
conducive  to  limited  diffusion),  O-C12-HSL enters  cells,  binds  to  LasR in  a
dimeric  formation  and  activates  lasI, producing  the  enzyme  LasI  that
synthesises O-C12-HSL, resulting in a positive feedback loop. The LasR-AHL
molecule also regulates the expression of the genes encoding for the virulence
determinants  elastase,  LasA  protease,  alkaline  protease  and  exotoxin  A
(Gambello and Iglewski, 1991, Toder et al. 1991, Gambello et al. 1993, Pearson
et  al.  1994).  RhIR  bound  with  C4-HSL regulates  the  expression  of  rhlAB
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(rhamnolipid),  lasB (elastase),  aprA,  RpoS, cyanide, pyocyanin and the lectins
PA-I and PA-II (Ochsner  et al. 1994,  Brint & Ohman, 1995,  Latifi  et al.  1995,
Pearson et al. 1995, Winson et al. 1995, Latifi et al. 1996, Winzer et al. 2000).
LasR-AHL also  controls  the  synthesis  of  a  negative  regulator,  RsaL,  which
inhibits transcription of lasI.
Alongside  the  LasI/R and  RhlI/R  QS circuits,  P.  aeruginosa also  utilises  a  
4-quinolone signal  molecule  (2-heptyl-3-hydroxy-4(1H)-quinolone)  termed the
Pseudomonas Quinolone  Signal  or  PQS.  Regulation  of  PQS  production  is
controlled by LasR, and in turn PQS controls the expression of  lasB,  rhlI and
rhlR and several rhl-dependent genes (Diggle et al. 2003), suggesting that PQS
acts a link between the two AHL-mediated QS circuits in P. aeruginosa.
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Figure 3.1. Hierarchical regulation of AHL QS in P. aeruginosa. O-C12-HSL enters the cell and
once a quorum is reached lasR is activated. Its product LasR binds O-C12-HSL in a dimeric
formation and this activates lasI, producing the enzyme LasI that catalyses the synthesis of O-
C12-HSL, forming a positive feedback loop. The LasR-AHL molecule also activates  rhlR,  rhlI
and  lasB leading  to  the  synthesis  of  rhlR,  C4-HSL  and  elastase  respectively.  RhlR-AHL
activates RhlA leading to the synthesis of rhamnolipid. LasR positively regulates the synthesis
of pqsH which converts HHQ (encoded by pqsABCDE) to PQS, which positively regulates rhlI.
The RhlR-AHL molecule negatively regulates pqsABCDE and pqsR. The PqsR-PQS molecule
positively regulates rhlR and pqsABCDE.
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3.1.2. The role of QS in P. aeruginosa biofilms
In Section 1.5.4. the role of QS in the formation and maintenance of biofilms
was  discussed.  For  P.  aeruginosa  in  particular,  evidence  supports  the
contribution of QS to several key areas; the production of rhamnolipids (Davey
et al. 2003; Pamp & Tolker-Nielsen 2007), lectins (Winzer et al. 2000; Diggle et
al. 2006) pyoverdine (Stintzi  et al. 1998; Banin  et al. 2005), extracellular DNA
(Allesen-Holm  et  al.  2006)  and EPS (Sakuragi  &  Kolter  2007).  Despite  this
evidence, the full role of QS in biofilm formation is still questioned, mainly due to
the  contribution  that  growth  conditions,  particularly  those involving  the
availability of key nutrients, has on biofilm structure. This is seen in the case of
swarming in  P. aeruginosa,  Shrout  et al. (2006) showed that swarming does
contribute to early biofilm formation the extent of which was dependent on the
type of carbon source supplied.
3.1.3. Interfering with QS
The search for  ways to  interfere with  QS has intensified and this  has been
discussed  in  Section  1.4.5.  ROS  are  also  thought  to  damage  AHL signal
molecules. Michels et al. (2000) was the first team to demonstrate degradation
of AHLs by oxidized halogens and propose a possible pathway (Fig.3.2). The
pathway is very pH dependent and some products may not be detected, for
example, at pH 3 only the products of reactions 1 and 2 are detectable.  At a
more favourable pH, halogenation of the AHL ultimately leads to splitting of the
molecule and hydrolysis of the lactone ring (Fig. 3.2).
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Figure 3.2.  Proposed pathway of AHL (O-C6-HSL) degradation by an oxidizing halogen. The
four reactions (1 to 4) lead from: A. Intact AHL to F. Hydrolysed molecule. This Figure has been
adapted from that of Michels et al. (2000).
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A microbiological approach to the same work (Borchardt  et al.  2001) provided
indirect  evidence  of  damage  to  O-C6-HSL and  O-C12-HSL,  but  not  C6  or
C12.HSLs.  Reactivity  of  HSLs  with  oxidized  halogens  was  determined  by
measuring  the  consumption  of  halogens  in  a  colorimetric  assay.  Using  a
Chromobacterium  violaceum  CV026  bioassay  they demonstrated  reduced
activity for O-C6-HSL but not C6-HSL, the conclusion being that the oxo side
group in some way facilitates AHL modification.
Hypochlorous  (HOCl)  and  hypobromous  (HOBr)  acids  are  non-radical
derivatives of oxygen (as is H2O2);  HOCl is a powerful two-electron oxidizing
agent and is capable of damaging biomolecules either directly (Hannum et al.
1995; Park et al.2008), or in the form of chlorine following decomposition. H2O2
on the other hand is a weak oxidizing agent and relatively poorly reactive and
yet it has been shown to damage some enzymes (Li  et al. 2011), which this
study also demonstrated in the reduced activity of penicillinase (Chapter 2).
The aim of this part of the study was to determine whether ROS were able to
reduce the activity of AHLs, QS signalling molecules utilized by several Gram
negative  bacteria,  including  those  found  within  chronic  wounds,  e.g.  P.
aeruginosa. Synthetic AHLs were exposed to HOCl and H2O2, two ROS that are
likely to be found in a chronic wound environment, (Section 1.6.2.) and their
activity compared to controls. It was also considered necessary to extend the
range of AHLs tested to those other than C6 and C12, and to utilize a more
reliable assay for AHLs with longer chain lengths than the C. violaceum assay
would accommodate. AHLs with chain lengths ranging from C4 to C14 were
tested and these included the dominant AHLs found in P. aeruginosa, C4-HSL
and O-C12-HSL. Initially,  to test  the experimental  conditions, only C8 AHLs,
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with various substitutions, were exposed to ROS. Bioreporter strains of E. coli,
relevant to AHL chain length, were used to demonstrate AHL activity. 
The second aim was to determine whether ROS were able to reduce the AHL
signal in growing populations of P. aeruginosa, and if any changes to the level
of  AHL signal might have an impact on the production of the RhlI-regulated
virulence factors LasB (elastase) and RhlA (rhamnolipid). The final aim of the
study was to attempt to ascertain the nature of the degradation of the AHL
molecule  by  looking  for  evidence  of  a  lactonase  activity  by  examining  the
molecular profile of exposed and synthetic AHLs with MS-MS.
Briefly, this study demonstrated that HOCl, but not H2O2, reduced the activity of
a range of AHLs in vitro, but not in vivo. MS-MS suggested that the AHL lactone
ring was hydrolysed following exposure to HOCl.
3.2 Materials and methods
3.2.1. Chemicals
Catalase (Cat# 60635), hydrogen peroxide (30%), LB broth powder, reduced
glutathione,  Bacto  agar,  potassium  phosphate  monobasic,  potassium
phosphate dibasic, ampicillin sodium salt and hydrochloric acid were obtained
from Sigma Aldrich Company Ltd (Poole, Dorset, UK). Ethyl acetate, acetonitrile
and  ethanol  were  obtained  from  VWR  BDH  Prolabo  (Lutterworth,
Leicestershire,  UK).  Tetracycline  hydrochloride  was  obtained  from  Merck
Chemicals  Ltd  (Beeston,  Nottingham,  UK).  Bleach  was  obtained  from
J. Sainsbury plc (London, UK).
The  AHLs  N-hexanoyl-L-homoserine  lactone  (C6-HSL),  N-octanoyl-L-
homoserine  lactone  (C8-HSL),  N-(3-oxodecanoyl)-L-homoserine  lactone  (O-
C10-HSL) and  N-dodecanoyl-L-homoserine lactone (C12-HSL) were obtained
from  Sigma  Aldrich  Company  Ltd  (Poole,  Dorset,  UK).  N-butanoyl-L-
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homoserine  lactone  (C4-HSL),  N-decanoyl-L-homoserine  lactone  (C10-HSL),
N-(3-hydroxyhexanoyl)-L-homoserine  lactone  (OH-C6-HSL),  N-(3-
hydroxyoctanoyl)-L-homoserine lactone (OH-C8-HSL), N-(3-hydroxydecanoyl-L-
homoserine  lactone  (OH-C10-HSL);  N-(3-hydroxydodecanoyl-L-homoserine
lactone (OH-C12-HSL);  N-(3-oxobutanoyl)-L-homoserine lactone (O-C4-HSL),
N-(3-oxohexanoyl)-L-homoserine  lactone  (O-C6-HSL),  N-(3-oxooctanoyl-L-
homoserine  lactone  (O-C8-HSL),  N-(3-oxododecanoyl)-L-homoserine  lactone
(O-C12-HSL)  and  N-(3-oxotetradecanoyl)-L-homoserine  lactone (O-C14-HSL)
were obtained from Nottingham University.
3.2.2. Strains and plasmids
All strains and plasmids used in this chapter are listed in Table 3.1.
Table 3.1. Strains and plasmids used in this study.
Strain or Plasmid Genotype and/or relative markers Reference
Strains
E. coli 
JM109 recA1 supE44 endA1 hsdR17 gypA96 relA1 thi D 
(lac-proAB)
Schaefer et al. 
(1996)
P. aeruginosa PAO1n (Nottingham WT strain)
Kindly donated by
Miguel Camara, 
Nottingham 
University
PAO1n/ LasI::Lux PAO1n containing  a LasI::Lux gene fusion
PAO1n/ LasB::Lux PAO1n containing a LasB::Lux gene fusion
PAO1n/ RhlI::Lux PAO1n containing a RhlI::Lux gene fusion
PAO1n/ 
RhlAI::Lux
PAO1n containing a RhlAI::Lux gene fusion
Plasmids
pSB401 AHL reporter plasmid; luxR”::luxCDABE (AmpR) Winson et al. 
(1998)
pSB536 AHL reporter; ahyR”::luxCDABE (AmpR) Swift et al. (1997)
pSB1075 AHL reporter plasmid; P. aeruginosa lasRI and 
luxCDABE from Photorhabdus luminescens (AmpR)
Winson et al. 
(1998)
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3.2.3. Storage and preparation of AHLs
All AHLs were stored at -20 °C, in acetonitrile at a concentration of 10 mg ml -1.
Prior to each assay, each AHL was diluted with acetonitrile to 1 mg ml -1. Unless
otherwise  stated  AHL  solutions  were  kept  on  ice  throughout  the  assay
procedure.  All  procedures  involving  acetonitrile  were  carried  out  in  fume
cupboard conditions.
3.2.4. Bioreporter strain culture conditions and media preparation
All bacterial strains were grown in sterile LB broth and maintained on sterile LB
agar (1.2%), with the addition of antibiotics as follows: (a) E. coli pSB401 and
pSB1075, tetracycline 10 µg ml-1 (b)  E. coli pSB536, ampicillin 50 µg ml-1 (c)
P. aeruginosa strains, tetracycline 75 µg ml-1. LB agar was cooled to 42 °C and
antibiotics added immediately prior to pouring of plates. Antibiotics were added
to LB broth immediately prior to use. All cultures were incubated at 37 °C, at
150 rpm. Streak plates were prepared for each culture, on LB agar containing
the appropriate antibiotic, incubated for 24 hours and stored at 15 °C. Twenty
millilitres of LB broth, as above, were inoculated with a single colony from a
stored agar plate and incubated overnight prior to use for each assay.
3.2.5. Exposure of bioreporter to synthetic AHLs
In order to determine the optimal concentration of AHL to use in the following
assays a dose response curve was generated by exposing the bioreporter  
E.  coli  pSB1075  to  serially  diluted  O-C8-HSL.  The  bioreporter  was  grown
overnight,  as  described  above,  and  diluted  1:10  in  LB  broth  containing
tetracycline. Stock AHL (10 mg ml-1) was diluted with acetonitrile to 10 µg ml-1.
Double dilutions of this concentration were prepared down to 0.0195 µg ml -1.
Fifteen microlitres of the highest concentration were added to each of 3 wells in
a sterile, 96-well white clear bottomed polystyrene plate (Sigma-Aldrich, Poole,
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Dorset, UK). This was repeated for each of the concentrations prepared. The
plate was left  in a fume cupboard until  the acetonitrile had evaporated.  One
hundred and fifty microlitres of the prepared bioreporter were added to each
well containing AHLs. Controls without the addition of AHLs (i.e. media only)
were also included. A lid was placed on the plate which was then incubated as
described for 3 h.
On completion of incubation luminescence was measured, followed immediately
by measurement of absorbance at 600 nm. Luminescence was measured on a
Mithras LB940 plate reader (Berthold Technologies) utilising Mikrowin software.
Absorbance was measured on a VersaMax 250 Microplate Reader (Molecular
Devices)  utilising  SoftMax  PRO  data  analysis  software.  Data  analysis  was
carried out using Microsoft Excel. The absorbance value for medium only was
deducted from all other absorbance values. For each well, the final value was
determined  by  dividing  the  luminescence  value  (RLUs)  by  the  absorbance
value. A dose response curve was calculated with SigmaPlot 12 software.
3.2.6. Bioreporter response to oxidant exposed C8-HSLs
Initially, 2.5 ng µl-1 O-C8-HSL was exposed to 15 µM HOCl for a total of 60 min,
and samples taken at 0, 10, 20, 30 and 60 min. HOCL was quenched with
reduced glutathione (GSH) to terminate any effect  on the AHL at each time
point.  Due to a rapid response to HOCl the assay was repeated to  include
further sampling points at 2, 4, 6 and 8 min. In order to determine whether the
OH group, or a lack of a side group made any difference to the response, C8-
HSL and OH-C8-HSL (2.5 ng µl-1) were also exposed to 15 µM HOCl. Controls
included adding HOCl, but not quenching with GSH to determine whether there
was any quenching activity from ethyl  acetate,  and adding water  instead of
HOCl to determine normal AHL activity. One of the water controls was exposed
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to  GSH  to  determine  whether  GSH  alone  had  any  effect  on  the  AHL
bioreporters.
Neat bleach was diluted 100-fold with 50 mM potassium phosphate buffer, pH 7
and the concentration of HOCl was determined using Ɛ235 = 100 M-1 cm-1. This
solution was further diluted with buffer to 3 mM. A 60 mM solution of reduced
glutathione and a 1 mg ml-1 solution of O-C8-HSL were prepared; all solutions
were kept on ice. Twenty four microlitres of GSH were placed in each of ten
1.5 ml microcentrifuge tubes and the tubes placed on ice. The conditions used
in this assay are summarised in Table 3.2. Four 15 ml sterile tubes were filled
as indicated. AHLs were added last of all and timing was commenced at this
stage.
Table 3.2. The volumes and concentration of chemicals added to tubes.AHL were added last
and this  was designated time zero.  For  those conditions indicated,  removed samples were
added to aliquots of glutathione.
Condition Volume Chemical Concentration
added
Final
concentration  in
tube
AHL  exposed  to
HOCl plus GSH
5.955 ml Potassium  phosphate
buffer pH 6.8
50 mM
30 µl HOCl 3 mM 15 μM
15 µl AHL 1 mg ml-1
AHL  exposed  to
HOCl minus- GSH 
5.955 ml Potassium  phosphate
buffer pH 6.8
50 mM
30 µl HOCl 3 mM 15 μM
15 µl AHL 1 mg ml-1 5 μg ml-1
Control plus GSH 2.9775 ml Potassium  phosphate
buffer pH 6.8
50 mM
15 µl dH2O
7.5 µl AHL 1 mg ml-1 5 μg ml-1
Control  minus
GSH
2.9775 ml Potassium  phosphate
buffer pH 6.8
50 mM
15 µl dH2O
7.5 µl AHL 1 mg ml-1 5 μg ml-1
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Immediately following the addition of AHL the tube was vortexed and 1.2 ml of
this mix was then transferred to a microcentriduge tube containing GSH (final
concentration  of  GSH  was  1.2  mM).  This  was  then  vortexed  and  200  µl
transferred immediately to each of five microcentrifuge tubes already containing
200 µl ethyl acetate, vortexed again and replaced on ice. This procedure was
repeated for  all  tubes, but  with omission of the GSH step for one exposure
condition and one control. Samples were taken for 0, 10, 20, 30 and 60 min for
HOCl  exposure  conditions,  and  at  0  and  60  min  for  controls.  These  steps
provided 5 replicates for each condition at each time sampling point.
On  completion  of  sample  removal  150  µl  was  carefully  removed  from  the
aqueous layer and transferred to a single well of a 96-well PCR plate (Elkay
Laboratory Products,  Basingstoke, UK). The PCR plate was left  in the fume
cupboard overnight to allow the ethyl acetate to evaporate. The following day 
30 µl of acetonitrile was added to each well of the PCR plate containing AHL.
This was left at room temperature for 10 minutes. Following gentle mixing the
30 µl aliquots were transferred to a white, clear-bottomed 96 well plate which
was left in the fume cupboard to evaporate. An overnight culture of E. coli was
diluted 1:10 with fresh LB and tetracycline and 150 µl of this was added to each
of the wells containing AHL. The same volume of broth was also added to a
further 5 wells to act as a blank for the spectrophotometer. A lid was placed on
the plate, which was incubated at 37 °C, 150 rpm, for 3 h. Following incubation
luminescence was measured, followed immediately by absorbance at 600 nm.
In order to quantify the AHL activity the luminescence value for each well was
divided by the absorbance value from which the mean of the media only value
had been deducted. Means of 5 replicates were calculated and the extent of
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AHL activity change was measured as a percentage change relative  to  the
control  at  time zero.  Each assay was  repeated three times and the  results
expressed as means and standard errors. This assay was repeated twice more
to include extra sampling points at 2, 4, 6, and 8 minutes, and also for C8-HSL
and OH-C8-HSL.
3.2.7. Bioreporter response to oxidant exposed C4, C6, C8, C10, C12 and C14
AHLs
In  order  to  determine  the  effect  of  chain  length  on  AHL activity  following
exposure to oxidants a range of both substituted, and unsubstituted AHLs with
carbon chain lengths of 4, 6, 8, 10, 12 and 14 were exposed to HOCl (15 µM)
for 60 min.  Residual AHL concentrations after 60 min were compared to the
time 0 min sample point. The assay was also repeated with H2O2  to determine
whether other oxidants also had an effect on AHL activity. In this case, 24 μl
catalase10 (20 000 U ml-1)  were used to quench the reaction. These assays
were carried out with only two sampling points, time zero and following 60 min
exposure. The following AHLs were not included in the assays: OH-C4-HSL,
C14-HSL and  OH-C14-HSL.  All  assays  were  carried  out  twice  and  a  two-
sample T-Test was used to determine statistical difference between conditions
(Minitab 16, Minitab Ltd, Coventry, UK), with a confidence of 95%.
3.2.8. Effect of HOCl on gene transfer reporter fusion strains of P. aeruginosa.
In order to determine whether the inhibitory effect of HOCl on AHL activity  in
vivo, P. aeruginosa  variants containing  lux fusions to the autoinducer proteins
LasI (O-C12-HSL) and RhlI (C4-HSL), and the RhlI regulated virulence factors
LasB (elastase) and RhlA (rhamnolipid), were used. These particular reporter
strains  demonstrate  luminescence  proportional  to  gene  expression.  Each
10
 2000 U mg-1 protein. One unit will decompose 1.0 μmol H2O2 min-1 at pH7 at 25 °C.
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reporter strain was cultured with the addition of HOCl (15 µM) to the growth
medium.  Control  conditions  with  water  replacing  HOCl  were  included  to
determine whether the concentration of HOCl was sufficient to inhibit bacterial
population growth.
An overnight culture of each P. aeruginosa reporter strain was prepared as in
Section  3.2.4.  and  diluted  1:10  with  pre-warmed  LB  broth  (Tetracycline
75 µg ml-1). In a white, clear-bottom, 96-well plate, 190 µl of each culture was
transferred to eight wells in two consecutive columns. Ten microlitres of HOCl
(300 µM)* were added to each well in the first column for each strain; 10 µl of
water  were added to each well  in the second column for each strain. Wells
containing 200 µl of LB broth only were included as a control.
The lid was replaced on the plate which was incubated at 37 °C, 150 rpm. The
plate was read for luminescence and absorbance at 600 nm following one hour
of incubation and thereafter every hour until growth reached stationary phase.
This  assay  was  conducted  in  triplicate.  Growth  plots  were  produced  with
SigmaPlot  12  software,  data  points  are  means  with  standard  error.  A two-
sample t-test was used to determine statistical difference between conditions at
each time point (Minitab 16), with a confidence of 95%.
3.2.9. MS-MS of ROS exposed and unexposed AHLs
Tandem Mass Spectroscopy was kindly performed by Dr M. Priston (Pharmacy
Department, Plymouth Hospitals NHS Trust) on an API 300 LC/MS/MS System
(Applied  Biosystems,  Paisley,  UK)  and  analysed  with  Analyst  Software  (AB
SCIEX UK Ltd, Warrington, Cheshire, UK). MS-MS was carried out on standard
and HOCl exposed solutions of O-C8-HSL and OH-C8-HSL. Standards were
diluted with acetonitrile to 1 µg ml-1 and delivered at 10 µl min-1. Solutions of
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exposed HSLs were diluted with methanol to 0.0625 - 0.5 µg ml -1, and delivered
at 3-12 µl min-1. The declustering potential was optimized for each AHL.
3.3. Results
3.3.1. Dose response curve for O-C8-HSL
The  dose  response  curve  (Fig.  3.3.)  was  used  to  determine  the  optimal
concentration of AHL to use in subsequent assays as it was necessary to avoid
a concentration that had achieved saturation. A concentration of 5 ng µl -1 was
considered to be acceptable.
Concentration of OC8-HSL (µg ml-1)
0 2 4 6 8 10
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U/
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1e+5
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4e+5
5e+5
Figure 3.3.  Dose response curve for O-C8-HSL.  E. coli  pSB1075, with the addition of various
concentrations of AHL, was incubated for three hours.
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3.3.2. HOCl reduced the activity of O-C8-HSL but not C8-HSL or OH-C8-HSL
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exposure of synthetic O-C8-HSL to 15 μM HOCl, resulted in a reduction of AHL
activity  of  approximately  90%  compared  to  control  (Fig.  3.4);  reductions  in
activity of synthetic C8-HSL and OH-C8-HSL were approximately 10% and 20%
respectively. There was no evidence that either ethyl acetate or GSH affected
AHL activity, or that ethyl acetate was able to quench HOCl. The modification of
O-C8-HSL activity by HOCl was rapid,  achieving a 70% reduction in activity
following two minutes of exposure (Fig. 5.5).
Figure 3.4. Exposure of C8 AHLs to HOCl (15 µM). All AHLs were exposed for a total of 60 min
with samples removed at Time 0, 10, 20, 30 and 60 min. AHLs were incubated with  E. coli
pSB1075 for 3 h, and activity was determined by measuring luminescence and optical density.
Data are expressed as the mean change in activity compared to control at Time 0 (T 0). Means ±
SE, n = 3.
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Figure 3.5.  Exposure of
O-C8-HSL to 15 µM HOCl. Samples were removed at 2 min intervals for 10 min. AHLs were
incubated with E. coli pSB1075 for 3 h and activity determined by measuring luminescence and
optical density. Data are expressed as the mean change in activity compared to control at Time
zero (T0). Means ± SE, n = 2.
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3.3.3. HOCl reduced the activity of AHLs with different chain length
HOCl significantly reduced the activity of oxo-AHLs with acyl chain lengths of 6,
8, 12 and 14; Activity of AHLs with an OH side group was reduced in that with
an acyl chain length of 6 only. The activity of all unsubstituted AHLs were not
significantly reduced (Fig.3.6.).
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Figure 3.6. Exposure of AHLs of different chain length to 15 µM HOCl. AHLs with no side group
(closed bars), AHLs with OH side group (diagonal bars) and AHLs with oxo side group (open
bars). Exposure was for a total of sixty min with samples taken at time zero (T0) and sixty min.
AHLs were incubated with  E. coli  pSB1075 for 3 h and activity was determined by measuring
luminescence and optical density. Data are expressed as the mean change in activity compared
to control at T0. Means ± SE, n = 2. * indicates a significant difference between HOCl exposed
AHL and control (P < 0.05).
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3.3.4. H2O2 caused insignificant changes to activity of the majority of AHLs
Exposure of a range of AHLs to H2O2 resulted in the significant reduction of
activity in C10-HSL only; this reduction is approximately 25%. There was no
significant reduction in activity in any of the remaining AHLs tested (Fig. 3.7).
AHL
C4 C6 C8 C10 C12 C14
A
H
L 
ac
tiv
ity
 (R
LU
/A
) r
el
at
iv
e 
to
 c
on
tro
l a
t T
0 (
%
)
0
20
40
60
80
100
120
*
Figure 3.7.  Exposure
of AHLs of different chain length to 100 μM H2O2. AHLs with no side group (closed bars), AHLs
with OH side group (diagonal bars) and AHLs with oxo side group (open bars). Exposure was
for a total of sixty min with samples taken at time zero, (T0) and sixty min. AHLs were incubated
with  E. coli  pSB1075 for  3 h and activity was determined by measuring luminescence and
optical density. Data are expressed as the mean change in activity compared to control at time
zero. Means ± SE n = 2. * indicates a significant difference between H2O2 exposed AHL and
control (P < 0.05).
148
3.3.5. HOCl exposure resulted in hydrolysis of lactone ring
Evidence from MS-MS suggests that exposure to HOCl resulted in hydrolysis of
the lactone ring in O-C8-HSL and possibly to a lesser extent in OH-C8-HSL.
The AHL OH-C8-HSL has a molecular mass of 243 Da which, with ionization
during MS-MS, showed a peak at m/z (mass to charge ratio) 244 for the intact
AHL (Fig. 3.8). The spectrum of the daughter ions from 244 showed a relatively
strong peak at m/z 101.9 (Fig. 3.9), indicating that in the control AHL the lactone
ring was intact.  The spectrum for the HOCl exposed OH-C8-HSL showed a
strong  peak  at  m/z 244  (Fig.  3.10)  indicating  the  presence  of  intact  AHL,
however the signal for an intact lactone ring (m/z 102) was relatively weak (Fig.
3.11).
O-C8-HSL has a molecular mass of 241 which, with ionization during MS-MS,
showed a peak at m/z 242 for the intact AHL (Fig. 3.12). The spectrum of the
daughter ions from m/z 242 showed a relatively strong signal at  m/z 102 (Fig.
3.13),  indicating  that  in  the  control  AHL the  lactone  ring  was  intact.  The
spectrum for the HOCl exposed O-C8-HSL showed a relatively weak signal at
m/z 242, and the MS-MS spectrum of the daughter ions of m/z 242 showed a
signal at  m/z 231.2 indicating the presence of hydrolysed lactone rings (Fig.
3.15)  on  a  chlorinated molecule  (product  F  in  Fig.  3.2).  The presence of  a
hydrolysed  intermediate  between  intact  AHL  and  hydrolysed  lactone  ring
(product  E  in  Fig.  3.2)  would  be indicated  by  a  signal  at  m/z 213  so  the
presence of a strong signal at  m/z 214.2 (Fig. 3.15) was suggestive that this
molecule may be present.
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Figure 3.8. MS-MS spectrum of control OH-C8-HSL. 
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Figure 3.9. MS-MS spectrum of products of 244 from control OH-C8-HSL. The arrow indicates the presence of intact lactone rings.
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Figure 3.10. MS-MS spectrum of HOCl exposed OH-C8-HSL. The arrow indicates the presence of the intact AHL.
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Figure 3.11. MS-MS of products of 244 from HOCl exposed OH-C8-HSL. There is a relatively low signal for 102.
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Figure 3.12. MS-MS spectrum of control O-C8-HSL. The arrow indicates the presence of intact AHL at 242.
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Figure 3.13. MS-MS spectrum of products of 242 for control O-C8-HSL. The arrow indicates the presence of intact lactone ring.
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Figure 3.14. MS-MS spectrum of HOCl exposed O-C8-HSL. The arrow indicates the reduced signal for the intact AHL.
156
 
Figure 3.15.  MS-MS spectrum for the products of 242 for HOCl exposed O-C8-HSL. The arrows indicate signals that represent the presence of hydrolysed AHL
(at 212) and hydrolysed lactone rings (at 231).
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3.3.6. HOCl did not reduce the signal of P. aeruginosa gene reporter fusion
strains
HOCl, at the concentration that reduced AHL activity in Section 3.10.2., did not
significantly reduce the signal from P. aeruginosa  gene fusion reporter strains
LasI::Lux, LasB::Lux, RhlI::Lux or RhlA::Lux, compared to control (water). For
three of the strains the largest difference in signal (not statistically significant)
occurred at six hours of incubation. All strains showed a consistent increase in
signal from one to six hours, following a one to two hour lag period, and all
strains apart from RhlA::Lux then demonstrated reducing signal strength for the
last three hours of incubation; RhlA::Lux showed a steady signal strength for a
further two hours, reducing in strength by the ninth hour of incubation.
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Figure 3.16. Exposure of P. aeruginosa reporter strain LasI to HOCl (15 µM). HOCl was added
to  a  1:10  dilution  of  an  overnight  culture  of  the  reporter  strain  and  incubated  for  9  h;
luminescence and absorbance measurements were taken every hour. The data are expressed
as the mean RLU/A. Mean ± SE, n = 3. There is no significant difference between data for
HOCL and control (t-test)
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Figure 3.17. Exposure of P. aeruginosa reporter strain LasB to HOCl (15 µM). HOCl was added
to  a  1:10  dilution  of  an  overnight  culture  of  the  reporter  strain  and  incubated  for  9  h;
luminescence and absorbance measurements were taken every hour. The data are expressed
as the mean RLU/A. Mean ± SE, n = 3. There is no significant difference between data for
HOCL and control (t-test).
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Figure 3.18. Exposure of P. aeruginosa reporter strain RhlI to HOCl (15 µM). HOCl was added
to  a  1:10  dilution  of  an  overnight  culture  of  the  reporter  strain  and  incubated  for  9  h;
luminescence and absorbance measurements were taken every hour. The data are expressed
as the mean RLU/A. Mean ± SE, n = 3. There is no significant difference between data for
HOCL and control (t-test).
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Figure 3.19. Exposure of P. aeruginosa reporter strain RhlA to HOCl (15 µM). HOCl was added
to  a  1:10  dilution  of  an  overnight  culture  of  the  reporter  strain  and  incubated  for  9  h;
luminescence and absorbance measurements were taken every hour. The data are expressed
as the mean RLU/A. Mean ± SE, n = 3. There is no significant difference between data for HOCl
and control (t-test).
3.4. Discussion
This study has demonstrated that HOCl significantly reduces the activity of a
range of AHLs in vitro. Though other groups have observed halogen damage to
AHLs (Michels  et  al. 2000,  Borchardt  et  al. 2001),  this  is  the first  time that
damage  to  AHLs  with  various  chain  lengths  and  substitutions  has  been
systematically assessed and reported. It was also demonstrated that, generally,
the  activity  of  the  same  AHLs  is  not  affected  by  H2O2.  The  in  vivo study
demonstrated that HOCl, at the concentration that damaged AHLs in vitro, did
not reduce the signal of P. aeruginosa reporter strains, which to our knowledge
has yet to be reported. A summary of the results from various sources, including
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this study, can be seen in Table 3.3. Where AHLs have been repeated this study
confers  with  other  groups  in  all  instances  except  that  involving  
O-C10-HSL; this study found no reduction in activity when exposed to HOCl, a
result at odds with that of Michels et al. (2000). However, even though the mean
reduction in activity did appear as though it should be significant (Fig. 3.6), the
large error bars ruled out arriving at this conclusion.
The overriding observation from all three studies was that substitution on the 3C
of the carbon chain rendered the AHL molecule vulnerable to modification by
oxidizing halogens, with the oxo side group being the predominant target (Fig.
3.6, Table 3.3). This does not appear to be specific to halogens; both substituted
and  unsubstituted  AHLs  were  oxidized  by  OH• radicals,  but  the  activity  of
substituted  AHLs  were  noticeably less  than  that  of  unsubstituted  molecules
following oxidation  (Frey  et  al.,  2010).  An insightful observation  from Frey’s
study and also that of Cui et al (2009) was that the product of C6-HSL oxidation
by OH• radicals was O-C6-HSL.
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Table 3.3. A summary of results from three studies investigating AHL modification by oxidizing
halogens.
AHL Reduction in activity Test agent Reference
C4-HSL No HOCl This study
O-C4-HSL No HOCl This study
C6-HSL No
No
No
HOCl
HOCl, HOBr
HOCl, HOBr
This study
Michels et al.2000
Borchardt et al. 2001
O-C6-HSL Yes
Yes
Yes
HOCl
HOCl, HOBr
HOCl, HOBr
This study
Michels et al.2000
Borchardt et al. 2001
OH-C6-HSL Yes HOCl This study
C8-HSL No HOCl This study
O-C8-HSL Yes HOCl This study
OH-C8-HSL No HOCl This study
C10-HSL No HOCl This study
O-C10-HSL No
Yes
HOCl
HOCl, HOBr
This study
Michels et al.2000
OH-C10-HSL No HOCl This study
C12-HSL No
No
HOCl
HOCl, HOBr
This study
Borchardt et al. 2001
O-C12-HSL Yes
Yes
HOCl
HOCl, HOBr
This study
Borchardt et al. 2001
OH-C12-HSL No HOCl This study
O-C14-HSL Yes HOCl This study
The results  from the  MS-MS on C8 AHLs concurred with  those of  Michels’
group (Michels  et al.  2000) in that evidence of a hydrolysed lactone ring was
present  (Fig.  3.15.),  and  also  a  possible  intermediate  molecule,  for  HOCl
exposed O-C8-HSL. Using the estimated pseudo first-order rate constants in
the Michels paper,  at  the pH conditions used for  this  study (6.8),  it  can be
postulated that reactions 1 and 2 in the pathway (Fig. 3.2) were too fast for
molecules A and B to be detected, which is supported by the lack of peaks at
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the  expected  m/z values  (242  and  276.5,  respectively).  Much  slower  rate
constants for reactions 3 and 4 (Fig. 3.2) mean that observed daughter ions at
m/z 231and possibly 213 are the equivalent of products E and F in the pathway
if chlorination occurred as indicated.
The lack of any significant changes to AHL activity following exposure to H 2O2
indicated that these molecules were not as vulnerable to oxidation as they were
to  chlorination  (Fig.  3.7),  in  terms of  affecting  activity.  It  is  possible  that  an
insufficient concentration was used, though a similar concentration reduced the
activity of the bacterial enzyme penicillinase (Chapter 2). Another possibility is
that oxidation of unsubstituted AHLs resulted in substituted AHLs, as in that
seen  by  Cui  (Cui  et  al., 2009)  and  Frey  (Frey  et  al., 2010),  the  modified
molecules  themselves  being  capable  of  normal  activity.  So,  C8-HSL would
become O-C8-HSL and O-C8-HSL would become OH-C8-HSL. It  is possible
that the fully substituted AHL is then less vulnerable to further oxidation, indeed
Frey’s group demonstrated that the rate constants for the reactions between
AHLs and OH• were higher for unsubstituted AHLs than substituted ones (Frey
et al., 2010).
A finding of this study was that the in vitro effect of HOCl on AHLs was not seen
in vivo for any of the P. aeruginosa reporter strains used (Figs. 3.9 to 3.12). The
concentration of HOCl was the same as that used for the in vitro experiments,
but the unknown factor with the  in vivo experiments was the concentration of
AHLs being produced, it could have meant that the concentration of HOCl was
insufficient to cause a measurable effect. Increasing the concentration of HOCl
would have introduced the problem of direct bacterial cell toxicity.
The main question as to why no effect was seen therefore relates to the fate of
HOCl in the bacterial culture; the most probable answer being that the HOCl
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was being quenched by components in the culture medium, or by molecules
produced by the P. aeruginosa strains. HOCl can readily damage biomolecules
such  as  proteins  (Malle  et  al., 2006),  so  it  is  possible  that  the  sub-lethal
concentration used was quenched by proteins within the growth medium. GSH,
an  efficient  quencher  of  HOCl  is  not  as  widespread  in  bacteria  as  other
antioxidant molecules such as SOD and catalase, being found in most Gram-
negative bacteria but relatively few Gram-positive bacteria (Fahey et al.,1978).
It is, along with other thiols, found in P. aeruginosa (Newton et al., 1996) which
would equip the bacteria with a sound defence against HOCl. However, even
though this may have explained the protective role of GSH against intracellular
AHL  damage,  unless  the  molecule  is  actively  secreted  by  the  organism,
extracellular AHLs would still  have been vulnerable and a reduction in intact
AHLs should have occurred.  Export  of  GSH by some strains of  Salmonella
typhimurium and E. coli has been reported (Owens and Hartman, 1986), and it
was observed that extracellular levels of GSH rose in parallel with cell density,
when, by the early stationary phase, there was more extracellular GSH than
intracellular. Evidence that  P. aeruginosa exports this molecule has not been
found, but it is feasible that they do employ this extra level of oxidative defence,
especially as the results of this study demonstrate that, at the concentration
used, HOCl does not reduce the signal from reporter strains.
Future work  could examine the effects  of  other  ROS/RNS on AHLs,  and to
investigate further the relationship between damaged AHLs and the formation of
biofilms.  For  example,  mutant  strains  of  P.  aeruginosa  that  do  not  produce
endogenous  AHLs  could  be  incubated  in  media  containing  HOCl  exposed
AHLs, in conditions that allow quantification of biofilm mass. Performing MS-MS
on  AHLs  exposed  to  H2O2 could  confirm  that  oxidation  was taking  place.
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Modification of AHLs, perhaps not being considered as degraded or damaged,
might still affect the behaviour of the test organism if it is no longer in the form
normally synthesised or recognized by the bacteria. So, even though this study
did not see evidence of “damage” to AHLs by H2O2,  it  would be valuable to
determine whether H2O2 exposed AHLs resulted in different physiological and
morphological responses of the bacteria to the modified AHL in vivo.
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Chapter 4
The effects of oxygen on the formation of bacterial biofilms and the
effects of oxygen and oxidants on 24 h bacterial biofilms
4.1. Introduction
Though  the  general  concept  of  antibiotic  resistance  in  bacteria  relates  to
genetically transferable mechanisms, the sessile form of a bacterial community,
known as a biofilm, can also be considered to be a means of resistance in itself.
How bacteria within biofilms are able to resist the action of antibiotics is being
widely investigated and several mechanisms have been proposed, including;
altered  gene  expression,  which  may  result  in  the  production  of  matrix
components  that  bind  antibiotics  (Sadovskaya  et  al.  2010,  Beaudoin  et  al.
2012),  and  slower  growing  bacteria  within  biofilm  structures  (Werner  et  al.
2004), which may be less vulnerable to antibiotics whose action requires that
cells  are  actively  growing  (Section  1.2.).  Biofilms,  therefore,  need  to  be
considered when investigating potential anti-resistance strategies. In the context
of  HBOT it  is  worth considering whether  improvement in  tissue oxygenation
directly affects the action of antibiotics, rendering them more effective against
biofilms, or whether oxidant generation acts as an adjunct to antibiotic therapy.
Wound microflora are diverse (Section 1.3.2.) and several species might have
been applicable to use in this study. However,  P. aeruginosa  and  S. aureus
were  chosen due  to  their  predominance in  chronic  wounds and  the  clinical
relevance  of  their  antibiotic  resistance.  Two  strains  were  obtained  for  each
species,  one,  exhibiting  antibiotic  sensitivity  and  the  other,  resistance;  this
enabled a comparison of  the properties between the two strains in  different
oxygen environments. Both species readily form biofilms and are known to be
ubiquitous in  the environment.  They have been identified in chronic  wounds
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(Davis et al. 2008) and are thought to be a factor in non-healing (Bjarnsholt et
al. 2008).
A protocol using broth cultures in 96-well microplates was devised based on
that  published  by  the  National  Committee  for  Clinical  Laboratory  Standards
(Ferraro, 2003). This was to allow for high replication numbers for the various
conditions and the limitation of the size of the sealed oxygen boxes. 
The first  aim of  this  study was to  investigate  whether  oxygen concentration
impacted the effectiveness of antibiotics against planktonic bacterial cultures.
This was achieved by exposing cultures of sensitive and resistant strains of
P.aeruginosa and  S. aureus to a range of antibiotic concentrations, in oxygen
concentrations of 5%, 21%, 40% and 100%. This trial was also necessary to
ascertain the MICs for planktonic cells to be able to estimate the concentration
necessary to kill the majority of biofilm cells.
The  second  aim  of  this  study  was  to  determine  the  effect  of  oxygen
concentration on the formation of biofilm mass in both sensitive and resistant
strains of bacteria. Both strains of P.aeruginosa and S. aureus were cultured for
24 h and their biofilm mass quantified by staining with crystal violet. The crystal
violet was solubilised in acetic acid and measured with a spectrophotometer.
The  final  aim  was  to  determine  whether  oxygen  concentration  was  able  to
modify the effects of antibiotics and oxidants on live biofilm cells. Twenty-four
hour  pre-formed  biofilms  of  an  antibiotic  sensitive  strain  of  S.  aureus were
exposed to (i) the antibiotic oxacillin, (ii) the oxidant generating system xanthine
oxidase, and (iii) both of these, in different oxygen incubation conditions (.5%,
21%, 40% and 100%) for a further 24 h. NADPH oxidase is the phagocytic
oxidant  generator  likely  to  be  found in  a  wound  environment  but  a  simpler
system was required for this study. Xanthine oxidase, like NADPH oxidase uses
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oxygen  as  a  substrate  and  the  rationale  for  its  use  is  that  with  increasing
oxygen availability (as during HBOT) there will be an increased production of
oxidant and improved killing of bacterial cells in the biofilm. Xanthine oxidase
catalyses the oxidation of xanthine as follows (Lacy et al. 1998):
                 Xanthine + H2O + 2O2                  uric acid + 2O2•- + 2H+             
                 Xanthine + H2O + O2                  uric acid + H2O2
The superoxide radical (O2•-) in buffer will dismutate into H2O2 as below:
                            2O2•- + 2H+                   H2O2 + O2        
Xanthine was the substrate used for this study. Xanthine oxidase is found in
vascular  smooth  muscle  cells  and  endothelial  cells  in  cardiac  and  skeletal
muscle, and is also found in human macrophages and mast cells (Hellsten-
Westing, 1993).  Xanthine oxidase activity has been linked with  inflammatory
processes occurring following skeletal muscle damage (Hellsten et al. 1997), so
it  is reasonable to consider that it  may also play a role in the generation of
oxidants in a chronic wound environment. However, in this study the enzyme is
being used as a surrogate for neutrophil NADPH-oxidase.
Live  biofilm  cells  were  quantified  by  incubating  with  the  fluorescent  dye
resazurin. Blue resazurin is reduced to pink resorufin by metabolically active
cells, a change that was measured by colorimetry in this study.
4.2. Materials and methods
4.2.1. Chemicals
Acetic acid and ethanol were obtained from VWR BDH Prolabo (Lutterworth,
Leicestershire,  UK).  Crystal  violet,  Mueller  Hinton  II  broth  (cation  adjusted),
sodium chloride, oxacillin (sodium salt), inorganic salts, xanthine and xanthine
oxidase (Cat.  # X4500, from bovine milk) were obtained from Sigma Aldrich
(Poole,  Dorset,  UK).  Resazurin  (Acros  Organics),  streptomycin  sulphate,
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tryptone soya broth (TSB) and tryptone soya agar (TSA) were obtained from
Fisher Scientific UK Ltd (Loughborough, Leicester, UK).
4.2.2. Bacterial strains used in this study
The bacterial strains used in this study are listed in Table 4.1.  P. aeruginosa
8626  and  S.  aureus  6571 were  kindly  donated  by  Plymouth  University.
P. aeruginosa  10848 was  obtained  from  NCIMB  (Aberdeen,  Scotland,  UK).
S. aureus 33591 was obtained from Fisher Scientific UK Ltd.
Table 4.1. The bacterial strains used and their antibiotic sensitivity.
* National Collection of Industrial and Marine Bacteria. ** American Type Culture Collection.
Strain Culture
collection
Antibiotic sensitivity
Pseudomonas aeruginosa 8626 NCIMB* Streptomycin sensitive
Pseudomonas aeruginosa 10848 NCIMB Streptomycin resistant
Staphylococcus aureus 6571 NCIMB Oxacillin sensitive
Staphylococcus aureus 33591 ATCC** Oxacillin resistant
4.2.3. Maintenance of bacterial cultures and preparation of media
All  strains  of  bacteria  were  stored  in  15% glycerol,  at  -80  °C and in  liquid
nitrogen. For short-term storage, streak plates of bacteria (on TSA) were sealed
with  Parafilm®M and stored at  4  °C.  Fresh plates  were  prepared every 4-6
weeks.  All  liquid  cultures,  to  provide  inoculation  material,  were  prepared by
incubating the bacteria in TSB at 37 °C for  P. aeruginosa and 35 °C for  S.
aureus. All  media,  dH2O and other  solutions were autoclaved at 121 °C for
15 min and stored at 4 °C. All solutions containing heat sensitive components,
such as antibiotics, were filter sterilised prior to use (0.22 μm filter pore size).
4.2.4. Determination of bacterial population density
Bacterial population density was determined by measuring the absorbance, at 
600 nm, of a 1 ml sample of liquid culture and using a growth calibration curve
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to estimate the CFU ml-1.  A 1 ml aliquot of the growth medium was used to
blank the spectrophotometer.
4.2.5. Preparation of bacterial population growth calibration curves
Fifty millilitres of TSB was inoculated with a single colony from a streak plate
and  incubated  overnight,  at  the  appropriate  temperature at  150  rpm.  The
following  morning,  50  ml  of  fresh  TSB  was  inoculated  with  500  μl  of  the
overnight  culture  and  incubated  in  a  shaking  water  bath  (150  rpm)  at  the
appropriate temperature. Every hour, for 5-6 h, 1 ml aliquots of culture were
removed and the  absorbance measured (Section 4.2.4.).  At  the  same time,
100 μl  of  culture was added to  900 μl  of  medium (1  ×  10-1 dilution);  further
dilutions were performed down to 1 × 10-12. For each time point, four dilutions
were chosen and 10 μl, from a single dilution, was dropped onto the top of a
TSA plate three times (Figure 4.1.A). The plate was gently tilted to allow each
aliquot of culture to flow, in a straight line, down the plate (Figure 4.1.B). This
was repeated for all dilutions chosen. All plates were incubated for 24-48 h. 
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Figure 4.1. Plate-saving method of applying liquid culture to agar plates to obtain CFU counts.
There were three replicates per plate, each of 10 μl aliquots. The plate was tilted to allow a flow
of culture across the plate. CFUs were counted in each streak.
Following incubation the CFUs were counted in each streak on each plate and
the mean for each plate was calculated, discounting plates that had too many or
too  few  colonies  (the  ideal  number  would  have  been between  10  and  50
colonies per streak). The following equation was used to determine CFU ml-1:
               CFU ml-1 = plating factor (100) × CFU count × dilution factor
Plots were constructed of CFU ml-1 × absorbance, and a line of best fit obtained.
This was repeated for all bacterial species used.
4.2.6. Preparation of cultures for inoculation of microplates
All bacterial strains (Table 4.1) were cultured overnight in TSB (Section 4.2.3)
and 50 ml of fresh TSB was inoculated with 50 μl of culture and incubated at the
appropriate temperature until population growth had reached 1 × 108 CFU ml-1,
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as determined by growth calibration curves for each strain. An aliquot of this
culture was further diluted with medium to 1 × 106 CFU ml-1. This was the correct
density of bacterial cells, with which to inoculate microplates (sterile, 96-well,
polystyrene, clear, flat bottom, 400 μl, Thermo Scientific Nunc), to give a final
density of  5  × 105 CFU ml-1 following a further  1:2 dilution in the well  (with
antibiotic solution or medium). The medium used was dependent on the trial
and will be discussed in each relevant section.
4.2.7. Sealed box system for control of oxygen exposure
Sealed plastic boxes were used to provide specified oxygen concentrations for
the incubation of bacterial species (Figure 4.2). Four boxes were prepared, one
for each oxygen concentration (5%, 21%, 40% and 100%). Boxes were cleaned
with Virkon disinfectant after each use.
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Figure 4.2. An example of a sealed box used in this study. The box pictured (234 × 234 × 95
mm)  was  fitted  with  an  oxygen  sensor  to  determine  filling  times  for  the  different  oxygen
concentrations and to measure oxygen consumption of bacterial inoculants in a microplate over
a period of 24 h to ensure that oxygen concentration would not be significantly depleted during
the incubation period, or that gas would not leak out. The boxes used in the main part of the
study did not contain an oxygen sensor.
4.2.8. Determination of gas flow time
Four  gas  cylinders,  each  filled  with  air  and/or  oxygen,  to  the  required
concentration, were prepared by DDRC. A cylinder was attached to its partner
box with flexible tubing and gas was run continuously into the box (this was
carried out in a fume cupboard) until the oxygen analyser recorded the correct
concentration in the box. This process was timed for each concentration. At the
end of the filling period the taps on the box were closed and the tubing to the
cylinders disconnected.
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4.2.9. Oxygen consumption during culture conditions
Two microplates  were  prepared in  the  same manner as that  for  a  trial  and
placed in the box containing the oxygen sensor. The box was filled with gas as
previously  described  (Section  4.2.6),  to  achieve  21%  oxygen,  and  was
incubated at 37 °C for 24 h. During this period the oxygen sensor was attached
to a recording device which monitored any change in oxygen concentration.
4.2.10.  Micro-broth  dilution  protocol  for  planktonic  MICs  in  different  oxygen
concentrations
Bacterial cultures were prepared for plate inoculation as described in Section
4.2.5. Double dilutions of antibiotic (streptomycin for P. aeruginosa and oxacillin
for S. aureus) were prepared by initially dissolving antibiotic solid in sterile water
and further dilution in Mueller Hinton II broth (MHB) to achieve a concentration
double that of the highest concentration being tested (this allows for a further
1:2 dilution when the antibiotic  solution was added to  the bacterial  culture).
These solutions were filter sterilised and serial double dilutions performed with
MHB to obtain 11 concentrations. In all  studies involving oxacillin, MHB was
supplemented with  2% (w/v)  NaCl  (Dillon,  1984).  Seventy five  microlitres of
each  antibiotic  concentration  were added  to  each  of  3  wells  in  a  sterile
microplate  (flat-bottomed).  Seventy  five  microlitres  of  bacterial  culture  were
added to each well containing antibiotic. Three wells were prepared with culture
and MHB only to act as a growth control and a further 8 wells were prepared
with  MHB only to  act  as contamination controls.  A total  of  four  plates were
prepared for each strain, one for each oxygen concentration.
All plates were read in a plate reader at 600 nm and then covered with Breathe-
Easy sealing film; two plates were placed in each oxygen box, one containing
the antibiotic sensitive strain and one the resistant strain. The boxes were filled
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with gas (Section 4.2.8) and incubated at the appropriate temperature, at 150
rpm, for 18 h for P. aeruginosa and 24 h for S. aureus. All plates were read at
600 nm, at the end of the incubation period. 
4.2.10.1. Data analysis
The absorbance value for MHB only was deducted from all other values and
means  calculated.  The  equation  to  calculate  the  mean  %  reduction  in
population  growth  is  given  in  Appendix  11.  Means  from  three  replicate
experiments  were  calculated, and  the  MIC  expressed  as  the  lowest
concentration of antibiotic to achieve a 90% reduction in population growth.
4.2.11. Quantitation of 24 h biofilm mass formation grown in different oxygen
concentrations
Bacterial cultures were prepared for plate inoculation as described in Section
4.2.5.  All  dilutions  for  this  trial  were  with  TSB.  A series  of  wells  containing
medium only was used as contamination control. Eight replicates were prepared
for each strain of bacteria and four plates were prepared for each species. The
plates were sealed with film and one plate was placed in each oxygen box. The
boxes were filled with gas as previously described and incubated for 24 h. All
wells were washed twice with sterile distilled water and 200 μl of 95% (v/v)
ethanol was added to each well which were then left for 15 min. Ethanol was
removed and wells were left to dry at room temperature before adding 200 μl of
0.1% (w/v) crystal violet. After 5 min at room temperature, the crystal violet was
removed and the wells  were washed twice with sterile distilled water  before
adding 200 μl of 33% (v/v) acetic acid. The plates were read at 570 nm.
4.2.11.1. Data analysis
The absorbance value for acetic acid was deducted from all other values and
means calculated. Means ± SE were calculated from 3 runs for each bacterial
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species and visualised using SigmaPlot software. One-way ANOVA was used
for  statistical  analysis  with  a  probability  level  of  P <  0.05  accepted  as  the
determination  of  statistical  significance.  For  analysis  of  individual  replicate
experiments  the  Mann-Whitney  Rank  Sum  Test  was  used  to  determine
significant differences between O2 concentrations and control (21%).
4.2.12. Effect of oxygen concentration on antibiotic decrease in live cells in pre-
formed 24 h S. aureus biofilms
4.2.12.1. Production of 24 h biofilms
Four microplates were inoculated with culture as previously described (Section
4.2.5) with TSB as the growth medium and using S. aureus strain 6571. Plates
were sealed with film and incubated at 35 °C for 24 h, at 150 rpm. Following
incubation all  medium was gently removed from each well and biofilms were
washed with sterile dH2O.
4.2.12.2. Addition of antibiotic
MHB  (150  μl)  containing  12.5  μg  ml-1 oxacillin  was  placed  in  eight  wells
containing biofilm, and MHB without oxacillin was added to eight more wells
containing  biofilm.  MHB  was  added  to  eight  empty  wells  to  provide  a
contamination control. Plates were sealed with film, placed in each oxygen box
and flushed with  gas as previously described.  Boxes were incubated at  the
appropriate temperature for 24 h following which, all medium was removed and
biofilms were washed with sterile dH2O.
4.2.12.3. Determination of live cell decrease with resazurin
Fresh  MHB  (150  μl)  containing  40  μM  resazurin  was  added  to  each  well
containing biofilm, plus 8 empty wells (this is to provide a value for R0 in the
equation to calculate live cell reduction, see Section 4.2.11.4). The plates, after
resealing to prevent contamination and wrapping in aluminium foil to eliminate
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light, were incubated in air at 37 °C for 30 min. All plates were then read at 570
nm  (maximum  absorbance  of  reduced  resazurin)  and  600  nm  (maximum
absorbance for oxidised resazurin).
4.2.12.4. Data analysis
Raw data were analysed with Microsoft Excel. The equation to calculate the
mean % reduction in live cells can be seen in Appendix 12. Means ± SE were
calculated from three runs and graphed using SigmaPlot software. One-way
ANOVA was used for statistical  analysis with  a probability level  of  P < 0.05
accepted as the determination of statistical significance.
4.2.13. Exposure of pre-formed 24 h S. aureus biofilms to oxacillin and xanthine
oxidase derived oxidants
Four  plates  of  biofilms  were  prepared  as  previously  described  (Section
4.2.11.1), using S. aureus strain 6571. A 750 μM xanthine solution was freshly
prepared, immediately prior to all runs, by adding 100 μl aliquots of 1 M NaOH
to 11.4 mg of xanthine until the xanthine had fully dissolved. Sterile MHB was
then added slowly, to check for precipitation, to a volume of 90 ml. The pH was
checked to ensure a value of between 7.0 and 7.5 and the volume made up
to100 ml with  MHB. Xanthine oxidase solution was prepared by diluting the
purchased enzyme suspension with sterile dH2O to the required concentration
immediately prior to use. Oxacillin solutions were prepared by dissolving solid in
dH2O to the required concentrations, immediately before use. Eight replicates
were prepared, of each of the conditions summarised in Table 4.2.
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Table 4.2.  Conditions prepared for each run of  S. aureus 6571  biofilm exposure to xanthine
oxidase derived oxidants.  The final  volume was that  for  each well  of  the microplate  and 8
replicates were prepared for each condition.
Condition Contents Final volume 
Contamination control MHB 150 μl
Growth control MHB + S. aureus 150 μl
Oxidant exposure MHB + S. aureus 
0.067 U ml-1 xanthine oxidase
100 μM xanthine
150 μl
Antibiotic exposure MHB + S. aureus
Oxacillin 12.5 μg ml-1
150 μl
Oxidant and antibiotic exposure MHB + S. aureus
0.067 U ml-1 xanthine oxidase
100 μM xanthine
Oxacillin 12.5 μg ml-1
150 μl
All plates were sealed with film and a single plate was placed in each oxygen
box. All boxes were filled with gas as previously described and incubated at
35 °C, 150 rpm, for 24 h. Following incubation all  biofilms were washed with
sterile  dH2O  and  live  cell  decreases  determined  as  described  in  Section
4.2.11.3. Data was analysed as in Section 4.2.12.4.
4.3. Results
4.3.1. Oxygen consumption during culture conditions
The O2 concentration in the box immediately prior to incubation was recorded
as 21.2%. This had fallen to 21% after 24 h of incubation.
4.3.2. Oxygen concentration did not affect planktonic MICs for P. aeruginosa or 
S. aureus
For all four strains of bacteria tested, the oxygen concentration did not affect the
MICs  for  their  respective  antibiotics  (Table  4.3).  As  expected,  the  resistant
strains had higher MICs than sensitive strains.
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Table 4.3.  MICs for resistant and sensitive strains of  P. aeruginosa  and S. aureus at different
oxygen  concentrations.  The  MIC  is  defined  as  the  lowest  concentration  of  antibiotic  that
achieves a 90% reduction in population growth (measured as absorbance at 600 nm); all values
are μg ml-1.
5% O2 21% O2 40% O2 100% O2
P. aeruginosa 10848 (R) 40 40 40 40
P. aeruginosa 8626 (S) 20 20 20 20
S. aureus 35591 (R) > 128 > 128 > 128 > 128
S. aureus 6571 (S) 0.125 0.125 0.125 0.125
4.3.3. Oxygen  concentration did not affect biofilm mass of S. aureus
Oxygen concentration, during biofilm development, did not result in a significant
difference in the final mass of 24 h biofilms of S. aureus strains 35591 or 6571,
as determined by staining with crystal violet (Fig. 4.3).
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Figure 4.3. Mean relative mass of 24 h biofilms of S. aureus strains 6571 and 33591, to that of
control biofilms grown in air. Biofilms were stained with crystal violet, the absorbance of which,
solubilised in acetic acid, was measured at 570 nm. Results are expressed as means ± SE, n =
3. Differences are not significant, as determined by one-way ANOVA.
4.3.4. Biofilm mass for P. aeruginosa could not be quantified
Despite trying a variety of methods, acceptable biofilms of P. aeruginosa, strains
10848  or  8626,  could  not  be  produced.  These  strains  produced  copious
flocculation on the surface of the medium rather than attaching to the surface of
the microplate well, resulting in a ring of unattached bacterial material that clung
to the upper part of the well (Figure 4.4). The inconsistency of the volume of
material meant that accurate measurements could not be attained.
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Figure 4.4. Photograph of  P. aeruginosa flocculations adhering to the tops of wells following
crystal violet staining. Some wells are clean, indicating that the flocculations were washed away
during the washing steps.
4.3.5. Oxygen concentration did not affect the activity of oxacillin on S. aureus
biofilms
In 24 h S. aureus 6571 biofilms exposed to oxacillin the O2 concentration did not
affect  the  activity  of  oxacillin  against  biofilm  cells  (Fig.  4.5).  Oxacillin,  at  a
concentration  × 100 that for  the planktonic MIC for this strain,  resulted in a
decrease in live biofilm cells of  approximately 50%; there was no significant
difference in cell death between oxygen concentrations.
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Figure 4.5. Mean live biofilm cells in 24 h  S. aureus 6571 biofilms, relative to growth control,
following exposure to xanthine oxidase derived oxidants, oxacillin and a combination of these
components.  Biofilms  were  grown  in  air  for  24  h prior  to  exposure  at  different  oxygen
concentrations. Concentrations of solutions: xanthine,100 μM, xanthine oxidase 0.067 U ml -1,
oxacillin,  12.5  μg  ml-1.  Reduction  in  live  biofilm  cells  was  determined  by  incubation  with
resazurin  (40 μM).  Results  are  expressed as means ± SE,  n  = 3.  *  indicates a significant
difference compared to xanthine oxidase generated oxidants, P < 0.05.
4.3.6.  Oxygen  concentration  did  not  affect  the  ability  of  xanthine  oxidase
derived oxidants to kill S. aureus biofilm cells
The oxygen concentration, in which 24 h S. aureus 6571 biofilms were exposed
to xanthine oxidase derived oxidants, did not affect the reduction in live cells  
(Fig. 4.5). Xanthine oxidase generated oxidants resulted in a 20-30% reduction
184
in live biofilm cells compared to a growth control, but there was no significant
difference in cells loss between oxygen concentrations.
The combination of oxacillin and xanthine oxidase generated oxidants resulted
in  a  mean  cell  loss  of  approximately  75%,  with  no  significant  differences
between oxygen concentrations (Fig.4.5). For all oxygen concentrations there
was  a  significant  difference  in  cell  death  due  to  xanthine  oxidase  alone
compared to xanthine oxidase in combination with oxacillin (Fig. 4.5), but no
significant  difference  between  oxacillin  alone  and  oxacillin  combined  with
xanthine  oxidase,  as  determined  by  one-way  ANOVA with  Holm-Sidak  All
Purpose Multiple Comparison Procedure.
4.4. Discussion
This  study compared the  effects  of  O2 concentration  on the  antibiotic  MICs
between sensitive and resistant strains of  S. aureus and  P. aeruginosa. Few
studies have examined the effect of hyperoxia on antibiotic efficiency and as far
as we are aware this is the first time that a study of both sensitive and resistant
strains has been reported. In air, the MICs for the resistant strains were lower
than those for the sensitive strains, and this differential was maintained in all
conditions.  Increasing  O2 concentration  did  not  affect  MICs  for  any  of  the
strains, indicating that O2 alone is insufficient to enhance antibiotic action under
these conditions.  However,  it  is  necessary to  consider  the properties  of  the
antibiotics used; Muhvich et al. (1989) postulated that their observed reduction
in MICs for trimethoprim, at 98% O2, was due to keeping critical enzymes, in a
synthetic pathway, in an oxidised state. This study used streptomycin against P.
aeruginosa strains; this is an aminoglycoside, a group of antibiotics that require
oxygen-dependent transport  into cells (Taber  et al.  1987).  Reduced bacterial
uptake  of  aminoglycosides  has  been  observed  under  anaerobic  conditions
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(Miller  et al.  1980), so it  might be reasonable to consider that increased O2
concentrations could facilitate increased bacterial uptake of the drug. However,
neither  this  study,  nor  that  of  Muhvich  (1989)  showed  such  an  effect.  No
increase in MIC was seen at 5% O2 for streptomycin, but it is possible that both
strains of P. aeruginosa had been able to utilise alternative electron acceptors to
maintain cell membrane potential. Unchanged MICs for resistant bacteria also
indicated  that  O2  conferred  no  benefit or  hindrance  on  the  mechanisms  of
resistance in these species.
This study has also examined the relationship between oxygen availability and
the ability of an oxidant generating enzyme to kill cells in biofilms; as far as we
are aware, this is the first time that this has been reported. In order to consider
any changes in biofilm mass due to O2 concentration alone and to ensure that
the  culture  conditions  resulted  in  sufficient  biofilm  formation  for  subsequent
studies,  biofilms  were  grown  in  different  O2 environments  and  their  mass
measured with crystal violet.
It  was  at  this  point  in  the  study  that  the  ability  to  produce  good  quality,
reproducible  biofilms  for  all  four  strains  of  bacteria  was  challenged;  wide
variability  of  biofilm  mass  was  a  persistent  problem,  particularly  for  P.
aeruginosa strains.  All  stages  of  the  protocol,  which  was  based  on  those
published  by  numerous  authors  (Peeters  et  al. 2008,  Pettit  et  al.  2005,
Sandberg et al. 2009, Tré-Hardy et al. 2008), were scrutinised and alternative
materials were trialled, but with no significant improvement. During the staining
phase of  the protocol  (following the  removal  of  crystal  violet  but  before  the
addition of acetic acid) attention was paid to the visual qualities of the biofilms;
wells  containing  S.  aureus had  easily  visualised,  uniform  bacterial  material
adhered to the whole surface of the well where culture had been in contact.
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However, wells containing P. aeruginosa were clear of any material apart from a
ring that would have been at the liquid-air interface (Fig. 4.4).
Further investigation led to the conclusion that this material was not attached to
the  well  but  was accumulating in  the  medium at  the air  interface,  and was
sticking to the well when liquid culture was removed. During washing steps this
material  was easily washed away,  resulting in  some wells  having no visible
material  present  at  all  (Fig.  4.4).  The  following  trials  were  conducted:  (i)
incubating culture for 4 h, replenishing medium and incubating for a further 24
h, (ii) incubating in a tissue-treated 96-well plate, (iii) incubating culture for 24 h,
replenishing medium and incubating for a further 24 h, (iv) incubating for 6 h, (v)
incubating culture on glass microscope slides, (vi) incubation of  P. aeruginosa
PAO1n (Nottingham PAO1 strain). None of these methods produced adhered,
uniform biofilms of P. aeruginosa on the surfaces (data not shown). Peeters et
al. (2008) also found substantial variability in P. aeruginosa biofilm mass using
crystal violet. It was decided to discontinue with P. aeruginosa strains but persist
with  S. aureus as there was adherent biofilm on the walls of the wells for this
species.  There  was,  however,  still  variability between separate  runs for  this
organism (Figs. 4.3 and 4.4) despite maintaining standardised inoculation cell
density and culture conditions. The large SE values mean that there are no
significant differences in biofilm mass between different O2 concentrations, a
result at odds with that of Xu  et al. (1998) who found that mean thickness in
biofilms grown in 100% O2 were approximately 33 μm thicker than those grown
in air.  It  was expected that  increased O2 availability during biofilm formation
might result in increased biofilm mass proportional to O2 concentration, due to
an increase in metabolically active cells (Xu et al. 1998). The biofilms measured
in this study and those in that of Xu were comprised of different species, which
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may have had a different response to modified O2 environments. It is possible
that a limitation to biofilm growth was nutrient depletion in the culture medium;
had  the  system  included  a  means  to  continually  replenish  medium  usable
biofilms might have been produced.
Because of the problems mentioned above, this study focused on investigating
the effects of O2 environment on the number of live cells, in pre-formed 24 h
biofilms, when exposed to an antibiotic, an oxidant, and both of these together;
the first  time this has been reported. For all  of  these conditions there were
reductions in live cells, compared to a growth control,  but the reduction was
stable at all O2 concentrations (Fig. 4.5), indicating that increased O2 availability
did not confer an advantage to the killing/inhibition mechanism of the antibiotic
or oxidant. The result with oxacillin, though not directly comparable with that for
planktonic culture MICs, suggests that O2 does not affect the effectiveness of
this  antibiotic  at  decreasing  live  cells  despite  the  fact  that  as  a  β-lactam
antibiotic, the lethality of oxacillin is reliant on the presence of actively growing
cells.  It  was hypothesised that increasing the O2 gradient would result  in an
increase in the number of metabolically active, and therefore more vulnerable,
cells. This result is inconsistent with other studies that have demonstrated that
O2 and nutrient limitations in biofilms result in slower growing and/or stationary
phase cells that  show increased tolerance to antibiotics (Anderl  et  al.  2003,
Walters et al. 2003); it is possible that nutrients, such as amino acids or carbon
sources were the limiting factor. Consistent with other studies (Moskowitz et al.
2004, Rose & Poppens, 2009) the concentration of antibiotic needed to reduce
biofilm live cells was much greater (× 100 in the present study) than that for
planktonic cultures, supporting the role of biofilm as a mechanism of antibiotic
resistance. However, cell density in the biofilm was likely to have been much
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higher than that used for the determination of planktonic MICs, which has been
shown to overestimate biofilm MICs (Cerca et al. 2005).
Oxidants, generated by the activity of xanthine oxidase, resulted in a loss of
approximately 20% of live cells in the biofilms, which again, was stable at all O2
concentrations (Fig. 4.5), a result which was initially puzzling as it was expected
that  an  increase  in  the  concentration  of  one  of  the  substrates  (O2)  would
increase the amount of oxidants produced with a concomitant increase in cell
death.  However,  the  Km for  O2,  as  a  substrate  for  xanthine  oxidase,  is
 2 . 7  x  10-5 M (Fridovich & Handler,  1962),  which,  given that  in  21% O2,  at
35 °C, the level of O2 in the medium would have been around 800 μM11 (US.
Geological Survey) it is likely that the enzyme had already reached saturation,
therefore, increasing the concentration of O2 would not have resulted in a higher
rate  of  oxidant  production.  Xanthine  oxidase has been used successfully to
generate oxidants (Aitken et al. 1993, Kelly et al. 2010), at O2 levels of 21% or
below. Though useful in these conditions perhaps xanthine oxidase was not, in
retrospect,  a  suitable  tool  for  the  investigation  of  the  effects  of  oxidant
production at O2 concentrations above 21%. Glucose oxidase with a Km of 2 x
10-4 M for O2 would probably not be much of an improvement.
An interesting observation is that the effect of combined xanthine oxidase and
oxacillin is additive, resulting in an approximately 80% decrease in live cells in
S. aureus biofilms, irrespective of O2 concentration. This could be due to each
component having a different mechanism for killing or inhibiting bacteria, or that
one of the components is somehow facilitating the action of the other. It would
be useful for future work to determine whether the effect is seen in planktonic
cultures, and to the same degree; this would help to differentiate between an
11
 This figure is based on dissolved oxygen in water, at sea level, at 35 °C.
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intracellular effect and an effect on the biofilm matrix. A possible scenario for β-
lactamase producing species is that an accumulation of β-lactamases in the
matrix are damaged by oxidants (Chapter 2), increasing the effectiveness of
antibiotics.  The  strain  used  in  this  study  though  a  β-lactamase  producer,
indicated a different mode of action. Future work could include testing multiple
species, sensitive and resistant strains, to expose in greater detail the additive
behaviour of oxidants and antibiotics.
The greatest  disappointment  of  this study was the inability to produce good
quality biofilms; this could have been the result of an individual failing, or in
accordance with other groups who have experienced similar problems but that
are under-reported. The main challenge to future work however, is in translating
this work to relate to real wound biofilms that are mixed communities of bacteria
(and fungi) and exist in a much more dynamic environment than in the well of a
microplate.
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Chapter 5
The dynamics of chronic wound microflora during HBOT 
5.1. Introduction 
In the South West of England diabetic patients with non-healing foot ulcers may
be referred for HBO therapy (HBOT) at the DDRC in Plymouth. Some patients’
ulcers  heal  well  during  treatment,  however,  some do  not  and  it  is  not  fully
understood why this is so. Analysis of the potential contributors to non-healing
and the evidence for direct correlations are problematic due to the numerous
variables involved; smoking, hypertension, compliance, and infection are just a
few of the many possible confounding factors that may influence healing. The
provision of appropriate controls is problematic;  wounds not receiving HBOT
may  not  be  directly  comparable  to  wounds  that  are  undergoing  HBOT as
wounds referred for HBOT may be in a worse condition. 
Our  aim  was  to  audit  the  microflora  of  non-healing  chronic  wounds  during
HBOT, to determine the dynamics of bacterial and fungal communities, and to
investigate  any  correlation  between  healing  or  non-healing  by  the  end  of
treatment. As discussed in Section 1.3.1., infection is thought to contribute to
non-healing and as far as we are aware, this is the first time that an audit of
wound microorganisms during a course of HBOT has been reported. In brief,
diabetic patients with a non-healing foot ulcer were recruited from the Diabetic
Foot Clinic (DFC) at Derriford Hospital in Plymouth. Initial wound swabs were
taken after consent to join the study had been obtained. Wounds that failed to
heal with routine antibiotic treatment were referred to DDRC for HBOT. Wound
swabs and wound tissue samples were taken at regular intervals throughout the
course of treatment.
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Wound sample DNA was isolated and analysed,  which involved polymerase
chain  reaction  (PCR)  amplification  followed  by  denaturing  gradient  gel
electrophoresis (DGGE). A range of bands were removed for sequencing and
subsequent identification. 
Yeast colonisation of chronic wounds has also been observed and may be a
factor in the non-healing state (Section 1.3.3.). To determine the presence of
yeasts,  fungi  specific  primers were  used to  amplify DNA, clone and identify
species  present  in  the  collected  samples.  Due  to  time  constraints  samples
investigated for the presence of fungi were limited to all wounds pre-HBOT and
two further samples during HBOT, for each of two wounds only.
Due  to  the  small  number  of  patients  recruited  (6)  and therefore  number  of
wounds (7),  it  was not feasible to perform statistical  analysis on the results.
Some  of  the  swabs  taken  during  HBOT  were  sent  to  the  microbiology
department  at  Derriford  hospital  for  routine  culture  and  identification;  these
results form part of a comparison of bacterial species identified, between routine
culture procedures, and molecular analysis.
5.2. Materials and methods
5.2.1. Chemicals
Acrylamide/bis-acrylamide (37.5:1, 40% solution), ampicillin (sodium salt), boric
acid,  bromophenol  blue,  Na-EDTA  (disodium  salt  dihydrate),  formamide
(deionised),  GenEluteTM  PCR Clean-Up Kit,  glycerol,  IPTG (isopropyl  β-D-1-
thiogalactopyranoside), LB dried medium, sodium hydroxide, sucrose, TEMED
(N, N, N', N'-tetramethylethylenediamine), Trizma Base, urea, X-Gal (5-bromo-
4-chloro-indolyl-β-D-galactopyranoside), xylene cyanol FF were obtained from
Sigma Aldrich Company Ltd (Poole, Dorset, UK). Ammonium persulfate tablets
(APS)  and  water  (sterile,  DNA grade)  were  obtained  from  Fisher  Scientific
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(Loughborough,  Leicestershire,  UK).  Ethanol,  glacial  acetic  acid  and
hydrochloric acid were obtained from BDH Biochemical (VWR, BDH Prolabo,
Lutterworth,  Leicestershire,  UK).  Agarose  and  Hyperladder  II  were  obtained
from Bioline Reagents Ltd (London). FTA Purification Reagent and Indicating
FTA cards  (FTATM  Nucleic  Acid  Collection,  Purification  and  Storage)  were
obtained from Whatman Ltd (Maidstone, Kent, UK). SYBR®  Gold Nucleic Acid
Gel  Stain  (10,000× in  DMSO)  and  SYBR®Safe  DNA Gel  Stain  (10,000× in
DMSO)  were  obtained  from  Invitrogen  (Life  Technologies,  Paisley,  UK).
HotStarTaq Master Mix was obtained from Qiagen Ltd (Crawley, West Sussex,
UK).  GoTaqFlexi  DNA  polymerase,  pGEM  T-Easy  Vectors  and  JM109
Competent Cells were obtained from Promega UK (Southampton, UK). Nutrient
and tryptone soya broth (TSB) and agar dried media were obtained from Oxoid
Ltd  (Basingstoke,  Hampshire,  UK).  Fresh  yeast  (Saccharomyces  cerevisiae)
was obtained from J. Sainsbury plc (London, UK). Bacterial DNA extracted from
Bacillus subtilis (B. subtillis) and Clostridium perfringens (C. perfringens) were
kindly  donated  by  Matthew  Emery  (Microbiology  Technician,  University  of
Plymouth).
5.2.2. Primers
All primers (Table 5.1) were purchased from Eurofins (Eurofins MWG Operon,
Ebersberg, Germany).
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Table 5.1. Primers used in this study. *These primers were also used with GC clamps (see text).
GC clamp: CGCCCGCCGCGCCCCGCGCCCGTCCCGCCGCCCCCGCCCG
Species Primer pair Sequence (5' - 3') Target Reference
Bacteria 9bfm
1512uR
GAGTTTGATYHTGGCTCAG
ACGGHTACCTTGTTACGACTT
1500 bp
16S
rDNA
Mühling et al. 2008
Bacteria 341F*
907R*
CCTACGGGAGGCAGCAG
CCGTCAATTCCTTTRAGTTT
550 bp
16S
rDNA
Ishii & Fukui, 2001
Fungal NS1
NS6
GTAGTCATATGCTTGTCTC
GCATCACAGACCTGTTATTG
CCTC
1400 bp
18S
rDNA
Wu et al, 2002
Fungal FF1
FR1
GTTAAAAAGCTCGTAGTTGAAC
CTCTCAATCTGTCAATCCTTATT
630 bp
18S
rDNA
Zhou et al, 2000
5.2.3. Wound study
The study received  approval  from the  NHS Cornwall  &  Plymouth  Research
Ethics Committee (REC Ref: 08/H0203/93). The study protocol, as submitted to
the ethics committee, can be found in Appendix 6.
5.2.3.1. Patient recruitment
Patient  recruitment  took  place  at  the  DFC  at  Derriford  Hospital  (Derriford,
Plymouth, UK). The principal inclusion criteria were that the patients were over
18 y and had at least one non-healing diabetic foot ulcer. In total, 8 patients
were identified as being suitable candidates for HBOT, and met the inclusion
criteria; however, two patients withdrew from HBO treatment before completion
and  were  not  included  in  the  analysis.  Six  patients  completed  the  HBOT
regimen; one of these patients had two diabetic foot wounds resulting in a total
of seven wounds analysed for the study. It is accepted practice that patients are
referred for HBOT if wound healing does not respond to a specific programme
of antibiotics, determined by local policy, a summary of which can be found in
Appendix 7.
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5.2.3.2. HBOT protocol
HBOT in the South West is carried out at the Diving Diseases Research Centre
(DDRC) in Plymouth. The centre has a large 9-place chamber (Fig. 5.1), two
smaller 3-place chambers and one monoplace chamber.
Figure 5.1. The 9-place HBO chamber at DDRC, Plymouth.
Though HBOT regimens vary,  depending on the clinical  circumstances, they
always involve the delivery of 100% oxygen, via a hood or face mask, for a
period of time followed by ‘air breaks’ when patients remove their masks and
breathe air. The regimen for the treatment of the patients in this study consisted
of  breathing 100% oxygen at  2.4 ATA for 80 min per  day (plus air  breaks),
Monday to Friday, for a total of 40 treatments. 
All patients were assessed at DDRC before HBOT commenced; this is normal
practice and is to determine that patients are suitable candidates for treatment
(i.e. they do not have any contraindications for HBOT).
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5.2.3.3. Transcutaneous oxygen monitoring
Transcutaneous oxygen monitoring (TCOM) is completed as part of the initial
assessment at DDRC to determine whether patients are likely to benefit from
HBOT (Section  1.6.1).  TCOM  is  a  non-invasive  procedure  which  quantifies
tissue  oxygenation  at  multiple  sites  on  the  body  with  the  use  of  Clark
electrodes. Probes are placed near the wound site, at the equivalent site on the
opposite  limb,  and  over  the  second  intercostal  cavity  on  the  chest.
Measurements are of transcutaneous partial pressure of oxygen (tcpO2) and the
units are mmHg. 
5.2.3.4. Wound sampling
Wounds were sampled prior  to  the first  HBOT session,  and then at  regular
intervals throughout HBOT. Figure 5.2. shows a model programme for taking
wound samples though this was not achieved for the majority of patients. This
was due to unexpected hospital admissions or illness that interrupted HBOT. It
was not possible to obtain samples from wounds not undergoing HBOT and the
majority of pre-HBOT samples were those taken during the HBOT assessment.
Wound exudate was obtained by swabbing the deepest,  central  area of  the
wound with a sterile cotton swab, according to the Levine technique (Levine et
al.1976).  The swab tip  was broken off  and inserted into  a cryotube (sterile,
polypropylene, 1.8 ml, Fisher Scientific UK, Ltd, Loughborough, Leicester, UK)
containing 1 ml of lysing buffer (Table 5.2). Wound tissue was collected only if
the wound required debriding; a small sample of non-viable tissue was removed
with a scalpel and transferred to a cryotube containing 1 ml lysing buffer (Table
5.2). All samples were stored at -80 °C. In the DFC all samples were taken by
Graham Bruce (podiatrist)  and in DDRC all  samples were  taken by nurses,
supervised by Alexandra Bishop (DDRC Research Nurse). At three time points
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(Fig.  5.2),  two  samples  were  obtained,  one  was  stored  as  described  for
molecular analysis  and the other  was sent  to  the microbiology laboratory at
Derriford Hospital for routine culture and identification. 
Table 5.2. Composition of lysing buffer for wound samples. * The pH was adjusted to 8.3 with
HCl prior to the addition of EDTA and sucrose. The buffer was autoclaved at 121 °C for 15 min.
Modified from Maniatis et al. (1982).
Reagent Quantity (500 ml)
Tris* 3.03 g
EDTA 8.09 g
sucrose 128.36 g
H2O to 500 ml
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Figure 5.2. Model sampling schedule for patients recruited to the wound study. 
During  the  first  few  weeks  of  the  study  Derriford  Microbiology  Laboratory
provided us with cultures of strains isolated from some of the wound samples;
these included: Enterococcus faecalis (E. faecalis), S. aureus, Corynebacterium
diphtheriae  (C.  diphtheriae),  an  Enterococcus species  and  a  non-lactose
fermenting  (NLF)  E.  coli. These  cultures  were  maintained  on  agar  slopes,
stored at 4 °C. Liquid cultures of these organisms were prepared by inoculating
nutrient broth with a single colony and incubating at 35 °C overnight. Some of
these cultures were used in the study to produce a molecular ladder to aid
identification of bands and to determine DGGE sensitivity.
5.2.4. DNA isolation 
5.2.4.1. Application of samples and bacterial cultures to FTA cards
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Whatman, FTATM Nucleic Acid Collection cards were used for the isolation and
storage of wound sample DNA. Samples were thawed and the contents of each
cryotube were vortexed vigorously for 5 s; 125 μl of liquid was applied to the
centre of a single circle on a FTA card and left to dry at room temperature for
approximately  1  h.  Following  overnight  incubation  of  wound  cultures  from
Derriford Microbiology Laboratory,  125 μl of each culture were transferred to
separate  FTA cards.  Similar  cultures  of  P.  aeruginosa  10848  (NCIMB  Ltd,
Aberdeen, UK) and S. aureus 6571 (kindly donated by University of Plymouth),
grown in TSB broth, were also applied to FTA cards for use as positive controls.
The  cards  were  labelled  and  stored  in  an  air-tight  container  at  room
temperature. Gloves were worn at all times when handling the cards.
5.2.4.2. Preparation of FTA card punches for analysis 
For each sample, the card was placed on to a small self-healing cutting mat that
had been cleaned with detergent followed by 70% ethanol and allowed to dry.
Using a Harris uni-core, 2 mm punch, a single punch was removed from within
the circle (indicating cards were used so that the area saturated with sample
could readily be identified) on the card and transferred to a sterile PCR tube
(0.2  ml,  domed  cap,  Elkay  Laboratory  Products  UK  Ltd,  Basingstoke,
Hampshire, UK). Following the addition of 200 μl of FTA Purification Reagent to
each tube they were incubated at room temperature for 5 min, with manual
shaking. The FTA Purification Reagent was then removed and discarded. This
step was repeated to  give  a total  of  two  washes.  The washing steps were
repeated  a  further  two  times  with  TE-1 buffer  (a  TE  buffer  with  a  lower
concentration of EDTA to avoid the chelation of Mg2+ ions during PCR, Table
5.3) but without manual shaking. Immediately following the washing steps the
card punches were used for PCRs.
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Table 5.3. Composition of TE-1 buffer. *Tris solution adjusted to pH 8.8 with HCl prior to addition
of EDTA. Final pH adjusted to 8.0.
Reagent Quantity (500 ml) Final concentration
TrisHCl* 1M stock solution 5 ml 10 mM
EDTA 0.5 M stock solution pH
8.0
100 μl 0.1 mM
H2O Volume to make total of 500 ml
5.2.5. Preparation of bacterial PCR products
The controls used for each PCR are listed in Table 5.4. All  samples from a
single wound were processed in one session and also included in each session
were punches from wound isolates S. aureus and E. faecalis, and cultures of P.
aeruginosa and C. perfringens. These were used to produce a molecular ladder
to aid in identification of bands and to determine DGGE sensitivity and optimal
DGGE conditions.
Table 5.4. Controls used for each PCR.
Control Rationale
Negative control – no punch added To confirm absence of contamination
Negative control – washed card punch that
does not carry a sample
To determine that the punch does not cause a
positive result
Positive control  – bacterial  DNA standard
(B. subtillis)
To  confirm  that  PCR  conditions  will  amplify
bacterial DNA
Positive  control  –  washed  card  punch
carrying bacterial culture
To confirm that the punch does not inhibit PCR
5.2.5.1. Nested PCR using 16S rDNA primers
Nested  PCR was  used  to  amplify  bacterial  DNA from  wound  samples  and
cultures, as a single stage of PCR cycling repeatedly failed to produce visible
bands on agarose gels. For the first round of PCR the universal bacterial primer
pair 9bfm and 1512 uR were used (Table 5.1). These primers target bacterial
16S rDNA to produce a PCR product approximately 1500 bp which included
hypervariable regions V1 to V9. PCR tubes were prepared with punches from
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samples  and  controls  as  described  in  Section  5.2.4.2,  and  reagents  were
added, as listed in Table 5.5.
Table 5.5. Composition of PCR. Total volume for each reaction was 50 μl. *Final concentration
in  50  μl  reaction  is  2.5  units  DNA  polymerase,  200  μM  of  each  dNTP  and  
1.5 mM MgCl2.
Component Volume
HotStarTaqMaster Mix* 25 μl
9bfm primer 10 pmol μl-1 10 μl
1512 uR 10 pmol μl-1 10 μl
RNase free water 5 μl for tubes with punches, 4 μl for tubes with bacterial DNA
standard
Template DNA One punch or 1 μl of bacterial DNA standard (10 ng μl-1)
Throughout  the  procedure  aseptic  conditions  were  maintained  and  a  PCR
dedicated laminar flow cabinet was used; all pipette tips contained filters (Elkay
Laboratory Products UK Ltd, Basingstoke, Hampshire, UK), and all equipment
and solutions, except those containing genetic material (DNA template, primers
etc), were UV irradiated for 20 min prior to use. Immediately following addition
of  reagents  the  tubes  were  placed  in  the  thermal  cycler  (Techne,  Bibby
Scientific Ltd, Staffordshire, UK), using the cycling protocol in Table 5.6. At the
end of cycling, PCR products were stored at 4 °C. Before continuing with stage
two of nested PCR, aliquots of the products from stage one were subjected to
agarose gel electrophoresis (Section 5.2.5.3) to determine that amplicons were
present and of the correct size.
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Table 5.6. PCR cycling protocol for primer pair 9bfm/1512uR. 30 cycles were completed.
Step Temperature Time
Initial activation 95 °C 15 min
Denaturation 94 °C   1 min
Annealing 52 °C   1 min
Extension 72 °C   1 min
Final extension 72 °C 10 min
The second stage of PCR utilised the primer pair 341F and 907R (Table 5.1),
which  targeted  bacterial  16S  rDNA  to  produce  an  amplicon  of  550  bp,
containing hypervariable regions V3 to V5. A gradient PCR was performed to
determine: (i) the optimal annealing temperature and (ii) the optimal position of
a GC clamp, i.e. on the forward primer, or the reverse primer. Twelve punches
were  prepared,  as  previously  described,  for  each  of  the  following;  a  single
wound sample, a positive control (P. aeruginosa) and a negative control. PCR
reagents were added (Table 5.7) resulting in six copies for each primer pair,
representing tubes for six different annealing temperatures, 52, 53, 54, 55, 56
and  57  °C.  The  basic  PCR  protocol  (Table  5.6)  was  used,  except  for  the
annealing temperature, where each block in the cycler annealed for 1 min at the
temperatures stated above.
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Table 5.7. Composition of gradient PCR. Total volume for each reaction was 50 μl. Wound (W),
positive control (+C), negative control (-C), number of punches (×6).
Component Volume W × 6 W × 6 +C × 6 +C × 6 -C × 6 -C × 6
HotStarTaqMaster Mix 25 μl      
341F primer 10 μM 10 μl  x  x  x
341F-GC primer 10 μM 10 μl x  x  x 
907R primer 10 μM 10 μl x  x  x 
907R-GC primer 10 μM 10 μl  x  x  x
RNase free water   5 μl      
Template DNA 1 punch      
Using the data from the gradient PCR, the second stage PCR conditions were
determined (Table 5.8). PCR products from stage one were diluted 10 fold with
sterile DNA grade water. The cycling protocol was the same as that in Table 5.6
except for the annealing temperature which was set at 54 °C.
Table 5.8. Composition of stage 2 PCR. Total volume for each reaction was 50 μl.
Component Volume
HotStarTaqMaster Mix 25 μl
341F primer 10 μM 10 μl
907R-GC primer 10 μM 10 μl
PCR products from stage 1   5 μl
5.2.5.2. Confirmation of PCR products with agarose gel electrophoresis 
PCR  products  from  all  stages  were  visualised  using  agarose  gel
electrophoresis. A 1.3% agarose gel was prepared by adding 0.8 g of agarose
to a 250 ml conical flask containing 60 ml of 1 ×TAE buffer (Table 5.9.); the flask
was  swirled  gently  to  mix  the  agarose  and  buffer  together.  The  flask  was
plugged with a roll of paper towel and placed in a microwave oven. The mixture
was heated to boiling point and removed from the oven for gentle mixing. This
step was repeated until the agarose had completely dissolved in the buffer.
Table 5.9. Composition of 50 × stock solution of TAE buffer, pH 8.3.
Reagent Quantity (1 litre 50 × stock solution)
Tris base 242 g
Glacial acetic acid 57.1 ml
EDTA 0.5 M, pH 8.0 100 ml
H2O Volume to make up to 1 l
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Whilst the gel was cooling an electrophoresis tray was prepared; both ends of
the tray were sealed with  tape and the tray placed on a level  surface.  Ten
microlitres of SybrSafe (10,000 ×) were added to the agarose solution just prior
to pouring and swirled gently to mix well. The agarose was carefully poured into
the tray and a comb was located securely at one end. The agarose solution was
left to set at room temperature. When the agarose gel was fully set the tape was
removed and the  tray placed in  an  electrophoresis  tank,  sufficient  1  × TAE
buffer was added to cover the gel. The comb was carefully removed from the
gel. Five microlitres of Hyperladder II were loaded into the first slot of the gel (50
to 2000 bp). Samples were prepared for electrophoresis by mixing 8 μl of PCR
product with 2 μl of 6 × gel-loading buffer (Table 5.10) and 8 μl of sample were
loaded into a single slot. When all samples were loaded electrophoresis was
performed at 100 V until the loading dye had migrated to the opposite end of the
tray. On completion of electrophoresis the gel was carefully transferred to an
imager (Gel Doc XR, Bio Rad Laboratories, Hemel Hampstead, Hertfordshire,
UK) for analysis.
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Table 5.10. Composition of 6 × gel loading buffer.
Component Quantity (10ml 6 x solution)
Bromophenol blue 0.025 g
Xylene cyanol FF 0.025 g
Glycerol (30 % in H2O) 3 ml
H2O 7 ml
Agarose gels were observed to confirm that positive control lanes demonstrated
clear bands, negative control lanes showed no visible bands, wound samples
produced clear bands and all bands corresponded to the ladder at the correct
length.
5.2.5.3. Production of molecular ‘ladder’ for DGGE
DNA was extracted, using FTA cards, from overnight cultures of P. aeruginosa,
S.  aureus,  and  E.  faecalis.  These,  along  with  extracted  DNA  from  C.
perfringens  underwent  PCR  with  the  primer  pair  341F/907R-GC.  Various
dilutions of the ladder were separated on DGGE gels to determine the optimal
concentration and gradient of denaturant to give clear migration to four distinct
bands on the gel. A 10 × dilution was used for all subsequent gels containing
wound sample PCR products. Equal volumes (100 μl) of diluted PCR products
from each culture were combined and stored at -20 °C. This was sufficient to
complete all DGGE gels to ensure reproducibility of the ladder.
3.2.6. DGGE analysis of bacterial PCR products
Following nested PCR, the PCR products of all wound samples were analysed
with DGGE. DGGE is an electrophoretic method that separates PCR products
according to their sequence and was first  described by Fischer and Lerman
(1980).  Double stranded PCR products  migrate  through a linear  gradient  of
increasing denaturant concentration which partially ‘melts’ the DNA fragment,
slowing further migration. The concentration of denaturant required to melt the
fragment is dependent on sequence so that gene fragments halt at positions in
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the gel corresponding to their melting temperature. A GC-clamp, attached to
one of the primers, results in a GC rich sequence as part of the amplicon; this
modifies  the  melting  behaviour  of  the  amplicon  and  prevents  complete
denaturation and migration out of the gel as single strands (Myers et al. 1985).
This study amplified fragments containing the hypervariable regions V3 to V5 of
16S rDNA and used DGGE to separate those fragments according to sequence
composition.
5.2.6.1. Preparation of DGGE solutions
The  solutions  prepared  for  DGGE  analysis  were  TAE  buffer  (Table  5.9),  
0% denaturant (Table 5.11), 80% denaturant (Table 5.11), APS (10% w/v) and
10 × gel-loading buffer (Table 5.12). Acrylamide solutions were wrapped in foil,
to protect from light, and stored at 4 °C. Any remaining solution was discarded
after 4 weeks. APS was made fresh, immediately before preparing a DGGE gel,
by dissolving one tablet (100 mg) in 1 ml dH2O. Gel-loading buffers were stored
at 4 °C in 500 μl aliquots.
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Table 5.11. Composition of 6% polyacrylamide solutions. 
Reagent Quantity (100ml)
0% denaturant
40% acrylamide 37.5:1 acrylamide:bisacrylamide 15 ml
50 × TAE buffer   2 ml
dH2O 83 ml
80% denaturant
40% acrylamide 37.5:1 acrylamide:bisacrylamide 15 ml
50 × TAE buffer   2ml
Urea 33.6 g
Deionised formamide 32 ml
dH2O To make up to 100 ml
Table 5.12. Composition of 10 × gel loading buffer.
Component Quantity (10ml 6 × solution)
Bromophenol blue 0.025 g
Xylene cyanol FF 0.025 g
Glycerol (50% in H2O) 3 ml
H2O 7 ml
5.2.6.2. Preparation of DGGE equipment
The equipment  used for  DGGE analysis  was the Bio-Rad DCode Universal
Mutation  Detection  System  (Bio-Rad  Laboratories,  Hemel  Hampstead,
Hertfordshire, UK). Parallel denaturing gradient gels were produced where the
denaturing  gradient  was  parallel  to  the  electric  field  and  the  denaturing
conditions were a combination of a linear denaturant gradient and a uniform
temperature of 60 °C. The system was prepared and assembled according to
manufacturer’s instructions (Bio-Rad Laboratories, 1996).
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5.2.6.3. Preparation of acrylamide gels 
Six  percent  polyacrylamide  gels  were  used  throughout  the  study  being  the
concentration most suited for larger (300-1000 bp) PCR products (Green et al,
2009). Gradient optimisation resulted in the final gradient used for all  wound
sample analysis being 35%-65%. High and low gel solutions were prepared by
combining  denaturant  solutions  in  two  sterile  50  ml  centrifuge  tubes  
(Table 3.13); 120 μl of APS and 18 μl of TEMED were added to each tube and
gently mixed.
Table 5.13. Composition of high and low denaturant polyacrylamide solutions.
Reagent 35% (low) 65% (high)
80% denaturant 6.5 ml 12.1 ml
  0% denaturant 8.5 ml   2.9 ml
The contents of each tube were transferred to two syringes and secured in the
appropriate position on the gradient former (part of the DCode system) which
combines the denaturant solutions, so that a gradient forms from low at the top
of the plate to high at the bottom. The top of the glass plates were covered in
cling  film  to  seal  the  plates  and  the  gel  was  left  to  polymerise,  at  room
temperature, for at least 1 h.
After polymerisation the top of the gel was rinsed with 1 × TAE buffer. A stacking
gel was prepared by adding 40 μl of APS, 6 μl of TEMED and 10 μl of 10 × gel
loading buffer to 5 ml of 0% denaturant polyacrylamide and this was poured on
top of the gel; a comb was carefully placed in the stacking gel, being careful to
avoid bubbles at the base of the teeth. The plate was sealed with cling film and
left  for  a further 1 h to polymerise.  The complete frame, consisting of glass
plates, polymerised gel and holding clamps was locked in place on the DCode
core  apparatus.  The  core  holds  two  frames  so  that  two  gels  can  be  run
concurrently and for this study both frames were used, with each gel containing
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the collective samples for an individual wound. The core was placed into the
electrophoresis tank and the comb carefully removed. Heated buffer from the
tank was used to flush each well to remove unpolymerised acrylamide.
5.2.6.4. Sample loading and electrophoresis conditions
All wound sample PCR products were diluted  × 10 and 16 μl of each dilution
were added to 4 μl of × 10 gel-loading buffer and mixed well; 16 μl of molecular
ladder was added to 4 μl  of  × 10 gel-loading buffer and mixed well.  Twenty
microlitres of the ladder/buffer mix were loaded into a well 4 to 5 wells from the
left side of the gel, using a gel pipette tip (flat, extra length, Elkay Laboratory
Products). Starting from the next well on the right, 20 μl aliquots of all wound
sample PCR products were loaded, each well containing a single sample. The
samples were loaded in temporal order from the beginning to the end of HBO
treatment.  The  lid  of  the  DCode  system  was  secured  over  the  core  and
electrophoresis  was  performed  at  100  V  for  5-10  min  to  migrate  the  PCR
products into the stacking gels. The gels were then electrophoresed at 60 V and
60 °C for 16 h.
5.2.6.5. Gel staining
Gels were checked to  ensure that  the loading dye had run through the gel
suggesting that electrophoresis had been completed. The frames were removed
from the tank and the glass and gel sandwich was placed in a tray containing
sufficient TAE buffer to just cover the gel; the top plate of glass was lifted free of
the gel. SybrGold gel stain was added (10 μl per 100 ml) and the tray was
agitated gently in the dark, at room temperature, for 30 min. Gels stained with
SybrGold did not require de-staining.
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5.2.6.6. Gel imaging
The gel was carefully transferred from the glass plate to the imaging platform of
the imager. An image of the gel was obtained using UV transillumination (as
rapidly as possible  to  reduce UV exposure).  The image was optimised with
Quantity One® software (Bio-Rad) to identify bands required for sequencing.
5.2.7. Identification of bacterial species within DGGE resolved bands
Representative bacterial species were identified by removing bands from DGGE
gels,  re-amplifying  the  contents  and  using  the  BLAST database  (NCBI)  to
identify the sequences.
5.2.7.1. Band removal from acrylamide gels
Using a printed image of the gel with marked bands of interest, a scalpel was
used  to  excise  the  band.  An  acrylic  UV  protector  screen  was  used  whilst
visualising the bands during removal  and the procedure was carried out  as
quickly as possible. Each individual band was placed in 50 μl ultra-pure water in
a 0.7 ml microcentrifuge tube and all bands were stored at 4 °C, overnight.
5.2.7.2. Preparation of band contents for sequencing
Each tube was centrifuged briefly and 5 μl of the contents were removed and
re-amplified  using  the  primer  pair  341F/907R  (no  GC  clamp),  under  the
conditions  previously  described.  The  PCR  products  were  screened  on  an
agarose gel (Section 5.2.5.2) prior to being cleaned with GenElute™ PCR Clean-
Up Kit. The DNA content of the cleaned PCR products was measured with a
nano-drop  spectrophotometer  (Thermo  Scientific,  Fisher  Scientific  UK)  and
diluted with ultra-pure water to 50 ng μl-1 and 20 μl of each sample was placed
in a 1.5 ml microcentrifuge tube. All tubes were sent for single read sequencing
(GATC Biotech Ltd, The London BioScience Innovation Centre, London, UK.).
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5.2.7.3. Sequence identification
All  sequence  data  were  analysed  by  searching  BLAST  (NCBI)  microbial
genomes  and  the  searches  were  optimised  for  highly  similar  sequences.
Identification  was  based  on  a  minimum  of  90%  identity  match.  Accession
numbers and % identity can be found in Appendix 8.
5.2.8. Qualitative analysis of DGGE gels
5.2.8.1. DGGE analysis using GelCompar software
All  DGGE gels  were  analysed with  GelCompar  II  software  (BioSystematica,
Llandysul, Ceredigion, Wales, UK) to create normalised databases of gel band
patterns.  The  molecular  ladders  were  used  as  reference  markers  for  band
alignment  and  normalisation.  Manual  adjustment  of  gels  was  carried  out  to
ensure that only major bands were included in the analysis.
5.2.8.2. Analysis of wound flora community dynamics with Primer-E
Presence/absence  and  abundance  data  from Gel  Compar  II  was  input  into
Primer-E software (Primer-E Ltd, Ivybridge, Devon, UK). For each gel, a Bray
Curtis similarity matrix was constructed and plotted as an MDS plot.  A RELATE12
test for seriality using Primer E multivariate statistic software was carried out for
each set of data. 
5.2.9. Identification of fungal communities in chronic wounds
In addition to  identification of bacteria,  the presence of fungal  species in all
wound samples taken prior  to  HBO treatment,  and in a  mid and an end of
treatment sample for wounds 1b and 6 were investigated. Budgetary and time
constraints  meant  that  not  all  samples  could  be  analysed  for  fungal
communities. 
12
 This compares the resemblance matrix to a model matrix of a linear temporal sequence and tests for 
similarities between the two. R is Rho.
212
5.2.9.1. Nested PCR using 18S rDNA fungi specific primers
Punches taken from wound sample FTA cards were used to amplify fungal DNA
with a nested PCR protocol. Nested PCR was chosen because, again, a single
stage of PCR gave a low yield of amplified material from wound samples. FTA
card punches were prepared for PCR as previously described (Section 5.2.4.2.)
and the first stage of PCR utilised the primer pair NS1/NS6 (Table 5.1) to obtain
an amplicon of approximately 1400 bp. A gradient PCR cycle with a range of
temperatures from 50.9 to 59.9 °C was carried out to determine the optimal
annealing temperature for these primers. Second stage PCR utilised the primer
pair  FF1/FR1  (Table  5.1),  which  produced  an  amplicon  of  630  bp.
Concentrations  (Table  5.14)  and  cycling  programmes  (Table  5.15)  were
consistent for all further fungal PCR protocols unless otherwise indicated in the
text.
Table  5.14.  Composition  of  PCR  for  either  primer  pairs.  Total  reaction  volume  =  50  μl.
 *5 × buffer supplied with polymerase.
Component Volume
5 × buffer* 10 μl
dNTPs 2 mM   5 μl
MgCl2 25 mM   3 μl
NS1 10 μM or FF1 10 μM 10 μl
NS6 10 μM or FR1 10 μM 10 μl
GoTaqFlexi DNA polymerase 5 u μl-1 0.25 μl
Template DNA One punch (or 1 μl PCR product)
RNase free water 11.75 μl
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Table 5.15. PCR cycling protocol for either primer pairs. All were run for a total of 35 cycles.
Step Temperature Time
Initial activation 95 °C 2 min
Denaturation 95 °C 1 min
Annealing 56 °C (NS1/NS6) 52 °C (FF1/FR1) 1 min
Extension 72 °C 1 min
Final extension 72 °C 5 min
Controls included: negative control;  positive control  with DNA extracted from
Saccharamyces  cerevisiae;  and  bacterial  control  using  DNA extracted  from
P. aeruginosa.
5.2.9.2. Confirmation of PCR products with agarose gel electrophoresis
All  PCR  products  were  screened  using  agarose  gel  electrophoresis,  as
previously described (Section 5.2.5.2.) In particular the absence of bands for
the negative control and bacterial DNA was monitored; it was crucial that the
primers did not amplify bacterial DNA.
5.2.10. Cloning of fungal PCR products
5.2.10.1. Preparation of fungal PCR products for cloning
PCR products from wound samples were cleaned with GenElute™  PCR Clean-
Up Kit and DNA was measured with a nano-drop spectrophotometer.
5.2.10.2. Fungal cloning protocol
The  protocol  described  below  is  based  on  that  produced  by  Promega
(Promega, 2010) for use with the pGEM®-T Easy Vector System which indicates
the presence of an insert in the lacZ gene of pGEM vector by the production of
white colonies instead of blue on indicating agar plates. The product of the lacZ
gene is  β-galactosidase which cleaves X-gal to form the bright blue pigment
5,5’-dibromo-4,4’-dichloro-indigo; when X-gal  is not hydrolysed,  this indicates
the presence of an insert in the lacZgene. LB broth was prepared by dissolving
20 g dried medium into 1 l of water; the pH was adjusted to 7.0 with NaOH. The
medium was autoclaved before use. LB plates with ampicillin, IPTG and X-Gal
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were prepared as follows; 15 g of agar was dissolved in 1 l of LB medium and
autoclaved, ampicillin was added to a final concentration of 100 μg ml -1 when
the medium had cooled to 50 °C, IPTG was added to a final concentration of 0.5
mM and X-Gal was added to a final concentration of 80 μg ml-1, 30-35 ml was
poured into 85 mm Petri dishes and allowed to set. IPTG stock solution (0.1 M
in water) was filter sterilised and stored at 4 °C. X-Gal solution (50 mg ml -1 in N,
N'-dimethyl-formamide) was covered in foil and stored at -20 °C. Poured agar
plates were stored at 4 °C. Two plates were prepared for each ligation reaction.
Ligation
All reagents and reaction tubes (0.5 ml) were kept on ice. The pGEM®-T Easy
Vector and Control Insert DNA were centrifuged briefly prior to use. The ligation
reactions were set up as detailed in Table 5.16. The Rapid Ligation Buffer was
vortexed vigorously before each use.
Table 5.16.  Components of ligation reactions. *The calculation for determining the amount of
PCR product to use is explained in the text. This table has been reproduced from the Promega
protocol (Promega, 2010).
Reaction Component Standard
Reaction
Positive 
Control
Background
Control
2 × rapid Ligation Buffer, T4 DNA Ligase 5 μl 5 μl 5 μl
pGEM®-T Easy Vector (50 ng) 1 μl 1 μl 1 μl
PCR product × μl* - -
Control Insert DNA - 2 μl -
T4 DNA Ligase (3 Weiss u μl-1) 1 μl 1 μl 1 μl
Nuclease free water to a final volume of 10 μl 10 μl 10 μl
The equation to determine the volume of PCR product to add to the ligation
reaction was: 
         50 ng vector ×   0.63 kb PCR product    ×   3   = 31.5 ng PCR product
                             3.0 kb vector                        1
All  the  reactions  were  mixed  by  pipetting  and  incubated  for  1  h  at  room
temperature.
Transformation
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All LB/ampicillin/IPTG/X-Gal plates were equilibrated to room temperature. All
ligation reaction tubes were centrifuged briefly and 2 μl from each reaction was
transferred to sterile 1.5 ml microfuge tubes kept on ice. Frozen JM109 High
Efficiency Competent Cells (>108  cfu μg-1) were thawed slowly on ice and then
mixed by gently flicking the tube. Using very gentle pipetting 50 μl of cells were
added to each tube, gently mixed again and then kept on ice for 20 min. The
cells were heat shocked by immersing the tubes in a water bath at exactly  
42 °C for 45 s. The tubes were then returned to ice for 2 min and 950 μl room
temperature LB medium were added to each tube. All tubes were incubated at
37 °C, with shaking at 150 rpm, for 1.5 h. Five LB/ampicillin/IPTG/X-Gal plates
were used for each reaction with 200 μl being spread onto each plate. One
plate was used for each of the controls.  All  plates were incubated at 37 °C
overnight. The following morning plates were checked for the presence of blue
or  white  colonies;  the  positive  control  plate  contained  predominantly  white
colonies,  which  indicated  that  ligation  had  successfully  occurred.  The
background control plate contained no colonies, and the wound sample reaction
plates  contained  predominantly  white  colonies,  which  indicated  that
transformation  and  ligation  of  PCR  products  into  the  vector  had  been
successful.
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5.2.10.3. PCR amplification of cloned fungal DNA
PCR components were prepared and 25 μl were added to 0.2 ml PCR tubes,
with 11 tubes being prepared for each wound sample. Table 5.17 shows the
PCR reaction composition for each tube.
Table 5.17. Composition of PCR for post-cloning colonies.
Component Volume
5 × buffer* 5 μl
dNTPs 2 mM 2.5 μl
MgCl2 25 mM 1.5 μl
M13F 10 μM 0.5 μl
M13R 10 μM 0.5 μl
GoTaqFlexi DNA polymerase 5 u μl-1 0.2 μl
RNase free water 14.8 μl
A sterile pipette tip was used to gently pick up no more than half of a single
white colony from one of the plates. The tip was gently agitated in a single PCR
tube containing reaction mix. This was repeated, picking 10 white colonies and
1 blue colony, for each wound sample. PCR was performed on each sample
(Table 5.18).
Table 5.18. PCR cycling protocol for post-cloning colonies (30 cycles).
Step Temperature Time
Initial activation 94 °C 4 min
Denaturation 94 °C 1 min
Annealing 58 °C 1 min
Extension 72 °C 1 min
Final extension 72 °C 5 min
All  PCR products  were  checked  on  agarose  gels,  as  previously  described,
cleaned with GenElute™  PCR Clean-Up Kit  and DNA was quantified using a
nano-drop spectrophotometer. PCR products were diluted to 1 ng μl -1 and 30 μl
were added to PCR tubes.
5.2.10.4. Analysis of sequence data
Sequencing results  were inserted into MEGA software (Tamura  et  al.  2011);
sequences were aligned following removal of the plasmid sequence, and using
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FF1 and FFR primers as motif identifiers. All sequence data were analysed by
searching  BLAST (NCBI)  fungi  genomes  and  searches  were  optimised  for
highly  similar  sequences.  Identification  was  based  on  a  minimum  of  85%
identity.  Alignment  and  comparison  of  sequences  from  bands  at  different
migration points were performed using the alignment tool in BLAST (bl2seq).
Accession numbers and % identity can be found in Appendix 9.
5.2.11. Incorporation of relevant patient data
A database of information was collated for each wound. This included pertinent
clinical information (Table 5.19), transcutaneous oximetry (TCOM) data (Table
5.20),  antibiotic  usage  (Table  5.21)  and  microbiology  culture  reports  from
Derriford microbiology laboratory (Table 5.22). This information was obtained
from clinical notes maintained by staff at DDRC.
Diabetic patients in the UK have HbA1C  measured every 3-6 months; this is a
measure  of  glycosylated  haemoglobin  and  correlates  with  mean  plasma
glucose.  The  target  for  diabetic  patients  is  6.5-7.5%  (Diabetes.  UK).  Four
patients  were  prescribed  antibiotics  during  HBOT (Table  5.21.).  No  patients
were prescribed anti-fungal  drugs during the study period.  Each patient had
TCOM performed during their HBO assessment (an example of a recording can
be seen in Figure 5.3). 
Figure 5.3. TCOM recording for patient 1. The initial rise during the first 20 min (breathing air) is
due to increasing pressure as the chamber is compressed to 2.4 ATA. The subsequent rise is
due to the patient breathing 100% O2 at 2.4 ATA. The dip mid-cycle is due to an air break.
For clarity three values (expressed as mm Hg) are given (Table 5.20); these
represent the value in the skin adjacent to the wound at sea level on air, at 2.4
ATA on air and at 2.4 ATA on 100% O2. Patient 5 also had recordings performed
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69 days later; these indicated an increase in TCOM at 2.4 ATA, on 100% O2 of
421%.
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Table 5.19.  Patient data pertinent to the study. * HbA1C,  measure of glycosylated haemoglobin.
** units per week. *** See Table 5.25. 
Patient 1
Wd 1a & 1b
Patient 2
Wd 2
Patient 3
Wd 3
Patient 4
Wd 4
Patient 5
Wd 5
Patient 6
Wd 6
Gender Male Male Male Female Male Male
Age 61 y 47 y 75 y 69 y 71 y 71 y
Type of diabetes Type II Type II Type II Type II Type II Type II
Duration of 
diabetes
7 y 5 y 3 y 16 y Unknown 21 y
HbA1C* 10.2 % 5.5 % 6.3 % 7.4 % 7.8 % 5.5 %
Vascular disease Yes No Yes Yes Yes Yes
Smoker No Yes No No No No
Alcohol intake 0** 4** 20-24** 0** <1** <20**
Antibiotics Yes*** No Yes*** Yes*** Yes*** No
Subsequent 
amputation
No No Yes No Yes No
Change in size of 
wound area (%)
Wd 1 ↓ 14
Wd 2 ↓ 49
↓ 40 No data ↑ 12.5 ↑ 10 No data
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Table 5.20. TCOMs for all patients (Pt) in study. Measurements were taken during the first-HBO
treatment. * Measured 69 days after the first reading for pt 5 (5a).
Pt
1
Pt
2
Pt
3
Pt
4
Pt
5a
Pt
5b*
Pt
6
Air, sea level
 (mm Hg)
6 9 21 40 13 47 64
Air, 2.4 ATA
(mm Hg)
129 23 31 73 40 377 405
100% O2, 2.4 ATA
(mm Hg)
1144 663 299 922 205 1068 797
Table  5.21.  Antibiotics  prescribed  for  wound  study  patients.  *  Indicates  either  pre-HBO  or
number of days into HBO treatment. For pre-HBO the patients were still taking antibiotics when
starting HBO. For further details on the actions of antibiotics see Chapter 1.
Patient Antibiotic Date prescribed* Notes
1
(Wound 1a &
1b)
Augmentin
Amoxicillin
Levofloxacin
Clindamycin
Doxycycline
Pre-HBO
+ 52 days
+ 63 days
+ 63 days
+ 73 days
Prescribed for 6 weeks. Combination of
amoxicillin  (see  below)  and  clavulanic
acid (β-lactamase inhibitor).
Penicillin  class,  β-lactam,  broad
spectrum of activity. Inhibits synthesis of
bacterial cell wall.
Fluoroquinolone class,  broad spectrum
of activity. Inhibits DNA gyrase.
Lincosamide, targets anaerobe bacteria.
Inhibits protein synthesis.
Tetracycline  group.  Inhibits  protein
synthesis.
2 Augmentin
Clindamycin
Levofloxacin
Pre-HBO
Pre-HBO
Pre-HBO
See above
See above
See above
4 Flucloxacin
Levofloxacin
Clindamycin
Pre-HBO
Pre-HBO
Pre-HBO
Penicillin  class,  narrow  spectrum  of
activity.  Inhibits  synthesis  of  bacterial
cell wall.
See above
See above
5 Levofloxacin
Clindamycin
Augmentin
+ 13 days
+ 13 days
+ 20 days
See above
See above
See above
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5.3. Results
5.3.1. Wound bacterial community dynamics during HBOT
5.3.1.1. Molecular methods identified aerobic and anaerobic bacteria in chronic
wounds
A diverse range of bacteria was identified in non-healing diabetic foot ulcers
using  molecular  methods.  A total  of  23  genera were  identified (Table 5.22).
Approximately 50% of organisms identified were anaerobes though several of
these were tolerant of aerobic environments. Each wound contained at least
one facultative anaerobe.
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Table  5.22.  Summary  of  bacteria  identified  in  wounds;  Swab  (S),  Tissue  (T).  *  Number  of
wounds with organism present.
Genus Species O2  Tolerance Wounds* S T
Achromobacter xylosoxidans Aerobe 1  
Alcaligenes multiple Obligate aerobe 1 
Bradyrhizobium Sp 523321 1 
Corynebacterium aurimucosum
diphtheriae
Aerobe
Aerobe
2
1


Enterobacter cloacae Facultative anaerobe 3  
Enterococcus faecalis
facium
Facultative anaerobe
Facultative anaerobe
2
1




Fusobacterium nucleatum Anaerobe 1 
Klebsiella oxytoca Anaerobe 1 
Lactobacillus plantarum Aerotolerant 1 
Microbacterium testaceum Aerobe 1 
Micrococcus luteus Obligate aerobe 1 
Morganella morganii Facultative anaerobe 2  
Porphyromonas gingivalis Anaerobe 1 
Prevotella dentalis 1 
Propionibacterium acnes Aerotolerant 1 
Providencia stuartii Facultative anaerobe 1 
Pseudomonas multiple
aeruginosa
Facultative anaerobe
Obligate aerobe
1
4

 
Saccharomonospora glauca 1 
Serratia proteamaculans Facultative anaerobe 1  
Staphylococcus aureus
epidermidis
warneri
Facultative anaerobe 1
1
1




Stenotrophomonas maltophilia Aerobe 2 
Streptococcus agalactiae Facultative anaerobe 1 
Streptomyces multiple Obligate aerobe 1 
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The most common genus identified was Pseudomonas, found in a total of four
wounds;  the  next  most  common  were  Staphylococcus,  Enterobacter and
Enterococcus, each found in a total of three wounds.
5.3.1.2. Bacterial populations changed during HBOT 
Bacterial populations did not remain static during HBO treatment. Some DGGE
bands were present throughout treatment, but some appear part way through
treatment and some were absent by the end of HBO. The majority of wounds
did not show a reduction in the number of bands present by the end of HBO,
though four out of seven wounds showed clearance of anaerobes by the last
treatment. As all DGGE profiles were unique the results for each wound will be
presented individually.
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5.3.1.2.1. Wound 1a
The DGGE profile for wound 1a (Fig. 5.4) shows a complex pattern of bands; a
key point was the persistence of bands for P. aeruginosa throughout HBOT. The
pattern of other bands were inconsistent. The MDS plot (Fig. 5.5) indicates that
the similarity of bacterial  populations did not correlate with the chronological
order of HBOTs. Wound 1a contained Lactobacillus plantarum an organism not
previously reported in a wound. This patients HbA1C of 10.2% suggests poorly
controlled blood glucose and antibiotics were prescribed during HBOT (Table
5.19). This wound was reduced in size by 14% at the end of HBOT and this
patient did not require amputation.
Figure 5.4. Wound 1a DGGE. +4 etc. - days into HBOT not number of treatments
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Figure 5.5.  MDS plot  (Bray Curtis  Similarity  Matrix)  of  presence/absence data from DGGE
bands from wound1a. +4 etc. indicates days into HBOT not number of treatments. Solid line,
40% similarity, dashed line, 60% similarity. * Antibiotics prescribed.
5.3.1.2.2. Wound 1b
The DGGE profile for wound 1b (Fig. 5.6), which was on the same patient as
wound 1a, indicated a loss of bacterial species by the end of HBOT, though
Pseudomonas was again a persistent genus, still being present at the end of
treatment. M. morganii was absent from the wound after 40 days of treatment.
The MDS plot (Fig. 5.7) indicates a shift in population similarity between pre-
HBOT samples and all  other samples,  apart  from that  taken during the last
treatment; each group having a similarity of 60%. A RELATE test for seriality
using  Primer  E  multivariate  statistic  software  also  indicated  the  samples
gradually changed through time (R = 0.36, p = 0.045). This wound was reduced
in size by 49% at the end of HBOT and this patient did not require amputation.
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Figure 5.6. Wound 1b DGGE. +4 etc. - days into HBOT not number of treatments
Figure 5.7.  MDS plot (Bray Curtis similarity matrix) of DGGE bands from wound 1b. +4 etc.
indicates  days  into  HBOT  not number  of  treatments.  Dashed  line,  60%  similarity.
* Antibiotics prescribed.
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5.3.1.2.3. Wound 2
In  wound  2  (Fig.  5.8),  Streptococcus  agalactiae  was  present  throughout
treatment,  and  the  same  appeared  to  be  the  case  for  S.  aureus.
C. aurimucosum appeared in the wound from day 22 and persisted to the end of
treatment. An unidentified organism appeared at day 6, but was cleared by day
20. P. aeruginosa was present on day 2, but appears to have been cleared by
day 3. The MDS plot indicated two distinct populations, one during the first 2
weeks of treatment and the other during the last 4 weeks (Fig. 5.9). This patient
had well  controlled  blood glucose and was not  prescribed antibiotics during
HBOT. The wound had reduced in size by 40% at the end of HBOT and did not
require subsequent amputation. 
Figure 5.8. Wound 2 DGGE. +2 etc. - days into HBOT not number of treatments.
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Figure 5.9.  MDS plot  (Bray Curtis similarity matrix) of  DGGE bands from wound 2.  +2 etc.
indicates days into HBOT not number of treatments. Dashed line, 60% similarity.
5.3.1.2.4. Wound 3
Wound 2 showed a distinct change in bacterial population community after the
first week of treatment; initially the wound was colonised by Prevotella dentalis,
which was replaced by Serratia proteamaculans after day 8, clearing the wound
by day 47 (Fig. 5.10). The 2 communities, which each showed 60% similarity,
can be seen in the MDS plot (Fig. 5.11). Similar to wound 1b, a RELATE test for
seriality also indicated the wound samples varied linearly through time (R  =
0.826,  p  =  0.002).  This  patient  had  well  controlled  blood  glucose  and  was
prescribed  antibiotics  during  HBOT  (Table  5.19).  No  data  was  available
concerning  a  change in  wound size  but  this  patient  did  require  subsequent
amputation.
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Figure 5.10. Wound 3 DGGE. +1 etc. - days into HBOT not number of treatments.
Figure 5.11.  MDS plot (Bray Curtis similarity matrix) of DGGE bands from wound 3. +1 etc.
indicates  days  into  HBOT  not number  of  treatments.  Dashed  line,  60%  similarity.
 * Antibiotics prescribed.
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5.3.1.2.5. Wound 4
Wound 4 contained a variety of bacteria (Fig 5.12) that resulted in a complex
community  dynamic  (Fig.  5.13).  This  wound  contained  Saccharomonospora
glauca a species not previously reported in a chronic wound. This patient had
well  controlled  blood  glucose  and  was  prescribed  antibiotics  during  HBOT
(Table  5.19).  The  wound  area  increased  in  size  by 12.5% and  subsequent
amputation was required.
Figure 5.12. Wound 4 DGGE. +2 etc. - days into HBOT not number of treatments.
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Figure 5.13.  MDS plot (Bray Curtis similarity matrix) of DGGE bands from wound 4. +2 etc.
indicates days into HBOT not number of treatments. Solid line, 40% similarity, dashed line, 60%
similarity.
5.3.1.2.6. Wound 5
In wound 5 (Fig. 5.14), Enterobacter cloacae was present before HBOT but was
absent by the start of treatment;  E. faecium and Achromobacter xylosoxidans
appeared  in  the  wound  during  the  second  week  of  HBOT.  By  the  end  of
treatment  E.  faecium had  been  cleared  whilst  Achromobacter  xylosoxidans
persisted. The MDS plot (Fig. 5.15) indicated three clear population changes
during  treatment;  during  the  first  10  days,  half  way  through  treatment,  and
during the last 4-5 weeks, and there was significant linearity to these changes
through  time  (RELATE  R  =  0.635,  p  =  0.001).  This  patient  had  fairly  well
controlled blood glucose and was prescribed antibiotics during HBOT (Table
5.19). The wound area had increased in size by 10% at the end of HBOT and
subsequent amputation was required.
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Figure 5.14. Wound 5 DGGE. +7 etc. - days into HBOT not number of treatments.
Figure 5.15.  MDS plot (Bray Curtis similarity matrix) of DGGE bands from wound 5. +7 etc.
indicates days into HBOT not number of treatments. Solid line, 40% similarity, dashed line, 60%
similarity. * Antibiotics prescribed.
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5.3.1.2.7. Wound 6
In  wound  6  (Fig.  5.16),  Fusobacterium  nucleatum,  present  before  HBOT,
appears to have cleared by day 18; C. aurimucosum and Enterobacter cloacae
persisted  in  the  wound  throughout  treatment.  Taking  all  DGGE  bands  into
consideration community changes were more complex (Fig. 5.17). This patient
had well  controlled  blood glucose and was not  prescribed antibiotics during
HBOT (Table 5.19). There was no data for wound size change available though
subsequent amputation was not required.
Figure 5.16. Wound 6 DGGE. +1 etc. - days into HBOT not number of treatments.
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Figure 5.17.  MDS plot (Bray Curtis similarity matrix) of DGGE bands from wound 6. +1 etc.
indicates days into HBOT not number of treatments. Solid line, 40% similarity, dashed line, 60%
similarity.
5.3.1.3.  Similarity  of  sequences  of  bands  at  different  migration  points  were
identified as the same species.
In wound 1a, sequences from bands G, K and L were aligned for similarity; the
sequence for  band K (P. aeruginosa)  had 99% similarity to  bands G and L
(Fig.  5.18).  Bands G and L had the same migration points  and were 100%
similar. The difference with band K was 3 bp, though the notation for band K
indicated  that  the  3  nucleotides  were  undetermined.  In  wound  1b,  aligned
sequences from bands J and L (both P. aeruginosa) showed 100% similarity. In
wound 3, there were 4 bands (E, F, G and H) identified as Prevotella dentalis;
bands G and H showed 100% similarity, E and F, E and G, F and G, and F and
H  showed  99%  similarity.  The  differences  with  band  E  were  due  to
undetermined nucleotides and with band F, a substitution of a single thymine in
place of a cytosine in bands G and H. Alignments not included below can be
found in Appendix 10.
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K  1  GCCGCGTGTGTGAAGAAGGTCTTCGGATTGTAAAGCACTTTAAGTTGGGAGGAAGGGCAG  60
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
L  3  GCCGCGTGTGTGAAGAAGGTCTTCGGATTGTAAAGCACTTTAAGTTGGGAGGAAGGGCAG  62
K 61  TAAGTTAATACCTTGCTGTTTTGACGTTACCAACAGAATAAGCACCGGCTAACTTCGTGC 120
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
L 63  TAAGTTAATACCTTGCTGTTTTGACGTTACCAACAGAATAAGCACCGGCTAACTTCGTGC 122
K 121 CAGCAGCCGCGGTAATACGAAGGGTGCAAGCGTTAATCGGAATTACTGGGCGTAAAGCGC 180
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
L 123 CAGCAGCCGCGGTAATACGAAGGGTGCAAGCGTTAATCGGAATTACTGGGCGTAAAGCGC 182
K 181 GCGTAGGTGGTTCAGCAAGTTGGATGTGAAATCCCCGGGCTCAACCTGGGAACTGCATCC 240
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
L 183 GCGTAGGTGGTTCAGCAAGTTGGATGTGAAATCCCCGGGCTCAACCTGGGAACTGCATCC 242
K 241 AAAACTACTGAGCTAGAGTACGGTAGAGGGTGGTGGAATTTCCTGTGTAGCGGTGAAATG 300
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
L 243 AAAACTACTGAGCTAGAGTACGGTAGAGGGTGGTGGAATTTCCTGTGTAGCGGTGAAATG 302
K 301 CGTAGATATAGGAAGGAACACCAGTGGCGAAGGCGACCACCTGGACTGATACTGACACTG 360
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
L 303 CGTAGATATAGGAAGGAACACCAGTGGCGAAGGCGACCACCTGGACTGATACTGACACTG 362
K 361 AGGTGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACG 420
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
L 363 AGGTGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACG 422
K 421 ATGTCGACTAGCCGTTGGGATCCTTGAGATCTTAGTGGCGCAGCTAACGCGATAAGTCGA 480
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
L 423 ATGTCGACTAGCCGTTGGGATCCTTGAGATCTTAGTGGCGCAGCTAACGCGATAAGTCGA 482
K 481 CCGCNNNGGGAGTACGGCCGCAAGGTTAAAACT 513
      ||||   ||||||||||||||||||||||||||
L 483 CCGCCTGGGGAGTACGGCCGCAAGGTTAAAACT 515
Figure 5.18.  Alignment of sequences from DGGE bands K and L from wound 1a. Both bands
are from P. aeruginosa.
5.3.2. Wound fungal community dynamics during HBOT
5.3.2.1. Wounds were colonised by fungal species 
All wounds in this study contained at least one species of fungi prior to starting
HBOT (Table 5.23); the mean number of organisms identified per wound was
2.1. The most common genus present was Aspergillus (Table 5.23. Wounds 2
and 7 were also investigated for the presence of  fungi  at  two points  during
HBOT, mid-treatment and at the end of HBO. A summary of the results can be
seen  in  Table  3.22.  All  wounds  demonstrated  communities  of  co-existing
bacteria and fungi. 
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Table 5.23. Fungal species identified in each wound pre-HBOT.
Organism 1a 1b 2 3 4 5 6
Aspergillus spp.     
Aspergillus penicillioides 
Candida parapsilosis 
Cladosporium cladosporioides 
Michrodochium bolleyi 
Michrodochium nivale 
Penicillium argillaceum  
Phoma herbarum 
Saccharomyces cerevisiae 
Sporobolomyces roseus 
Total 4 2 1 2 2 1 3
Table 5.24. Frequency of fungal species in pre-HBO wounds.
Fungal species Number of wounds
Aspergillus spp. 6
Candida sp. 1
Cladosporium sp. 1
Michrodochium spp. 1
Penicillium sp. 2
Phoma sp. 1
Saccharomyces sp. 1
Sporobolomyces sp 1
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Table  5.25.  Fungi  identified  at  three  points  during  the  wound study  in  wounds 1b  and  6  
* No PCR bands were detected post cloning.
Wound 1b Wound 6
Pre-HBO Aspergillus spp.
Saccharomyces cerevisiae
Aspergillus spp.
Candida parapsilosis
Penicillium spp.
Mid-HBO Aspergillus spp.
Chaetomium elatum
Fusarium oxysporum
Phoma herbarum
Sporobolomyces roseus
Aspergillus spp.
End of HBO Aspergillus spp.
Phoma herbarum
None*
5.3.3. A comparison of cultural and molecular techniques for bacteria
There were 16 occasions when duplicate swabs were analysed; one in Derriford
microbiology  laboratory  (see  Section  1.3.1)  and  the  other  with  molecular
methods  (PCR-DGGE,  sequencing);  of  those,  three  samples  showed  no
bacterial growth using cultural methods; however, molecular analysis detected
the presence of at least one organism in each swab. The number of bands in
the DGGE however, indicated that there may have been several more (Table
5.26).  None  of  the  organisms  identified  with  molecular  analysis  were
concurrently identified with cultural analysis of the duplicate swab.
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Table 5.26. Organisms detected in wound swabs (at least 1 from each wound) with cultural and
molecular  analysis.  *  Named  organisms  are  those  identified  with  sequencing;  approximate
number of bands on DGGE gel for that swab. ++  moderate numbers, +++  large numbers.
Wound and day of swabbing Culture Molecular analysis*
Wd 1a, Clinic No bacterial growth Lactobacillus plantarum
>6 bands
Wd 1a, +10 Mixed bacterial growth Pseudomonas aeruginosa
>5 bands
Wd 1b, +20 Coliform bacilli +++
Pseudomonas aeruginosa +++
No bands sequenced
>6 bands
Wd 2, +2 Mixed bacterial growth 
Diphtheroid bacilli ++
Coliform bacilli ++
Staphylococcus aureus ++
P. aeruginosa
>1 band
Wd 2, +14 Diphtheroid bacilli +++
Coliform bacilli +++
Staphylococcus aureus ++
No bands sequenced
>4 bands
Wd 2, +55 Mixed bacterial growth
Staphylococcus aureus ++
Streptococcus agalactiae
Corynebacterium aurimucosum
>5 bands
Wd 3, Pre-HBO Mixed bacterial growth Prevotella dentalis
>4 bands
Wd 3, +3 Mixed bacterial growth +++ No bands sequenced
>1 bands
Wd 3, +47 No bacterial growth Stenotrophomonas maltophilia
>3 bands
Wd 4, Pre-HBO No bacterial growth Stenotrophomonas  maltophilia
Streptococcus agalactiae
Bradyrhizobium sp 523321
Saccharomonospora glauca
>5  bands
Wd 4, +11 Mixed skin flora Micrococcus luteus
>3 bands
Wd 5, Clinic Mixed bacterial growth Enterobacter cloacae
>7 bands
Wd 5, Pre-HBO Staphylococcus aureus
Enterococcus sp.
No bands sequenced
>2 bands
Wd 5, +16 Mixed skin flora
Enterococcus sp.
No bands sequenced
>1 bands
Wd 6, Clinic Coliform bacilli
Staphylococcus sp.
Enterococcus sp.
Diphtheroid bacilli
Mixed anaerobes
Fusobacterium nucleatum
Enterobacter cloacae
Corynebacterium aurimucosum
>6 bands
Wd 6, +14 Coliform bacilli
Staphylococcus sp.
Enterococcus sp.
Diphtheroid bacilli
Bacteroides sp.
Fusobacterium nucleatum
>7 bands
5.4. Discussion
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This  study  examined  for  the  first  time  changes  in  bacterial  and  fungal
community  population  dynamics  during  HBO  treatment.  The  polymicrobial
nature of non-healing chronic wounds has already been extensively reported
(Redkar  et al.  2000; Hill  et al. 2003; Davies et al. 2004; Gjødsbøl  et al. 2006;
Dowd et al. 2008; Frank et al. 2008). The species identified in this study support
that  body  of  work,  though  two  species,  Saccharomonospora  glauca and
Lactobacillus  plantarum,  are  to  our  knowledge,  so  far  unreported in  chronic
wounds.
The  first  major  observation  from  this  study  is  that  the  bacterial  community
during a course of HBO is complex and dynamic. It is disappointing that we
were  unable  to  recruit  patients  to  act  as  non-HBO controls,  as  an audit  of
wound microflora over time is lacking in published work. Gjødsbøl et al. (2006)
identified resident bacteria (species present in “all or all but one” of the sampling
times) in chronic venous ulcers over a period of 8 weeks but did not present the
bacterial community for each wound at each time point, so apart from reporting
that 76% of wounds had two or more resident species, it  is not known how
stable  the  rest  of  the  community  was  over  time.  S.  aureus  and  
P. aeruginosa  were two of the most common resident species in the study of
Gjødsbøl et al. and, interestingly, they observed that P. aeruginosa was resident
in ulcers that increased in size, but not resident in ulcers that reduced in size. In
our study  P. aeruginosa was present in four HBO treated wounds and band
patterns suggested that they do persist over time; however, 3 of those 4 wounds
were reduced in size by the end of HBO (Table 5.19), despite the presence of
this organism. The small number of wounds included in this study negates any
firm conclusions concerning this observation, but it is useful to consider whether
HBO is able to modify the toxicity of organisms in some manner, to facilitate
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healing, even though the organism is still  present. A point that must also be
considered  is  that  DGGE is  a  tool  that  indicates  the  presence  of  bacterial
genetic material in a wound, not the presence of live organisms. Wounds are
cleaned as a part of routine care but it cannot be assumed that all dead material
is removed.
It  has  been  conjectured  that  the  presence  of  anaerobic  bacteria  in  chronic
wounds  may  be  a  factor  in  non-healing  (Section  1.3.1)  and  indeed,
approximately 50% of organisms found in our study were facultative anaerobes
(Table 5.22); the majority of those were tolerant to oxygen to varying degrees
meaning  that  they would  be  less  vulnerable  to  the  direct  toxicity  of  a  high
oxygen environment afforded by HBO. However, anaerobes were cleared from
four of the wounds by the end of treatment. There does not appear to be any
correlation between the clearance of anaerobes and either a reduction in wound
size or the level  of  tissue oxygenation achieved during HBO, supporting the
observation that  wound healing is multifactorial  and not exacerbated by any
single component.
The MDS plots of species suggested that bacterial populations during HBOT do
undergo distinct changes in 5 out of 7 of the wounds (wounds 1b, 2, 3, 5 and 6).
For example, wound 3 had two populations with 60% similarity, one consisting
of 2 samples at the beginning of HBOT, and the other consisting of 5 samples
taken  during  the  remainder  of  the  treatment  period,  indicating  a  shift  in
population after only a few treatments. Early shifts in population similarity was
seen in 3 wounds and suggested that bacterial species were responding to the
modified  oxygen environment;  wounds 2 and 6 were  on patients  not  taking
antibiotics, which rulined that out as a factor for change and wound 3 saw a loss
of anaerobic bacteria even though this patient was not prescribed antibiotics
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that target anaerobes. Wound 5 demonstrated a shift  in population similarity
from day 13 of treatment and as antibiotics were not prescribed until day 13,
this change must have been the result of some other factor.
An interesting observation was that the 2 patients (wounds 3 and 5) with the
lowest TCOMs at 100% O2  at 2.4 ATA, went on to require amputations; at the
pre-HBO assessment they just achieved the minimum required to indicate that
HBO might be effective (299 and 205 mm Hg, respectively).  The TCOM for
wound 5 did  show significant  improvement  after  69  days  of  HBOT (Section
5.2.11), indicating that oxygen delivery to the wound had increased, perhaps
due to neo-angiogenesis. However, this wound still increased in size by 10%
and required amputation. It is difficult to arrive at any firm conclusions as to why
this wound failed to heal, but it highlights the point that despite an improvement
in  tissue  oxygenation  and  all  the  concurrent  physiological  benefits,  some
wounds will not heal. This wound demonstrated shifts in bacterial population but
it  could  not  be  determined  whether  these  changes  were  beneficial  or
detrimental to healing, despite the end result. There were many other factors
that could have affected this wound; poor blood glucose control, poor immune
response and other health problems, may have contributed significantly to the
lack of healing.
The  identification  of  fungi  in  wounds  is  of  increasing  interest  as  evidence
suggests that members of this group may play a role in the non-healing state;
Heald et al. (2001) identified fungal species, predominantly Candida spp., in all
17 of the diabetic foot ulcers that they examined and observed that 15 wounds
healed  or  improved  when  anti-fungal  therapy was  implemented,  following  a
period of non-response to standard antibiotic therapy. A later survey of fungal
infections in chronic wounds (Dowd et al. 2010) found that 41% of DFUs were
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fungal positive, again with  Candida spp. being the dominant species present.
This  study adds to  this  work in  finding that  100% of  the wounds contained
fungal species, including 6 species that to our knowledge have been previously
unreported in DFUs. Of interest, though not significant due to the small sample
size, a single Candida species, Candida parapsilosis, was found in one wound
only; the most frequent species identified were  Aspergillus spp. Why Candida
spp. were not found more frequently in this study is unclear; hospital clinics and
the home environment could potentially increase the diversity of contamination.
DDRC may have a specific environmental pool of fungal species that would limit
exposure, but patients only attended for 3-4 h each day and unless being re-
dressed the wounds were always covered.
Also previously unreported is an audit of fungal species present in DFUs before,
during and at the end of HBOT. Due to time and financial constraints only two
wounds were  examined,  which  showed different  patterns  of  infection  (Table
5.25). Definitive conclusions cannot be drawn from such a small sample size
but two points are of interest; (i) the patient with the higher fungal load had less
well controlled blood glucose than the patient with less fungal species present
(Table  5.25)  and (ii)  the  patient  with  the  higher  fungal  load was  prescribed
antibiotics. It is now widely accepted that diabetic patients are more likely to
experience  fungal  foot  infections  than  their  non-diabetic  counterparts
(Rosseeuw et al. 1999), and Alteras et al.  (1979) found a correlation between
blood  glucose  and  the  presence  of  fungi  in  the  toe  webs  and  toe  nails  of
diabetic patients. It has also been suggested that patients taking antibiotics are
also more likely to have fungal infections; a study investigating the development
of nosocomial candidemia found that taking two or more antibiotics was a major
risk factor (Bross,  et al.  1989).  It  is possible that antibiotics,  in reducing the
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bacterial load, provide a less competitive environment for fungi to proliferate.
This may explain why the fungal load of wound 1b was greater than wound 6,
but not why wound 6 was cleared of fungi during HBOT but wound 1b was not.
A possible explanation is that improved neutrophil function, due to increased
oxygen availability, was able to clear the lower burden of wound 6 but not that of
wound 1b.
The use of DGGE as a tool, to examine environmental and medical bacterial
populations, has become very popular and has facilitated the identification of
viable  but  non-culturable  species.  Particularly  in  the  medical  field,  routine
culture is limited by not what is there but what is looked for, and often what is
looked for is determined by the clinical symptoms of infection; anaerobes and
fungi generally being under-reported (Bowler and Davies, 1999). However, the
results of DGGE need to be examined with some caution; bias can occur at
several points: choice of primers, PCR programme parameters, nested PCR,
denaturing  gradients  etc.  Protocol  optimisation  will  hopefully  reduce  these
effects and result in accurate gel resolution of PCR products; however, this will
depend to  some degree on the  sensitivity required.  It  could  be argued that
DGGE is too sensitive a tool if the study is concerned with identifying to species
level  the population under examination;  and pre-determining this question is
important  when  analysing  banding  patterns.  This  study  used  GelCompar
software which makes the assumption that every band in a single column of gel
is a different species with its own migration position. However, as DGGE can be
sensitive  to  single  bp  differences,  it  is  likely  that  more  than one band in  a
column is from the same species of bacteria.  In fact, this is what this study
observed as sequencing results from bands at different migration points on the
gel were identified as belonging to the same species. Aligning the sequence
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data from such bands indicated that some of the differences were indeed only
2-3 bp (Section 5.3.1.3),  so it  is  important to ascertain whether this level  of
sensitivity  is  a  help  or  a  hindrance  when  leading  on  to  band  analysis  and
comparison of population similarity. Most bacteria have multiple copies of the
16S  gene,  for  example  P.  aeruginosa has  4  copies  of  this  gene
(http://rrndb.mmg.msu.edu/search.php),  which  could  account  for  the  different
migration points of the PCR products seen in this study. For this reason, gel
banding analysis may give an impression of greater diversity than is actually
present.
The final  protocol  for  PCR-DGGE in  this  study was  arrived at  after  several
months of preparatory work optimising conditions. However, compromises had
to be made and sometimes this resulted in sub-optimal gels. For example, initial
dilution of the PCR products gave very dense bands that were poorly resolved
(Figure 5.4. column +7), but further dilution resulted in clearer bands but the
loss of fainter bands. Altering the denaturant gradient to separate dense bands
into what could have been different species again resulted in the loss of some
bands.  Others  have  found  that  single  bands  can  contain  multiple  species
(Gafan & Spratt, 2005) which still do not migrate to different points in the gel
with very narrow gradients, which may indicate that species diversity is greater
than that calculated. In conclusion, DGGE, though having limitations regarding
the precise resolution of different species, does provide an excellent means of
monitoring any changes in bacterial populations over time, providing that the
protocol  design  addresses  and  limits  intra-gel  variability.  If  identification  of
species present is required the production of a clone library would give a more
detailed picture. A summary of the pros and cons for using DGGE or cloning as
tools in assessing wound microflora communities is presented in Table 5.21. In
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this study the decision to use cloning for fungi was influenced by the lack of time
available to optimise DGGE, which was crucial to avoid some of the cons of this
technique (Table 5.21), and the decision to analyse a fewer number of samples,
making  cloning  a  more  direct  means  of  determining  identification  of  fungal
species.  Ideally,  a  combination of  the  two techniques for  bacteria  and fungi
would have been optimal.
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Table 5.21. Pros and cons of DGGE and cloning as techniques for analysing microflora
Technique Pros Cons
DGGE A large  number  of  samples  can  be
analysed together
May overestimate diversity
An  excellent  tool  for  monitoring
changes in community
It is not quantitative
Once optimised the technique is quick Limit  on  amplicon  size  may  reduce
accurate  identification  following
sequencing
Allows  rapid  visualisation  of  sample
community
Co-migration of species
PCR artifacts may show as bands
Standardisation  of  gels  can  be  a
problem due to inconsistent gradients
Choice  of  bands  for  sequencing  is
subjective
Cloning A  direct  technique  with  minimal
electrophoresis
Very  labour  intensive  for  a  large
number of samples
Larger  size  of  insert  allows  greater
accuracy  of  identification  following
sequencing
It is not quantitative
This  study has  provided  a  valuable  snapshot  of  bacterial  and,  to  a  limited
extent, fungal, community dynamics during a course of HBOT; future work could
expand on this with a greater number of participating patients. This could be
achieved  by  a  multi-centre  collaboration,  with  common  procedural  and
analytical protocols. Ensuring that non-HBOT patients were also included would
provide  a  detailed  temporal  analysis  of  wound  microflora  during  the
healing/non-healing process. A more detailed picture of wound microflora over
time  might  help  physicians  construct  more  effective  antibiotic  regimens,
including the informed use of  anti-fungals.  DGGE could be used to  monitor
population changes over time and cloning could provide accurate identification
of  species  in  order  to  determine if  the  presence  of  specific  organisms was
instrumental in the non-healing process. This study has highlighted the need for
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further investigation into the population dynamics of bacteria and fungi during
the treatment process. It has also reiterated the differences in the qualitative
aspect  of  information  gleaned  between  culture  methods  and  molecular
methods, and how the latter can provide a more diverse, detailed and ultimately
valuable analysis of wound microflora; the importance of which is discussed
further in Chapter 6.
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Chapter 6
Final Discussion
6.1. Summary of the findings of this study
This  study  has  provided  evidence  of  oxidative  damage  to  an  antibiotic
degrading  enzyme  (penicillinase)  and  to  bacterial  QS  signalling  molecules
(AHLs) that resulted in reduced activity. It  has demonstrated that oxidants in
conjunction  with  antibiotics  reduced  the  number  of  live  cells  in  pre-formed
bacterial  biofilms  to  a  greater  extent  than  either  agent  alone.  The  audit  of
microflora  in  a  non-healing  diabetic  foot  ulcer  during  HBOT has provided a
picture of microbial community changes over time.
This  final  discussion  will  bring  together  these  findings  to  illustrate  how  a
modified oxygen environment may affect mechanisms of antibiotic resistance
during a course of HBOT and how this may facilitate wound healing.
6.2. A possible scenario of HBOT mediated changes to a non-healing wound
A chronic, non-healing wound is a wound that has become locked into a cycle of
infection and inflammation. Periodic antibiotics may give temporary relief from
some of the symptoms of bacterial  contamination, but eventually the wound
deteriorates and, in the case of DFUs, the final solution is usually to amputate a
proportion of the limb back to healthy tissue.  Evidence is  accumulating that
HBOT provides a viable alternative for some wounds. Until now it has not been
known  whether  or  how  improved  tissue  oxygenation  may  modify  antibiotic
resistance in  a  non-healing  wound environment  but  this  study has provided
evidence that suggests possible means whereby this could occur.
In  formulating  this  scenario  two  assumptions  have  been  made:  (i)  HBOT
increases tissue oxygenation to at least normoxic levels in the wound area and
(ii) increased oxygen availability facilitates oxidant production by phagocytes.
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Chapter 1 discussed the positive effects of increasing the pO2 of a non-healing
wound  and  one  of  those  effects  was  the  formation  of  new  blood  vessels
(neoangiogenesis). One outcome of increased tissue vascularisation would be
an improvement of the delivery of systemic antibiotics, carried in blood plasma.
Maintaining effective bactericidal/bacteriostatic concentrations of antibiotics in
blood is futile if the drugs cannot be delivered to the area contaminated with
microorganisms, and lengthy courses of antibiotics may result in poor patient
compliance  if  side-effects  are  being  experienced.  HBOT,  delivered  as  an
adjunct  to  antibiotic  therapy  early  in  the  treatment  process,  might  result  in
improved healing by facilitating antibiotic delivery to the wound. Unfortunately,
HBOT is often regarded as a last resort option when all other therapies have
been tried, by which time the wound will have severely deteriorated.
Many  β-lactamase  producing  bacteria  secrete  these  enzymes  into  the
extracellular milieu where they degrade β-lactam antibiotics before they enter
bacterial cells (Ciofu et al. 2000). In a wound environment containing ROS/RNS
such as H2O2, HOCl and ONOO- a significant proportion of β-lactamases could
be  modified  allowing  antibiotics  to  enter  cells  undamaged.  This  work  has
provided  evidence  that  serine  and  metallo-β-lactamases  are  vulnerable  to
damage by H2O2, HOCl and ONOO- (Chapter 2), a situation particularly valuable
regarding the latter group due to the paucity of drugs effective against them.
The concentration and stability of ONOO- in a chronic wound is unknown so it
cannot  be  assumed that  the  concentration  used  in  this  study would  be  as
effective  in  vivo.  However,  it  is  feasible that  the concentrations of H2O2 and
HOCl used could occur in wounds and that they could significantly reduce the
activity of β-lactamases.The increased vulnerability of bacteria should result in a
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subsequent reduction in bacterial load that could facilitate bacterial clearance by
the immune system.
Chapter  3  provided  evidence  that  HOCl  was  capable  of  damaging  AHLs,
depending on chain length and substitution,  in vitro. The implication of this  in
vivo would depend on the presence and abundance of bacterial species and
whether vulnerable AHLs were secreted. In the case of P. aeruginosa, O-C12-
HSL could be damaged but the C4-HSL would not, however with a reduction in
available O-C12-HSL it is possible that only background levels of C4 would be
produced, which could be insufficient to drive a response. Organisms that don’t
produce vulnerable AHLs but do respond to them could be affected in some
way, though whether this would be a positive or negative effect regarding wound
pathology would depend on the modified outcome.
The  in vivo results did not reflect the  in vitro results of AHL damage and an
explanation  for  this  was  presented  in  Section  3.4.  These  results  may  also
predict  those that would be seen for β-lactamases in a wound environment,
however  HBOT extends  for  several  weeks,  allowing  for  the  possibility  that
bacterial  antioxidant  defences may become depleted and less effective over
time  which  may  allow  damage  to  occur.  As  AHLs  and  β-lactamases  are
secreted into the extracellular environment, the antioxidant status of the patient
should  also  be  considered.  In  general,  levels  of  human  extracellular
antioxidants, i.e. GSH and SOD, are low and extracellular fluids contain virtually
no  catalase  activity  (Halliwell  &  Gutteridge,  2007).  Studies  that  have
investigated  antioxidant  capacity  following  repeated  HBOT  have  shown
reduction or no change to levels of endogenous antioxidants (Benedetti  et al.
2004,  Eken  et  al.  2005,  Gürdöl  et  al.  2008,  Gröger  et  al.  2009).  However,
oxidative damage to selected markers was still detected, which would suggest
251
that,  with  prolonged  HBOT,  antioxidant  defences,  at  already  low  levels
extracellulary, could be insufficient to prevent oxidative damage to molecules
secreted by bacteria. There are several non-enzyme antioxidant defences found
in  human plasma,  e.g.  erythrocytes,  albumin,  urate,  (Halliwell  &  Gutteridge,
2007),  that  could  play a  role  in  scavenging  ROS in  a  wound  environment.
Ultimately, whether damage occurs or not will depend on the balance between
levels of ROS and antioxidant defences.
If  AHLs,  instrumental  in  the  formation  of  biofilms  in  wounds,  were  to  be
damaged by extracellular HOCl then it is feasible that HBOT could reduce the
biofilm load of a wound. However, as discussed in Chapter 1, QS and biofilm
formation is complex and a more comprehensive picture might be devised when
more is known about the effects of QS interference in multi-organism biofilms.
The lack of an effect of oxidants on AHLs, in vivo, from this study may indicate
that  antioxidant  defences  are  effectively  quenching  the  ROS,  as  discussed
above,  and this  has implications for  biofilm formation in wounds undergoing
HBOT. Again, HBOT may overwhelm antioxidant defences rendering AHLs, and
other QS signalling molecules vulnerable to damage. This study did not produce
P. aeruginosa biofilms of sufficient quality and reproducibility to investigate the
effects of damaged AHLs on biofilm formation. 
The investigation of S. aureus biofilms in this study suggested that HBOT could
facilitate  the  reduction  of  biofilm  mass  by  the  additive  effects  of  oxidant
production and antibiotics on the reduction of live cells in biofilms (Chapter 4). It
was  not  determined  whether  the  effects  of  the  ROS were  directly  lethal  to
biofilm cells or whether they modified bacterial defences that made them more
vulnerable to antibiotics. The kinetic properties of ROS generating enzymes in
humans,  as  discussed  in  Section  4.4.  relating  to  oxygen  concentration  and
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enzyme  saturation,  may mean  that  HBOT will  not  result  in  increased  ROS
production.  However,  HBOT,  in  returning  wounds  to,  at  least,  a  normoxic
environment should still facilitate ROS production.
A schematic representation of how HBOT might aid wound healing, from the
perspective of contamination, is presented in Figure 6.1. HBOT increases pO2
in the wound environment which results in the formation of new blood vessels
(neoangiogenesis). Improved vascularisation means that the blood supply to the
damaged  tissues  is  improved  allowing  better  delivery  of  plasma-borne
antibiotics. This should allow for the accumulation of target concentrations to
achieve bactericidal or bacteriostatic outcomes. Secondary to this, increased
pO2 might  lead  to  improved  immune  cell  function  by  providing  increased
oxygen,  a  substrate  for  the  production  of  ROS/RNS.  As  well  as  improved
microorganism  clearance  an  increase  in  extracellular  concentrations  of
ROS/RNS  might  occur;  this  would  provide  a  deleterious  environment  for
secreted AHLs and β-lactamases. QS interference may hinder the formation of
biofilm in the wound and the combination of oxidants and improved antibiotic
delivery might result in improved killing of live cells within any biofilm that does
form. Taken together this improved antibiotic efficacy would result in increased
wound healing.
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Figure  6.1.  Schematic  representation  of  how  HBO  could  facilitate  wound  healing  by  the
modification of antibiotic delivery and efficacy. HBO increases pO2 which results in increased
neoangiogenesis, facilitating improved delivery of antibiotics to the wound. Increased pO2 also
facilitates ROS/RNS production by immune cells which results in damage to the QS signalling
molecules that influence biofilm formation. The combination of ROS and antibiotics results in
increased killing of biofilm cells and ROS/RNS damages β-lactamase enzymes. Together these
effects  increase  antibiotic  efficacy,  which,  along  with  improved  delivery,  leads  to  improved
wound healing.
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One  of  the  critical  components  in  the  treatment  regimens  of  DFUs  is  the
prescription of antibiotics. It is crucial that the correct drugs are prescribed, at
optimal doses, at the correct time and herein lies a potential hindrance to wound
healing. This study, along with others has highlighted the drawbacks of relying
on  conventional  culture  methods  to  identify  microorganisms  in  non-healing
wounds. Antibiotic prescribing protocols (Appendix 7) therefore, are based on
providing  broad coverage rather  than targeting  key species  and the  lack  of
evidence supporting antibiotic therapy for the treatment of non-healing wounds
is of  concern (O'Meara et  al. 2000).  It  is  possible  that  this  approach clears
wound  flora  that  have  no  significant  detrimental  role,  removing  competition
which then allows the proliferation of pathological species. Wound ischaemia
might result in wounds receiving only sub-inhibitory concentrations of antibiotics
which may be conducive to biofilm formation rather than detrimental (Hoffman
et al. 2005). HBOT, by improving antibiotic delivery, might reduce this possibility.
There are wound treatment centres that now utilise a different approach to the
prescribing of antibiotics to treat non-healing wounds. Molecular methods are
used  to  optimise  the  identification  of  wound  microflora  so  that  antibiotic
regimens can be formulated that are specific to each individual wound, targeting
key species. These changes have resulted in improved healing rates (62.4%
compared  to  48.5%)  in  wounds  that  had  antibiotic  prescriptions  based  on
personalised molecular diagnostics (Dowd et al. 2011).
The audit of wound microflora during HBOT in this study (Chapter 3) highlighted
the complexity  of  changing bacterial  and fungal  communities  over  time and
supported the focused approach achievable through accurate identification by
molecular  methods.  It  was  not  possible  to  draw  any  definitive  conclusions
regarding  wound  microflora  and  non-healing  as  no  clear  correlations  were
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detected. Bacterial population changes did occur over time but whether these
were  due  to  HBOT or  other  factors,  such  as  antibiotic  use,  could  not  be
determined. One of the key observations from this study was that chronic DFUs
are colonised by a broad range of bacteria and fungi and the challenge is to
identify which species are pathological in this environment. It is to be expected
that  certain  species,  ubiquitous in  the  environment  around us,  are  found in
wounds; whether they delay healing in that wound needs to be determined. A
wound is a breach in one of our defences against infection and this allows the
opportunity for commensal and commonplace organisms to become potentially
harmful. Fungi, in particular, have been largely ignored in chronic wounds and
this study has reiterated that fungi do colonise these wounds. As discussed in
Section 5.4., there is evidence to suggest that the presence of fungi does delay
healing (Heald et al. 2001). So, perhaps it is time for clinicians to reassess their
approach to the investigation and treatment of infected non-healing wounds, to
encompass a molecular approach to diagnostics and to include fungi in their
serach for colonising organisms.
6.3. Summary of recommended further work
It  would  be  valuable  to  separate  the  two  β-lactamases  in  penicillinase  and
investigate further the differential activity following exposure to ROS. The site of
ROS damage/modification  could be determined with  mass spectroscopy.  An
improved protocol for the synthesis of ONOO-, yielding sufficient quantity and
concentration of product would allow further investigation into the effects of this
RS  on  penicillinase.  This  work  from  this  study  could  be  extended  by
investigating  a  range of  β-lactamases from other  classes and from different
bacterial species.
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Future work could examine the effects of other ROS/RNS, such as ONOO-, on
AHLs,  and  to  investigate  the  relationship  between  damaged  AHLs  and  the
formation of biofilms. For example, mutant strains of P. aeruginosa that do not
produce  endogenous  AHLs  could  be  incubated  in  media  containing  HOCl
exposed synthetic AHLs, in conditions that allow quantification of biofilm mass.
This work could also be extended to include QS signalling molecules utilised by
Gram-positve  bacteria.  Performing MS-MS on AHLs exposed to  H2O2 could
confirm whether oxidation was taking place. 
In  relation  to  biofilms,  further  work  could  investigate  the  effect  of  ROS and
antibiotics  on  the  biofilms  of  a  greater  diversity  of  bacteria,  in  both  mono-
species  and multiple-species  biofilms,  including  both  antibiotic  sensitive  and
resistant strains. It would also be useful to include a pressure component to the
oxygen environment, equivalent to that experienced by wound tissue during a
session of HBOT. Carrying out microscopy on forming and pre-fomed biofilms
would  be  valuable  to  visualise  changes  in  biofilm  architecture  following
exposure to  damaged AHLs or  ROS/antibiotic  combinations.  Using selective
stains could ascertain  whether  changes are occurring to  live cells  or  matrix
components. Including fungal species in the work discussed above would be
beneficial and could include mixed-species biofilms of bacteria and fungi.
Continuing to investigate wound microflora population dynamics, with molecular
techniques, over time would be valuable, which may include a course of HBOT
or with conventional treatment only, to further determine how these populations
change and whether  there are any correlations with  healing.  In  the case of
HBOT, a greater number of  participating patients,  possibly via a multi-centre
collaboration,  would  provide  more  statistically  relevant  data.  Every  attempt
should be made to include non-HBOT control wounds. It would be valuable to
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include analysis of fungal species present at every sampling point, as well as
bacteria to build a more detailed picture of fungal colonisation of non-healing
wounds over time. Wound biopsies would be valuable for the visualisation of in
situ biofilms using microsopy techniques. Screening of wound exudates for the
presence and identification of AHLs would also be beneficial.  
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Appendix 1
Calculation to determine catalase activity:
Catalase activity =                    ΔA240 min-1                               
                               40×mg enzyme ml-1 reaction mixture
Ɛ of H2O2 = 40 mM-1 cm-1
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Appendix 2
Initial rate of penicillinase activity
Initial rate = b × (a + y0 – c)
Where c = absorbance of CENTA only.
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Appendix 3
Calculation to determine LPO activity:
LPO activity =                    ΔA350 min-1                               
                        26×mg enzyme ml-1 reaction mixture
Ɛ of triiodide = 26 mM-1 cm-1
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Appendix 4
Concentrations of HOCl were calculated from the standard curve using the 
following equation:
Concentration of HOCl = y-a
                                          b
y = absorbance
a = y intercept
b = slope
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Appendix 5
Amino acid sequences
Beta-lactamase I
1      milknkrmlk igicvgilgl sitsleaftg eslqveakek tgqvkhknqa thkefsqlek
61    kfdarlgvya idtgtnqtis yrpnerfafa stykalaagv llqqnsidsl nevitytked
121  lvdyspvtek hvdtgmklge iaeaavrssd ntagnilfnk iggpkgyeka lrhmgdritm
181  snrfetelne aipgdirdts takaiatnlk aftvgnalpa ekrkiltewm kgnatgdkli
241  ragiptdwvv gdksgagsyg trndiavvwp pnsapiivli sskdekeaiy ndqliaeatk
301  vivkgs
Beta-lactamase II
1      mkkntllkvg lcvgllgtiq fvstissvqa sqkvektvik netgtisisq lnknvwvhte 
61    lgsfngeavp snglvlntsk glvlvdsswd dkltkeliem vekkfqkrvt dviithahad
121  riggiktlke rgikahstal taelakkngy eeplgdlqtv tnlkfgnmkv etfypgkght
181  ednivvwlpq ynilvggclv kstsakdlgn vadayvnews tsienvlkry rninavvpgh
241  gevgdkglll htldllk
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Appendix 6
Application for NHS Research and Development 
Approval
Changes in Diabetic Foot Ulcer Wound 
Microbiology in Patients Undergoing 
Hyperbaric Oxygen Therapy
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Chief Investigator Mrs Lindsey Glew (PhD student) University of Plymouth1
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Dr Gary Smerdon Hyperbaric Medical Centre3
Educational Supervisors Dr John Moody University of Plymouth1
Dr Gary Smerdon Hyperbaric Medical Centre1
Dr Karen Tait Plymouth Marine Labooratory1
Collaborators Mr Graham Bruce PCT2
Dr Philip Bryson Hyperbaric Medical Centre3
Research Nurse Ms Alexandra Bishop Hyperbaric Medical Centre3
Sponsor                                Diving Diseases Research Centre4
1 School of Biological Sciences, University of Plymouth, Drake Circus, Plymouth, PL4 8AA
   01752 232909
2 Plymouth Hospitals NHS Trust, Derriford Hospital, Derriford, Plymouth, PL6 8DH
  0845 155 8155 Fax: 0845 155 8235
3 The Hyperbaric Medical Centre (Diving Diseases Research Centre), Tamar Science Park, 
Research    Way, Plymouth PL6 8BU
  01752 209999
4 Contact – Dr Gary Smerdon
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Changes in Diabetic Foot Ulcer Wound Microbiology in Patients 
Undergoing Hyperbaric Oxygen Therapy
Aims
The primary aim is to qualitatively characterise the change in wound microbiology in chronic
diabetic foot ulcers as a result of hyperbaric oxygen therapy. The secondary aim is to compare
the  microbial  community  in  chronic  diabetic  foot  ulcers,  identified  by  standard  cultural
analysis, with that identified by molecular analysis.
Background
Chronic wounds are those which are slow to heal within a normal time span or fail to heal
entirely. They remain open, are characterised by persistent inflammation, and do not progress
to fully healed wounds. Evidence suggests that underlying pathophysiological conditions, e.g.
diabetes  [1]  and  the  presence  of  microbial  infection  [2]  both  contribute  to  a  non-healing
wound. However, exactly what physiological processes are at work and how they interact with
the  effects  of  microbial  infection  have  been  poorly  defined.  Hence,  a  full  and  detailed
understanding of the microbial communities present in chronic wounds is a valuable tool in
deciding which treatment is the most appropriate.
Investigation of the microflora of wounds has been carried out previously, but mainly using
traditional culture based techniques (reviewed by Bowler, [3]). Commonly held indicators of
infection include a bacterial load of 105 colony forming units (cfu) per gram of tissue, regardless
of species, and identification of key pathogenic organisms [3, 4]. The most commonly isolated
organisms  from  infected  wounds  are  cited  as  staphylococci,  pseudomonads,  and  beta-
haemolytic streptococci. However, this may be due to the ease of culturing these bacteria over
fastidious anaerobes, and those in the VBNC13 state. Indeed, many studies indicate that the
anaerobic  and  difficult  to  culture  wound  microbes  are  prevalent  in  wounds,  and  short
incubation periods contribute to their being overlooked [3, 5, 6]. However, anaerobes are still
often  treated  as  one  group,  as  exemplified  by  a  recent  study  [2];  a  clear  hindrance  to
understanding wound microbiology. Further, differences in methods of sampling wounds may
lead to variability in results i.e. swabbing versus tissue samples, and differences in swabbing
technique. For example, it is thought that different microbial populations inhabit the upper and
lower layers of a wound, and hence tissue biopsies have been used as reference standards
when assessing swabbing techniques for accuracy [6, 7, 8]. Further to the identification of key
organisms  is  the  appreciation  of  the  interaction  between bacterial  species  and  with  their
environment, rather than the singular effects of individual species  For example, Mayrand and
McBride [9] provide evidence of bacterial synergy, with the dependence of  Porphyromonas
asaccharolytica upon  Klebsiella pneumoniae to cause infection. Further, Trengove  et al. [10]
concluded that the presence of four or more bacterial species was associated with delayed
healing in leg ulcers. Trengove also highlighted the dynamic nature of the wound environment;
additional bacterial species were detected over time.
Recently,  studies  of  wound  microbiology  have  benefited  from  the  advent  of  molecular
techniques  which  can  overcome the  difficulties  of  culture  based  analysis:  the  DNA of  the
bacteria is identified and sequenced directly, avoiding the need to culture to identify individual
species [5]. Further, in a comparison of culture and molecular techniques, molecular methods
identified key organisms that resisted identification by culturing [11, 12].  Therefore, use of
molecular  and culture  based techniques in  tandem should provide a more comprehensive
analysis of wound microbiology.
13
 Viable but not culturable: bacteria in this state are still viable but will not grow on laboratory media
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In  treating  chronic  wounds,  evidence  suggests  that  simultaneous  treatment  with  both
antibiotics  (AB)  and hyperbaric  oxygen therapy (HBO)14 is   beneficial  (reviewed by  Roeckl-
Wiedmann  et  al. [13]),  resulting  in  a  higher  incidence  of  healing,  and  a  reduced  rate  of
amputation for patients with lower limb chronic wounds. It is known that HBO can increase
tissue  oxygen  gradients  [14],  promote  blood  vessel  proliferation  [15],  facilitate  increased
phagocytic  killing  in  hypoxic  tissues  [16],  and  inactivate  at  least  one  microbial  toxin
(Clostridium perfringens alpha-toxin) [14]. However, the direct (e.g. increased oxygen tensions)
and indirect (e.g. increased phagocytic killing) effects of HBO upon the microbial community
have not been investigated in vivo. Using molecular and culture techniques for the analysis of
samples from wound swabs and tissue samples, we hope to identify bacterial species present,
and monitor the change in community composition throughout HBO therapy. This information
may throw some light onto why a sub-group of patients undergoing HBO do not experience
satisfactory wound healing. Further, we hope to determine the accuracy with which culture
techniques are able to characterise the microbial population of chronic wounds, compared to
molecular techniques. It is realised that the taking of tissue samples is contentious; several
studies  have  previously  highlighted  the  greater  range  of  bacteria  found in  deeper  tissues,
compared to surface swabs, however, the goal is usually that of deciding on a cost-effective
technique  for  routine  sampling.  One  of  the  aims  of  this  study  is  to  characterise,  as
comprehensively  as  possible,  the  bacterial  population  of  chronic  wounds,  and  how
composition of that population changes over time, in healing, and non-healing wounds. It is
possible that prescribed broad-spectrum antibiotics, which form a component of the treatment
regime, are selecting for antibiotic resistance, and failing to target clinically important bacteria. 
Patient Inclusion/Exclusion and Identification
Patient Inclusion Criteria
• At least one diabetic foot ulcer, regardless of infection status (see Medical History 
below)
• Over 18 years of age 
Patient Exclusion Criteria
• None
Patient Identification
Patients attending the Diabetic Foot Clinic (DFC) are referred from the Podiatry Clinic (PC) by
Mr. Graham Bruce. Patients will therefore by identified at the PC where they will be provided
with a Patient Information Sheet (PIS) and letter asking them to join the study by Mr. Graham
Bruce. Patients wishing to join the study will be consented on their first visit to the DFC, by Dr
Patrick English, Mr Graham Bruce, or a member of DDRC clinical staff (Ms. Alexandra Bishop or
Dr Philip Bryson).  Patients will therefore have between 1-3 days to consider joining the study,
depending on when their  first  appointment at  the DFC is.  No PCT staff  will  be involved in
patient recruitment or consenting. 
We aim to recruit approximately 20 patients, with ca. 25% eventually referred for HBO after
their initial DFC treatment, providing a test group of 5 patients.
Medical history
In order to interpret the data obtained from this study in the correct context we will collect
specific information from the patients’ DDRC medical notes. A number of factors may influence
the  microbiology  of  the  patient’s  wound,  but  as  this  is  a  prospective  study  it  would  be
14
 HBO is a therapy whereby a patient intermittently breathes 100% oxygen whilst in a chamber at a 
pressure greater than that at sea level.
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impractical  and  in  certain  cases  unethical  to  control  them.  Hence,  to  account  for  these
variables we will obtain information about each patient’s:
• Underlying medical condition (e.g. diabetes, hypertension, osteomyelitis)
• Recent  treatments  (e.g.  AB  or  other  drugs,  wound  dressing,  wound  debridement,
prescribed footwear, repeat HBO)
• Recent blood glucose (HbA1C, see Protocol: Blood Glucose Monitoring below)
• Social factors (e.g. mobility, smoking)
• Transcutaneous oxygen monitoring (TCOM)15 measurements
Protocol
Wound Sampling
Wounds will be sampled using both swabs and tissue sampling. Swabbing will be carried out by
the DDRC Research Nurse at the DFC. Swabbing at the DDRC will be carried out by the DDRC
Research Nurse or by other DDRC nurses charged with caring for the patient. Swabbing will be
carried  out  using  the  Levine  technique  (6),  as  this  technique  provides  swabs  most
representative of the wound microflora and will ensure all swab samples are taken in the same
manner. 
Tissue sampling involves removing a small amount of wound bed material with a scalpel. This is
a  normal  method  of  wound  sampling,  and  is  usually  carried  out  during  routine  wound
debridement16.  The DDRC Research Nurse,  other  DDRC nurses,  and Mr.  Graham Bruce are
competent in this technique. The wound tissue sample will only be taken if it is appropriate to
do so17.
Swabbing  will  take  place  at  named ‘swabbing  events’  (see  below  and  Fig  1).  At  specified
swabbing  events,  two  swabs  will  be  taken;  one  will  be  sent  to  Derriford  Microbiology
Laboratory for standard cultural analysis, the other will be frozen at -80 oC and stored at the
DDRC to await molecular analysis (see below, Wound Sample Analysis). Where only one swab is
taken, this will be used for molecular analysis alone. At the points indicated (Fig 1) one tissue
sample will  be  taken,  which will  be  divided in  two,  one piece of  tissue going to  Derriford
Microbiology Laboratory for cultural analysis, the other to await molecular analysis. 
At all swabbing events, the state and size of the wound will be recorded using Visitrak® (Smith
and Nephew), currently used as standard by staff at the DDRC. Visitrak ® is an acetate tracing
system which records the 2D wound surface area. 
Patient Treatment and Sampling Schedule
Patients participating in this study will follow their normal treatment regimen, as set out by
their doctor. Whether a patient is referred for HBO or not is a clinical decision independent
from participation in this  study.  Importantly,  the treatment  and sampling  schedule set  out
below  and  in  Fig  1  are  a  guideline  only;  patients  differ  in  their  treatment  (e.g.  type  of
antibiotic/dressing, length of treatment) and so the following schedule will be used as a model,
with a degree of flexibility.
15
 A non-invasive means of measuring tissue oxygenation
16
 The removal of devitalised and dead tissue from the wound, which would otherwise impair healing.
17
 As with any treatment, the sampling of a wound is implicitly dependent upon its healing state; we will not
sample a wound where doing so will cause unnecessary harm to the patient. For tissue sampling, this may
be where the previous tissue sampling site has not healed, or where there are clear signs of granulation
tissue and wound healing  (e.g. a significant reduction in wound size), or if the wound is an awkward shape
(e.g. too deep and narrow). Ultimately, this decision is the responsibility of  the clinical staff  taking the
sample.
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Following agreement to take part in this study, two swabs and a tissue sample will be taken at
the DFC on the patient’s initial visit,  and they will begin their treatment regime. Treatment
prescribed by the DFC may consist of dressings and antibiotic therapy, the length of which is
usually  around four  weeks.  After  a  further four  weeks,  the patient  returns  to  the DFC for
assessment. Here, another swab and tissue sample will be taken. At this point, assessment of
the patient’s wound by the DFC doctor determines whether the patient would benefit from
HBO. Hence, the patients divide into two separate groups for the purposes of the study.
Non-HBO referred patients, or those choosing not to receive HBO therapy, will continue with
their prescribed treatment regimes, and will have two wound swabs taken after three weeks or
when they return to the DFC. Further swabs and tissue samples will then be taken every 2-4
weeks at  times convenient to  the patient,  i.e.  when they make a routine visit  to  the DFC.
Treatments  for  patients  in  this  group  may  involve  a  change  in  antibiotic  therapy,  vascular
surgery, or non-intervention. The latter group will form the most applicable control group for
HBO treated patients. 
Patients are referred for HBO at the DDRC as a final attempt to heal the wound. Each HBO-
referred patient will  serve as their own control  from all  swabs and tissue samples prior to
beginning HBO. Upon referral, patients visit the DDRC for assessment (usually around one week
after referral). HBO treatment begins the following week. Two swabs and a tissue sample will
be  obtained  immediately  prior  to  the  first  treatment.  Patients  usually  receive  40  HBO
treatments over eight weeks (one per weekday).  Consequently, swab samples will  be taken
after treatment 2, 5, 7, 10, 15, 20, 30, and 40, with two swabs being taken after treatment 10
and 40, if appropriate. Tissue samples will be taken after treatments 5 and 10.  Sampling is
clustered around the first four weeks of HBO treatment to reveal any immediate changes in
wound microflora as a result of the treatment.
In total, each  patient referred for HBO will undergo at least 11 swabbing sessions consisting of
14 swabs and 5 tissue samples; each non-referred  patient will undergo at least 3 swabbing
sessions consisting of 5 swabs and 2 tissue samples. Swab sampling will therefore provide a
time-course for changes in the microbial community,  both prior to,  and during subsequent
treatment  regimes.  Tissue  samples  will  provide  a  comparative  and  hopefully,  more
comprehensive audit of lower limb wound microbiology.
Wound Sample Analysis
Molecular analysis of the samples will be by Polymerase Chain Reaction DNA amplification and
Denaturing  Gradient  Gel  Electrophoresis  (PCR-DGGE)  using  universal  primers  for  rDNA,
producing a DNA fingerprint of the wound. Corresponding isolates from each swab-culture will
also be run alongside PCR products from the same swab to aid in bacterial identification (they
will  provide  a  ladder).  Unmatched  bands  will  be  identified  by  sequence  analysis  e.g.  a
sequenced band on an initial gel identified as Pseudomonas aeruginosa can be matched up to
a corresponding band on another gel by virtue of its position, without having to sequence it.
Hence,  a  time  course  of  DNA  fingerprints  will  be  generated,  comparing  the  microbial
community before and during HBO treatment in each patient.
Comparisons in the microbial community will be made between the healing and non-healing
patients in the periods prior to, and during, HBO treatment. Further, the community elucidated
from the DNA fingerprinting will be compared to that identified by hospital standard culture
methods.
Formal statistical analysis is not feasible for this study due to the low patient numbers involved
(please see enclosed letter). Descriptive statistics will be included in the final analysis.
Blood Glucose Monitoring
As part of the normal treatment plan of DFC patients, an HbA1C test is carried out (through a
blood sample). This provides a good indication of the patient’s blood glucose levels over the
past  three  months.  Blood  glucose  levels  could  have  an  impact  upon  the  microbiology  of
wounds, especially in diabetic patients, therefore, each patient will have their Hb A1C taken at
the beginning (by Mr Graham Bruce as part of their regular treatment at the PC), and at the
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end of the study, (by the DDRC Research Nurse). However, if the patient has had a recent Hb A1C
test, they will only have one taken at the end.
TCOM 
Patients  have  TCOM  measurements  recorded  routinely  during  the  first  HBO  treatment  to
assess  vascular  competence.  Measurements  will  be  taken  every  two  weeks  during  HBO
treatment to quantify changes to tissue oxygenation in the area around the wound. It will not
be  practical  to  perform  TCOM  in  non-HBO  patients.  TCOM  will  be  performed  during
compression,  if  possible,  as  this  will  provide  the  most  accurate  assessment  of  tissue
oxygenation levels achieved during treatment sessions.
Patient Impact
No data from this study will impact upon the patient’s care, other than data normally obtained
throughout the course of the patient’s treatment (typically this would include an initial HbA1C
test and swabs and tissue samples throughout the patient’s care).  All molecular analysis of
samples will be carried out after the sampling period of the study is finished. Further, all clinical
decisions will remain independent of the study.
Research Governance 
This research will be a joint project between the DDRC, University of Plymouth, and Plymouth
Hospitals NHS Trust. Patients participating in this study are initially under the care of the NHS
trust whilst at the PC and DFC, but during HBO they are under the care of the DDRC. Hence, the
PHNT will  be responsible for patient care at  the PC and DFC, and for the scientific  review
process.  The  DDRC  will  be  responsible  for  collecting  the  samples  and  patient  information
throughout the study and the University of Plymouth will be responsible for sample and data
analysis, and scientific knowledge. 
Funding
The DDRC and the University of Plymouth are jointly responsible for funding of the Ph.D. as the
thesis is supervised by both organisations. Total funding for the Ph.D. is £50,000 over three
years. Funding for this specific project will be provided by DDRC. Costs incurred by this project
and the organisation liable are proposed below:
• DDRC Research nurse time (consenting, swabbing, travelling), DDRC - £1,400 
• Swabs, scalpels, tissue containers and other disposables, DDRC - £400
• Microbiological analysis of swabs at Derriford Microbiology Laboratory, DDRC - £1,300 
• Molecular analysis  of swabs at the university, DDRC and University of Plymouth   -
£3,000 
All patients participating in this study will be undergoing normal therapies, as prescribed by
their doctor, and as such the DFC or Plymouth Hospitals NHS Trust will accrue no extra costs
associated with this study.
Patient Data Handling
The DDRC Research Nurse will be responsible for collecting all patient information required for
the study. All patient information and wound samples will be stored in an anonymised form,
using a DDRC patient identification number. Samples will only be able to be matched up to
patients by the DDRC nurse. Researchers will only be able to identify samples by the DDRC
patient identification number. Anonymised data will be stored by the Chief Investigator for five
years.
Health and Safety 
Risk assessments will be carried out at the appropriate stages of the study. All DNA extractions
will be performed at DDRC where there is hospital-grade, clinical waste disposal facilities.
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Publishing
It is the intention of the Research Group to publish the data obtained from this study. It will
also form part of a Ph.D. thesis.
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Appendix 7
A summary of antibiotic prescribing criteria for diabetic foot ulcers, taken from 
Infection Therapy (www.plymouthdiabetes.org). IV-intravenous.
Grade of infection First antibiotic choice Duration
Mild Oral Flucloxacillin 1-2 weeks
Moderate Oral Levofloxacin
Oral Clindamycin
2-4 weeks
Severe IV Teicoplanin
Oral/IV Rifampicin
Oral/IV Levofloxacin
Metronidazole or 
Piperacillin
2-4 weeks
Bone and joint Oral Levofloxacin
Oral Clindamycin
2-12 weeks depending 
on viable/non-viable 
bone 
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Appendix 8
Accession numbers and identity similarity for bacteria found in this study.
275
Appendix 9
276
Genus Species Accession number Maximum identity (%)
Achromobacter xylosoxidans NC 014640.1 99
Alcaligenes multiple multiple 86-89
Bradyrhizobium Sp 523321 NC 017082.1 99
Corynebacterium aurimucosum
diphtheriae
NC 012590.1
NC 016802.1
98
96
Enterobacter cloacae NC 018405.1
FP 929040.1
97-99
98-99
Enterococcus faecalis
faecium
NC 019770.1
NC 020207.1
99
99-100
Fusobacterium nucleatum NC 003454.1 97
Klebsiella oxytoca NC 018106.1 92
Lactobacillus plantarum NC 020229.1 99
Microbacterium testaceum NC 015125.1 99
Micrococcus luteus NC 012803.1 99
Morganella morganii NC 020418.1 99
Porphyromonas gingivalis NC 015571.1 85
Prevotella dentalis NC 019968.1 90
Propionibacterium acnes NC 018707.1 or 006085.1 99
Providencia stuartii NC 017731.1 98
Pseudomonas multiple
aeruginosa
multiple
NC 018080.1
83-100
97-100
Saccharomonospora glauca CM 001484.1 100
Serratia proteamaculans NC 009832.1 98-99
Staphylococcus aureus
epidermidis
warneri
NC 009632.1
multiple
multiple
NC 020164.1
91
99
98
93
Stenotrophomonas maltophilia NC 015947.1 95-99
Streptococcus agalactiae NC 019048.1 99
Streptomyces multiple multiple 100
Accession numbers and identity similarity for fungi found in this study
Genus Species Accession number Maximum identity
Aspergillus Multiple
penicillinoides
Multiple
gi 12862455 AB002078.1
99-100
99
Candida parapsilosis Multiple strains 100
Chaetomium elatum Multiple strains 99
Cladosporium cladosporioides gi 408474862 JX470338.1
or gi  408474860 
JX470336.1
99
99
Fusarium oxysporum Multiple strains 99
Michrodochium bolleyi
nivale
gi 296410172 HM216190.1
gi 33334391 AF548077.1
99
100
Penicillium Multiple
argillaceum
Multiple
gi 19909869 AB033534.1
or gi 15822823 AB032120.1
99
97
97
Phoma herbarum Multiple strains 99
Saccharomyces cerevisiae gi 120971643 EF153845.1 99
Sporobolomyces roseus gi 111283898 DQ832235.1
or gi 340536084 
HQ913900.1
99
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Appendix 10
G  5  GCCGCGTGTGTGAAGAAGGTCTTCGGATTGTAAAGCACTTTAAGTTGGGAGGAAGGGCAG  64
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
K  1  GCCGCGTGTGTGAAGAAGGTCTTCGGATTGTAAAGCACTTTAAGTTGGGAGGAAGGGCAG  60
G  65 TAAGTTAATACCTTGCTGTTTTGACGTTACCAACAGAATAAGCACCGGCTAACTTCGTGC 124
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
K  61 TAAGTTAATACCTTGCTGTTTTGACGTTACCAACAGAATAAGCACCGGCTAACTTCGTGC 120
G 125 CAGCAGCCGCGGTAATACGAAGGGTGCAAGCGTTAATCGGAATTACTGGGCGTAAAGCGC 184
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
K 121 CAGCAGCCGCGGTAATACGAAGGGTGCAAGCGTTAATCGGAATTACTGGGCGTAAAGCGC 180
G 185 GCGTAGGTGGTTCAGCAAGTTGGATGTGAAATCCCCGGGCTCAACCTGGGAACTGCATCC 244
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
K 181 GCGTAGGTGGTTCAGCAAGTTGGATGTGAAATCCCCGGGCTCAACCTGGGAACTGCATCC 240
G 245 AAAACTACTGAGCTAGAGTACGGTAGAGGGTGGTGGAATTTCCTGTGTAGCGGTGAAATG 304
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
K 241 AAAACTACTGAGCTAGAGTACGGTAGAGGGTGGTGGAATTTCCTGTGTAGCGGTGAAATG 300
G 305 CGTAGATATAGGAAGGAACACCAGTGGCGAAGGCGACCACCTGGACTGATACTGACACTG 364
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
K 301 CGTAGATATAGGAAGGAACACCAGTGGCGAAGGCGACCACCTGGACTGATACTGACACTG 360
G 365 AGGTGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACG 424
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
K 361 AGGTGCGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACG 420
G 425 ATGTCGACTAGCCGTTGGGATCCTTGAGATCTTAGTGGCGCAGCTAACGCGATAAGTCGA 484
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
K 421 ATGTCGACTAGCCGTTGGGATCCTTGAGATCTTAGTGGCGCAGCTAACGCGATAAGTCGA 480
G 485 CCGCCTGGGGAGTACGGCCGCAAGGTTAAAACTC  518
      ||||   |||||||||||||||||||||||||||
K 481 CCGCNNNGGGAGTACGGCCGCAAGGTTAAAACTC  514
Alignment of sequences from DGGE bands G and K from wound 1a.
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G  1  CGTGCAGGATGACGGCCCTATGGGTTGTAAACTGCTTTTATGCGGGGATAAAGTGCGCGA  60
      ||||||||  ||||||||||||||||||||||||||||||||||||||||||||||||||
E  5  CGTGCAGGNNGACGGCCCTATGGGTTGTAAACTGCTTTTATGCGGGGATAAAGTGCGCGA  64
G  61 CGTGTCGTGCATTGCAGGTACCGCATGAATAAGGACCGGCTAATTCCGTGCCAGCAGCCG 120
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
E  65 CGTGTCGTGCATTGCAGGTACCGCATGAATAAGGACCGGCTAATTCCGTGCCAGCAGCCG 124
G 121 CGGTAATACGGAAGGTCCGGGCGTTATCCGGATTTATTGGGTTTAAAGGGAGCGTAGGCC 180
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
E 125 CGGTAATACGGAAGGTCCGGGCGTTATCCGGATTTATTGGGTTTAAAGGGAGCGTAGGCC 184
G 181 GCCAGGTAAGCGTGTTGTGAAATGTACCGGCTCAACCGGTGAATTGCAGCGCGAACTGTC 40
      || |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
E 185 GCNAGGTAAGCGTGTTGTGAAATGTACCGGCTCAACCGGTGAATTGCAGCGCGAACTGTC 244
G 241 TGGCTTGAGTGCACGGTAAGCAGGCGGAATTCATGGTGTAGCGGTGAAATGCTTAGATAT 00
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
E 245 TGGCTTGAGTGCACGGTAAGCAGGCGGAATTCATGGTGTAGCGGTGAAATGCTTAGATAT 304
G 301 CATGAAGAACTCCGATTGCGAAGGCAGCTTGCTGCAGTGCGACTGACGCTGATGCTCGAA 360
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
E 305 CATGAAGAACTCCGATTGCGAAGGCAGCTTGCTGCAGTGCGACTGACGCTGATGCTCGAA 364
G 361 GGTGCGGGTATCAAACAGGATTAGATACCCTGGTAGTCCGCACGGTAAACGATGGATGCC 420
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
E  65 GGTGCGGGTATCAAACAGGATTAGATACCCTGGTAGTCCGCACGGTAAACGATGGATGCC 424
G 421 CGCTGTCCGCCCCTTTGTGGCGGGTGGCCAAGCGAAAGCGTTAAGCATCCCACCTGGGGA 480
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
E 425 CGCTGTCCGCCCCTTTGTGGCGGGTGGCCAAGCGAAAGCGTTAAGCATCCCACCTGGGGA 484
G 481 GTACGCCGGCAACGGTGAAACTCAA  505
      |||||||||||||||||||||||||
E 485 GTACGCCGGCAACGGTGAAACTCAA  509
Alignment of sequences from DGGE bands G and E from wound 3.
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G  1  CGTGCAGGATGACGGCCCTATGGGTTGTAAACTGCTTTTATGCGGGGATAAAGTGCGCGA  60
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||| ||||
F  12 CGTGCAGGATGACGGCCCTATGGGTTGTAAACTGCTTTTATGCGGGGATAAAGTGTGCGA  71
G  61 CGTGTCGTGCATTGCAGGTACCGCATGAATAAGGACCGGCTAATTCCGTGCCAGCAGCCG 120
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
F  72 CGTGTCGTGCATTGCAGGTACCGCATGAATAAGGACCGGCTAATTCCGTGCCAGCAGCCG  31
G 121 CGGTAATACGGAAGGTCCGGGCGTTATCCGGATTTATTGGGTTTAAAGGGAGCGTAGGCC 180
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
F 132 CGGTAATACGGAAGGTCCGGGCGTTATCCGGATTTATTGGGTTTAAAGGGAGCGTAGGCC 191
G 181 GCCAGGTAAGCGTGTTGTGAAATGTACCGGCTCAACCGGTGAATTGCAGCGCGAACTGTC 240
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
F 192 GCCAGGTAAGCGTGTTGTGAAATGTACCGGCTCAACCGGTGAATTGCAGCGCGAACTGTC 251
G 241 TGGCTTGAGTGCACGGTAAGCAGGCGGAATTCATGGTGTAGCGGTGAAATGCTTAGATAT 300
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
F 252 TGGCTTGAGTGCACGGTAAGCAGGCGGAATTCATGGTGTAGCGGTGAAATGCTTAGATAT 311
G 301 CATGAAGAACTCCGATTGCGAAGGCAGCTTGCTGCAGTGCGACTGACGCTGATGCTCGAA 360
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
F 312 CATGAAGAACTCCGATTGCGAAGGCAGCTTGCTGCAGTGCGACTGACGCTGATGCTCGAA 371
G 361 GGTGCGGGTATCAAACAGGATTAGATACCCTGGTAGTCCGCACGGTAAACGATGGATGCC 20
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
F 372 GGTGCGGGTATCAAACAGGATTAGATACCCTGGTAGTCCGCACGGTAAACGATGGATGCC 431
G 421 CGCTGTCCGCCCCTTTGTGGCGGGTGGCCAAGCGAAAGCGTTAAGCATCCCACCTGGGGA 480
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
F 432 CGCTGTCCGCCCCTTTGTGGCGGGTGGCCAAGCGAAAGCGTTAAGCATCCCACCTGGGGA 491
G 481 GTACGCCGGCAACGGTGAAACTCAAG  506
      ||||||||||||||||||||||||||
F 492 GTACGCCGGCAACGGTGAAACTCAAG  517
Alignment of sequences from DGGE bands G and F from wound 3.
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H  6  CGTGCAGGATGACGGCCCTATGGGTTGTAAACTGCTTTTATGCGGGGATAAAGTGCGCGA  65
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||| ||||
F 12  CGTGCAGGATGACGGCCCTATGGGTTGTAAACTGCTTTTATGCGGGGATAAAGTGTGCGA  71
H  66 CGTGTCGTGCATTGCAGGTACCGCATGAATAAGGACCGGCTAATTCCGTGCCAGCAGCCG  
125
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
F  72 CGTGTCGTGCATTGCAGGTACCGCATGAATAAGGACCGGCTAATTCCGTGCCAGCAGCCG  31
H  26 CGGTAATACGGAAGGTCCGGGCGTTATCCGGATTTATTGGGTTTAAAGGGAGCGTAGGCC 185
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
F 132 CGGTAATACGGAAGGTCCGGGCGTTATCCGGATTTATTGGGTTTAAAGGGAGCGTAGGCC  91
H 186 GCCAGGTAAGCGTGTTGTGAAATGTACCGGCTCAACCGGTGAATTGCAGCGCGAACTGTC 245
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
F 192 GCCAGGTAAGCGTGTTGTGAAATGTACCGGCTCAACCGGTGAATTGCAGCGCGAACTGTC 251
H 246 TGGCTTGAGTGCACGGTAAGCAGGCGGAATTCATGGTGTAGCGGTGAAATGCTTAGATAT 305
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
F 252 TGGCTTGAGTGCACGGTAAGCAGGCGGAATTCATGGTGTAGCGGTGAAATGCTTAGATAT 311
H 306 CATGAAGAACTCCGATTGCGAAGGCAGCTTGCTGCAGTGCGACTGACGCTGATGCTCGAA 365
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
F 312 CATGAAGAACTCCGATTGCGAAGGCAGCTTGCTGCAGTGCGACTGACGCTGATGCTCGAA 371
H 366 GGTGCGGGTATCAAACAGGATTAGATACCCTGGTAGTCCGCACGGTAAACGATGGATGCC 425
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
F 372 GGTGCGGGTATCAAACAGGATTAGATACCCTGGTAGTCCGCACGGTAAACGATGGATGCC 431
H 426 CGCTGTCCGCCCCTTTGTGGCGGGTGGCCAAGCGAAAGCGTTAAGCATCCCACCTGGGGA 485
      ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
F 432 CGCTGTCCGCCCCTTTGTGGCGGGTGGCCAAGCGAAAGCGTTAAGCATCCCACCTGGGGA  91
H 486 GTACGCCGGCAACGGTGAAACTCAA  510
        |||||||||||||||||||||||||
F 492 GTACGCCGGCAACGGTGAAACTCAA  516
Alignment of sequences from DGGE bands H and F from wound 3.
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Appendix 11
Equation to calculate mean % reduction in population growth for MICs:
Mean % reduction = [1-((AT-AT0)/(AG-AG0))]×100
AT = mean absorbance of test wells at the end of incubation
AT0 = mean absorbance of test wells before incubation
AG = mean absorbance of growth wells at the end of incubation
AG0 = mean absorbance of growth wells before incubation
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Appendix 12
Equation to calculate the mean % reduction in live cells in biofilms:
Mean % reduction* = (1-((AT570-(AT600×R0))/(AG570-(AG600×R0))))×100
AT570 = mean absorbance of test wells at 570 nm
AT600 = mean absorbance of test wells at 600 nm
AG570 = mean absorbance of growth wells at 570 nm
AG600 = mean absorbance of growth wells at 600 nm
R0 = AO570/AO600
AO570 = absorbance of oxidised resazurin plus medium at 570 nm minus the 
absorbance of medium only at 570 nm
AO600 = absorbance of oxidised resazurin plus medium at 600 nm minus the 
absorbance of medium only at 600 nm
* reduction in this context refers to the reduction in absorbance as an indirect 
measure of live cell population not to the redox state of resazurin
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